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ABSTRACT OF THE DISSERTATION
THE ROLE OF MARKET KNOWLEDGE IN RECOGNIZING AND EXPLOITING
ENTREPRENEURIAL OPPORTUNITIES IN TECHNOLOGY INTENSIVE FIRMS
by
Anna-Maija Renko
Florida International University, 2008
Miami, Florida
Professor Sumit K. Kundu, Major Professor
Entrepreneurial opportunity recognition is an increasingly prevalent phenomenon. Of
particular interest is the ability of promising technology based ventures to recognize and
exploit opportunities. Recent research drawing on the Austrian economic theory emphasizes
the importance of knowledge, particularly market knowledge, behind opportunity
recognition. While insightful, this research has tended to overlook those interrelationships
that exist between different types of knowledge (technology and market knowledge) as well
as between a firm’s knowledge base and its entrepreneurial orientation. Additional shortfalls
of prior research include the ambiguous definitions provided for entrepreneurial
opportunities, oversight of opportunity exploitation with an extensive focus on opportunity
recognition only, and the lack of quantitative, empirical evidence on entrepreneurial
opportunity recognition.
In this dissertation, these research gaps are addressed by integrating Schumpeterian
opportunity development view with a Kirznerian opportunity discovery theory as well as
insights from literature on entrepreneurial orientation. A sample of 85 new biotechnology
ventures from the United States, Finland, and Sweden was analyzed. While leaders in all 85
companies were interviewed for the research in 2003-2004, 42 firms provided data in 2007.
Data was analyzed using regression analysis.
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The results show the value and importance of early market knowledge and technology
knowledge as well as an entrepreneurial company posture for subsequent opportunity
recognition. The highest numbers of new opportunities are recognized in firms where high
levels of market knowledge are combined with high levels of technology knowledge
(measured with a number of patents). A firm’s entrepreneurial orientation also enhances its
opportunity recognition. Furthermore, the results show that new ventures with more market
knowledge are able to gather more equity investments, license out more technologies, and
achieve higher sales than new ventures with lower levels of market knowledge. Overall, the
findings of this dissertation help further our understanding of the sources of entrepreneurial
opportunities, and should encourage further research in this area.
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I. INTRODUCTION

“But perhaps most importantly, an inquiry into entrepreneurial opportunity has the potential
to unlock one of the greatest intellectual puzzles of our time, namely the creation of new
value in society”.
Sarasvathy, Venkataraman, Dew, & Velamuri (2003)

Background of the research

It is a widely held belief that dynamic high technology industries are composed of
entrepreneurial firms (Maidique and Hayes 1984) and that these markets encourage
entrepreneurial firm-level behavior (Khandwalla 1987; Oakey 2003; Hindle and Yencken
2004). Entrepreneurial opportunity discovery is a necessary step on the path to
commercializing science and technologies (Venkatarman 1997; Shane 2000; Shane and
Venkataraman 2000). Instances of entrepreneurial discovery are social and purposeful
developments of previously nonexistent knowledge. Opportunities are results of
idiosyncratic emergences of knowledge that are inherently novel.

It follows that

entrepreneurial opportunities, as breakouts from the limits of prior knowledge, are
unpredictable (Murphy and Shrader 2004). As statistical predictions are based on reliable
causes that are known, trying to predict entrepreneurial discovery is impossible.
Some researchers argue that the subjective or socially constructed nature of opportunity
makes it impossible to even separate opportunity from the individual; undiscovered
opportunities are impossible to know and impossible to study (Singh 2000). Others contend
that opportunity is an objective construct visible to or created by the knowledgeable
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entrepreneur. Either way, a set of weakly held assumptions about the nature and sources of
entrepreneurial opportunities appear to dominate much of the discussion in the literature
(McMullen, Plummer and Acs 2007). Given this ambiguity, one would initially be
discouraged to study the nature, sources, or social and cognitive processes of entrepreneurial
opportunities. However, entrepreneurial opportunities also present one of the most exciting
topics of research within entrepreneurship. Since researchers have only recently started to
understand the importance of opportunity recognition as a distinctive area of enquiry for
entrepreneurship research, there are numerous contributions yet to be made on the topic.
Although it is hard to get any group of entrepreneurship researchers to agree on a definition
of their field, the key concept of an opportunity that either exists objectively or is perceived
subjectively by the entrepreneur is in the heart of entrepreneurship (Sanders 2007).
The potential sources of entrepreneurial opportunities in the society are almost as
numerous as the opportunities that are recognized. Each entrepreneurial opportunity has its
own story; a distinct narrative that describes how this opportunity came into being. In an
attempt to categorize these potential sources of opportunities, Drucker (1985) suggested the
following twelve sources that may potentially lead to entrepreneurial opportunity
recognition: the unexpected success, the unexpected failure, the unexpected outside event,
inconsistent economic events, inconsistency between reality and our assumption about
reality, inconsistency between our perceptions and actual customer expectations,
inconsistency within the logic of a process, process need, industry and market structures,
demographics, change in perception, and new knowledge. It is clear that it is impossible to
consider all these sources and their sub-groups within one study. This research focuses on
new knowledge as a driver of entrepreneurial opportunities and the resulting economic
growth (Wennekers and Thurik 1999).
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Research gap and questions

This research contributes to the expanding literature on entrepreneurial opportunities. It
has been argued that although the examination of opportunities is a central aspect of
entrepreneurship, it is largely overlooked (Shane and Venkataraman 2000; Ardichvili,
Cardozo and Ray 2003; Shane 2003). Shane and Venkataraman (2000) thus suggest that
future entrepreneurship research should concentrate on three fundamental questions (p. 218):
1) “why, when, and how opportunities for the creation of goods and services come into
existence;
2) why, when, and how some people and not others, discover and exploit these
opportunities and;
3) why, when, and how different modes of action are used to exploit entrepreneurial
opportunities.” (Shane and Venkataraman 2000)
This study directly contributes to answering all of these three categories of questions.
More specifically, the research is based on Austrian economic theories and the work of
Kirzner (1973; 1979; 1997). Following Kirzner, numerous researchers have emphasized the
role of knowledge in entrepreneurial opportunity discovery (Christensen, Madsen and
Peterson 1994; Gaglio 1997; Shane 2000; Gaglio and Katz 2001; Sarasvathy 2001b;
Ardichvili et al. 2003; Eckhardt and Shane 2003; Holcombe 2003; Hills and Singh 2004;
McKelvie and Wiklund 2004; Murphy and Shrader 2004; Lumpkin and Lichtenstein 2005;
Park 2005; Sanz-Velasco 2006; Cohen and Winn 2007; Ozgen and Baron 2007). More
specifically, based on this stream of literature one concludes that there is something magical
about market knowledge and coming up with entrepreneurial opportunities. Idiosyncratic
knowledge of markets and customers makes it possible for some individuals to recognize
entrepreneurial opportunities in conceptual models on opportunity recognition (Gaglio and
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Katz 2001; Ardichvili et al. 2003; Shane 2003; Gaglio 2004), and there is also some
empirical research that supports this claim (Teach, Schwartz and Tarpley 1989; Hills,
Shrader and Lumpkin 1999; Shane 2000; Hills and Singh 2004; McKelvie and Wiklund
2004).
Despite the growing research base, the mechanisms through which different forms of
knowledge contribute to entrepreneurial opportunities are still unclear. Few empirical tests
of entrepreneurial opportunities are reported in the existing literature, not least because of
the difficulties in defining and measuring opportunities. The studies that have tried to
empirically test the role of different types of knowledge in entrepreneurial opportunity
recognition are mostly limited to case evidence (Shane 2000; McKelvie and Wiklund 2004;
Park 2005; Sanz-Velasco 2006) with only a few exceptions of empirical research with
quantitative data (Teach et al. 1989; Singh 2000; Choi and Shepherd 2004; Saemundsson
and Dahlstrand 2005). Still, entrepreneurship researchers agree that entrepreneurial
opportunities and recognizing them is one of those critical areas that distinguishes the study
of entrepreneurship from other business disciplines. Hence, the more comprehensive
assessment of the knowledge behind entrepreneurial opportunities conducted in this research
should advance our understanding of entrepreneurial opportunities in particular and the field
of entrepreneurship in general.
Entrepreneurship researchers that have followed the Austrian economics tradition
essentially argue for a linear relationship between the amount of knowledge the individual
has and the amount of entrepreneurial opportunities recognized by the individual, given the
same level of alertness (Christensen et al. 1994; Gaglio 1997; Shane 2000; Gaglio and Katz
2001; Sarasvathy 2001b; Ardichvili et al. 2003; Eckhardt and Shane 2003; Holcombe 2003;
Hills and Singh 2004; McKelvie and Wiklund 2004; Murphy and Shrader 2004; Lumpkin
and Lichtenstein 2005; Park 2005; Sanz-Velasco 2006; Cohen and Winn 2007; Ozgen and
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Baron 2007). However, elsewhere in the literature researchers have demonstrated that there
are interrelationships between different types of knowledge; possessing one kind of
knowledge may blind sight an entrepreneur or a firm to another type of knowledge. These
interrelationships have best been demonstrated as tradeoffs between technology knowledge
and market knowledge. (Hamel and Prahalad 1991; Leonard-Barton 1995; Christensen and
Bower 1996; Christensen 1997; Leonard-Barton and Rayport 1997; O’Connor 1998;
Takayama and Watanabe 2002; Thieme and Song 2002)
The purpose of this research is to understand the role of market knowledge in
entrepreneurial opportunity recognition in technology intensive firms. In order to achieve
this, the nature of entrepreneurial opportunities - as well as the processes through which they
are discovered and developed - has to be explored. Based on this research, we will have a
better understanding of
1) how opportunities for the creation of goods and services come into existence,
2) why some people, and not others, discover and exploit these opportunities: What is the
role of idiosyncratic market knowledge and new scientific knowledge in the creation and
discovery of technology based entrepreneurial opportunities?
3) how different modes of action are used to exploit entrepreneurial opportunities: How
does market knowledge contribute to the exploitation of technology based entrepreneurial
opportunities?
Following the literature review presented in this paper, specific hypotheses (refutable
assertions) are developed regarding the role of market knowledge in entrepreneurial
opportunity recognition and exploitation. These hypotheses specify three different
mechanisms through which market knowledge influences entrepreneurial opportunity
recognition and exploitation. The mechanisms suggested are (1) the moderating role of
market knowledge (positive or negative, depending on the amount of market knowledge) in
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the relationship between technology knowledge and entrepreneurial opportunities recognized
in a young venture, (2) the direct positive effects of market knowledge on the entrepreneurial
opportunities recognized in a young venture, and (3) the positive moderation of market
knowledge in the relationship between entrepreneurial opportunities recognized in a young
venture and the subsequent profit potential of the venture. The hypotheses are tested in a
dataset from young biotechnology ventures.
In line with Shane and Venkataraman (2000), this study is based on the premise that the
discovery, evaluation, and exploitation of opportunities is a defining feature of the field of
entrepreneurship. Entrepreneurship has also been defined as the creation of new
organizations (Gartner 1989; Thornton 1999; Reynolds 2007). The domain of potential
business opportunities includes those that can lead to new startups (Fiet 2002).

Empirical setting

A wealth of research efforts has been devoted to examining the cognitive characteristics
of individuals that discover entrepreneurial opportunities (Mitchell, Busenitz, Bird, Gaglio,
McMullen, Morse and Smith 2007). Also, researchers have studied the economic nature of
the opportunities themselves, and typically considered them as situations following from
uneven distribution of information in the marketplace (Kirzner 1997). Entrepreneurial
opportunities also have a contextual component to them, even though this aspect has not
received much attention from researchers. For one, even alert individuals only discover
opportunities in industries they are familiar with (Shane 2000). In addition, idiosyncratic
knowledge characterizes especially industries that are dynamic in nature and experience
rapid obsolescence of information and products. In a high growth industry the population
density is low and the carrying capacity of the industry is high (Hannan 1998). There has
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been a disturbing lack of consideration of the industry situation as a basis for modeling
entrepreneurial opportunities and their discovery. As an entrepreneurial opportunity results
from the interaction of a person with his or her environment, an approach sensitive to both
the actor and the industry environment is needed to understand entrepreneurial opportunity
recognition.
This research focuses on technology intensive industries. Technology-intensive industries
are characterized by products that are based on significant amounts of scientific and
technical know-how. Complexity and speed of change are corollaries of know-how intensity,
not foundational concepts of technology intensive markets. (John, Weiss and Dutta 1999)
Biotechnology is an example of a technology intensive sector and also the empirical context
of this research. Biotechnology provides an excellent setting for the examination of the
entrepreneurial opportunity recognition. Roughly speaking, biotechnology is defined as the
application of knowledge of living organisms and their components to industrial products
and processes (Brink, McKelvey and Smith 2004). Out of the different technology categories
underneath the biotechnology “umbrella”, this study focuses on pharmaceuticals,
diagnostics, medicine and the application of biomaterials for medical purposes.
Modern biotechnology is a field characterized by dynamism and rapid obsolescence of
scientific and technological information. Idiosyncratic knowledge among players in the field
of biotechnology should result in plentiful entrepreneurial opportunities, if we follow the
Austrian logic (Hayek 1945; Kirzner 1973; Kirzner 1997; Shane 2003). Two characteristics
are typical of biotechnology products in the categories specific above. First, at the launching
of a project, the product still requires a functional definition. This means that the idea has
been identified, the patent has most likely been filed, but the business opportunity is still
unclear. Second, the development requires a program of scientific research of the main
phenomena associated with the product. This development, including the typical preclinical
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and clinical test phases, is highly regulated by authorities such as the Food and Drug
Administration (FDA). Hence, the “components” of the opportunity discovery and
development process are given; if the idea is to be developed into a commercial product, it
should be patented and has to go through certain phases of testing and development. A
wealth of the research that has tried to encapsulate the peculiarities of entrepreneurial
opportunity recognition has focused on identifying various motivations of or stages in the
opportunity recognition process (Teach et al. 1989; Gaglio and Taub 1992; Krueger 1993;
Bhave 1994; Gaglio 1997; Krueger, Reilly and Carsrud 2000; Gaglio and Katz 2001;
Lumpkin, Hills and Shrader 2004; Lumpkin and Lichtenstein 2005; Park 2005; Mitchell et
al. 2007). If entrepreneurial opportunities are a function of the characteristics of an
entrepreneur, the new venture idea, and the environmental variables as suggested by Singh
(2000), then holding factors in the “environment” constant makes it easier to study the role
of the entrepreneur as well as the venture idea. By focusing on entrepreneurial opportunities
in biotechnology, the main components of the opportunity recognition environment are
given in that the underlying technical knowledge behind the opportunity has to be patented,
and that in order to be commercialized, the opportunity typically has to go through a highly
regulated and standardized development process. Hence, instead of trying to draw
generalizations on the components of opportunity recognition and development process – a
task that has proven to be a challenging and controversial one, not least because of the great
variations in the ways that individuals come up with business opportunities – we can truly
focus on the role of market knowledge in entrepreneurial opportunity recognition and
exploitation.
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Even though individuals initially discover opportunities, they are typically developed in
firms. Recognizing (or discovering) 1 an entrepreneurial opportunity is perceiving a
possibility to introduce innovative (rather than imitative) goods or services to a marketplace
through (a) the founding and formation of a new venture, or (b) the significant improvement
of an existing venture (Singh 2000; Gaglio 2004). Because recognition only entails
perception, it follows that exploitation of an opportunity is a separate activity. The
exploitation of an opportunity refers to those activities committed to (a) the founding and
formation of a new venture, or (b) the significant improvement of an existing venture in
order to introduce innovative (rather than imitative) goods or services to marketplace.
Because undiscovered opportunities are impossible to identify for research purposes, it
follows that the level of analysis in the current study is a firm. Previous attempts to examine
entrepreneurship on the organizational level have been mostly limited to the study of
entrepreneurial orientation / corporate entrepreneurship (Miller and Friesen 1982;
Khandwalla 1987; Covin and Slevin 1991; Zahra 1993) but recently opportunity recognition
has also been increasingly linked to organizational context (Lumpkin and Lichtenstein 2005;
Park 2005; Companys and McMullen 2007). Further, it should be noted that opportunity
recognition is a process and that it can occur both prior to firm founding and after firm
founding throughout the life of the firm (Singh 2000).
By focusing on technology based startups, the research provides important information on
organizations that are considered to be the driving force of knowledge based economy
(Reynolds 2007). A better understanding of opportunity recognition processes used in such
technology sectors has obvious benefits in helping governments develop and refine
appropriate policies and support programs. (Park 2005)

1

A detailed discussion on the different views of opportunity recognition vs. discovery follows in section II of
the dissertation.
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II. LITERATURE REVIEW

Entrepreneurial opportunities defined

Researchers’ interest in economic opportunities cuts across a broad swathe of disciplines
including management, organization theory, marketing, and entrepreneurship (Ardichvili et
al. 2003), and the concept of opportunity is a key concept especially within entrepreneurship
and marketing theory (Blenker, Philipsen and Damgaard 2005). For example, the stylized
fact that the actor that has a superior understanding of what is “knowable” about production
and the market (i.e., superior knowledge schemas) is more likely to spot opportunities
(Dickson 1992) is relevant for entrepreneurship as well as marketing researchers. Economic
opportunities include both the technological opportunities that make the creation of new
goods and services possible, as well as the market opportunities that enable these new goods
and services to be commercialized for wealth creation (Companys and McMullen 2007).
Since entrepreneurial opportunities have been a subject of increasing research interest
one would expect to find clear definitions for the term in the existing literature. How do
entrepreneurial opportunities differ from the rest of the business opportunities, or do they?
Vesper (1993) distinguishes a business opportunity from a new venture opportunity by
saying that a business opportunity is one in which an entrepreneur within an established
business recognizes an opportunity for new profit potential, whereas a new venture
opportunity is one that can only be taken advantage of through the founding of an
independent new venture. Both categories include both incremental and radical
opportunities. Like Vesper, many in the entrepreneurship discipline use the term
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“opportunity” to mean the chance to start a business (Long and McMullan 1984; Hills et al.
1999; De Carolis and Saparito 2006; Mueller 2007), but few researchers are explicit about
the condition that in order for a business opportunity to be entrepreneurial, it needs to be
related to starting up a new business.
Overall, a look at the various definitions offered for the term “entrepreneurial
opportunity” in the new millennium leads to confusion. Researchers have suggested a
myriad of definitions with varying foci (See Table 1). What is more, some researchers study
entrepreneurial opportunities without ever defining the term. For example, a recent article by
Ozgen and Baron (2007) focuses on entrepreneurial opportunity recognition without ever
defining what is being recognized. However, Ozgen and Baron (2007) measure opportunity
recognition on the level of an individual using a three item scale, where the items are as
follows: (1) While going about day-to-day activities, I see potential new venture ideas all
around me, (2) I have a special alertness or sensitivity toward new venture opportunities, (3)
Seeing potential new venture opportunities does not come very naturally to me (reverse
scored). From the way that they operationalize opportunity recognition one can assume that
opportunities are perceived as some things “out there”, which can be recognized by alert
individuals and lead to new venture formation (Ozgen and Baron 2007).
Summarizing the articles in a recent issue of Small Business Economics devoted to
entrepreneurial opportunities, McMullen et al. (2007) point out that most of the articles in
the special issue equated an entrepreneurial opportunity with the generation of new goods or
services. Newness (novelty) also seems to be the common characteristic in a number of
definitions of opportunity provided in Table 1.
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Table 1: Some definitions of entrepreneurial opportunity, 2000-2007

Denrell,
Fang &
Winter
(2003)
Singh
(2000)

Goss (2007)

SanzVelasco
(2006)

Dutta &
Crossan
(2005)

Entrepreneurial
opportunity

Schumpeterian
opportunity

X

A feasible, profit-seeking, potential venture that provides an
innovative new product or service to the market, improves
on an existing product /service, or imitates a profitable
product / service in a less-than-saturated market. (p. 23)
… are disequilibrating, depend upon new
information, are highly innovative, rare, and involve
processes of creation […] to establish new ways of doing
things and turning these into a viable business.

Opportunity

(1) involves a definite offer to the customer, (2) envisages a
definite customer segment, (3) creates definite value, (4) has
a definite revenue model; and (5) is accomplished through
technology.

Entrepreneurial
opportunity

[Entrepreneurial opportunities are] a set of environmental
conditions that lead to the introduction of one or more new
products or services in the marketplace by an entrepreneur or
by an entrepreneurial team through either an existing venture
or a newly created one. (p. 426)
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New venture
creation

X

X

X

X

X

X

X

O

O

Creative

Exists whenever prices fail to reflect the value of a
resource’s best use.

Profit
potential

Strategic
opportunity

Attributes (O=implicit; X=explicit)
Valuable

Actor

Novelty

Definition

Individual

Exact term

Firm

Author(s)

X

X

X

X

X

X

X

X

[Entrepreneurial opportunities are] situations in which new
goods, services, raw materials, markets and organizing
methods can be introduced through the formation of new
means, ends, or means-ends relationships. (p. 336)

Eckhardt &
Shane
(2003)

Entrepreneurial
opportunity

Gaglio
(2004)

Opportunity

The chance to introduce innovative (rather than imitative)
goods, services, or processes to an industry or economic
marketplace. (p. 534)

Sarasvathy,
Venkataram
an, Dew &
Velamuri
(2003)

Entrepreneurial
opportunity

An entrepreneurial opportunity […] consists of a set of ideas,
beliefs and actions that enable the creation of future goods
and services in the absence of current markets for them.
Original definition Venkataraman (1997)

Opportunity 2

Underutilized or unemployed resources, as well as new
capabilities or technologies may offer possibilities to create
and deliver new value for prospective customers, even
though the precise forms that new value will take may be
undefined. (p. 108)

Opportunity

An unexploited project which is perceived by an individual
to afford potential benefit.

X

Entrepreneurial
opportunity

Situations in which new goods, services, raw materials, and
organizing methods can be introduced and sold at greater

X

Ardichvili,
Cardozo &
Ray (2003)
Casson &
Wadeson
(2007)
Shane &
Venkataram
2

X

X

X

X

X

X

X

X

X

X

X
X

X

Ardichvili et al. (2003) do not provide one clear definition for an opportunity. Instead, they reflect multiple perspectives of opportunity that have been
presented in precious research. The sentence provided here as their definition for opportunity best summarizes the essence of what the authors themselves
seem to describe as an opportunity.
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New venture
creation

Creative

Profit
potential

Attributes (O=implicit; X=explicit)
Valuable

Actor

Novelty

Definition

Individual

Exact term

Firm

Author(s)

an (2000)
Companys
&
McMullen
(2007)
Mueller
(2007)
Ozgen &
Baron
(2007)
Wiklund &
Shepherd
(2003)
DeCarolis &
Saparito
(2006)
Cohen &
Winn (2007)

Entrepreneurial
opportunity

than their cost of production. (Original: Casson 1982)
An opportunity to engage in entrepreneurial action, in which
entrepreneurial denotes a sub-class of some broader category
of human action. Because all human action is arguably
motivated by profit (Homans, 1974), the adjective
entrepreneurial is used to qualify the manner by which this
profit is sought – i.e., through the introduction of new goods
or services.

X

X

X

New venture
creation

Creative

Profit
potential

Attributes (O=implicit; X=explicit)
Valuable

Actor

Novelty

Definition

Individual

Exact term

Firm

Author(s)

X

Entrepreneurial
opportunity

Startup activity

O

X

Opportunity

N/A

O

O

Opportunity

N/A, but reference is made to Shane & Venkataraman,
(2000); opportunities to bring into existence future goods
and services.

Entrepreneurial
opportunity

N/A. Imply that entrepreneurial opportunity equals starting
up a new organization.

O

Entrepreneurial
opportunity

N/A

O
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O

X
O

To summarize the definitions of entrepreneurial opportunity in Table 1, out of the 13
definitions provided by various researchers, four state or imply that a firm can be the actor
that discovers or recognizes opportunities. In addition, Wiklund & Shepherd (2003), who do
not provide a clear definition for opportunity, empirically test the following hypothesis on
the firm level: “A bundle of knowledge-based resources applicable to the discovery and
exploitation of opportunities is positively related to firm performance”. This implies that
firm is perceived as capable of discovering and exploiting opportunities. Outside of Table 1,
it should be mentioned that Lumpkin and Lichtenstein (2005) link organizational learning to
opportunity recognition of an organization, and define opportunity recognition as the firm’s
ability to identify a good idea and transform it into a business concept that adds value and
generates revenues (Lumpkin and Lichtenstein 2005). Even though terminology for
organizational learning and organizational resources, for example, has been established in
the literature, organizational opportunity recognition is still almost unheard of 3 . This is most
likely a result of the fact that for many entrepreneurship scholars, the establishment of a new
organization is an essential part of the definition of entrepreneurship (Katz and Gartner
1988).
Out of the 13 researchers who define opportunity (Table 1), ten state or imply that
individuals discover (recognize) opportunities. Regarding the attributes that researchers have
attached to (entrepreneurial) opportunities, novelty is the most common attribute among the
definitions in Table 1; nine out of the seventeen studies listed in the table talk about newness
or novelty. Profit potential and new venture creation are both characteristics of six
conceptualizations out of the total of seventeen presented here. Finally, creativity is an

3

Two exceptions in the recent literature include Rice, Kelley, Peters & O’Connor (2001) who use opportunity
recognition terminology in their study of eight radical innovation projects in six large, multinational, R&D
intensive firms, and Brown, Davidsson & Wiklund (2001) who operationalize opportunity-based firm behavior.
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integrated characteristic of an opportunity in four studies, and three studies attach the
attribute “valuable” to the opportunity concept.
Based on Table 1 one arrives to the same conclusion with McMullen et al. (2007): There
is no consensus on the very nature of entrepreneurial opportunities. McMullen et al. (2007)
summarize the main sources of confusion as follows: (1) the “objectivity” of opportunity, (2)
the perceived importance of one particular individual in determining the direction of the
social world, and (3) what distinguishes the sub-class of “entrepreneurial” opportunity from
the broader category of opportunity in general (McMullen et al. 2007). With regards to this
third source of confusion, it is especially the relationship between innovations and
entrepreneurial opportunities that remains blurred in the existing literature. For example,
Companys & McMullen (2007) review existing literature and summarize the sources of
opportunities into three categories: Economic, cultural cognitive, and sociopolitical (Table
2). Economic opportunities encompass technological and market opportunities resulting
from material innovation, whereas cultural cognitive opportunities consist of cultural
innovations introduced into the marketplace by either producers or consumers. Sociopolitical
opportunities include network opportunities resulting from the structural features of social
networks and political opportunities attributable to changes in the governance structures of
these networks.
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Table 2: Sources and types of entrepreneurial opportunities

Economic

Cultural cognitive

Sociopolitical

Sources

Resources and
capabilities,
information

Templates,
knowledge

Network and
governance
structures

Subtypes

Technological
Market

Producer
Consumer

Network
Political

Examples

Technological:
Product innovation
Factor innovation

Producer:
Cultural
communities
Robust designs

Network:
Knowledge
heterogeneity
Structural holes

Market:
Latent needs
User innovation

Consumer:
Fads
User practices

Political:
Elite cleavages
Deregulation

Source: Companys & McMullen 2007, 308
What is interesting about the Companys & McMullen (2007) discussion of economic
opportunities is that they use the terms innovation and opportunity interchangeably. In
addition,

since

innovation

equals

entrepreneurial

opportunity,

it

follows

that:

“Entrepreneurial opportunities for innovation exist at the individual, firm, and industry
levels” (Companys & McMullen 2007, 319).
Yet another source of confusion in the existing literature seems to prevail around the
profitability requirement that some researchers attach to the opportunity concept. According
to Shane and Venkataraman (2000, 220), entrepreneurial opportunities are defined as “those
situations in which new goods, services, raw materials, and organizing methods can be
introduced and sold at greater than their cost of production” (For original definition, see
Casson 1982). From this it follows that the “better” the entrepreneurial opportunity, the more
substantial its contribution to the firm’s bottom line performance. This definition of
entrepreneurial opportunity has been criticized because the profit potential of an opportunity
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can only be evaluated in retrospect (Singh 2001). Also, opportunities in the Casson (1982)
sense are not discovered until they are being exploited because it is only then that the
entrepreneur knows if new things can be introduced and sold at prices higher than their costs
(McKelvie and Wiklund 2004). In a more recent publication, Shane (2003, 18) redefines an
entrepreneurial opportunity as “a situation in which a person can create a new means-ends
framework for recombining resources that the entrepreneur believes will yield a profit”. It is
worthwhile to note that in this definition, the profit requirement of an opportunity has been
released. Entrepreneurial opportunities are not necessarily profitable and because of this they
should not be thought as Ricardian, Schumpeterian, or other kinds of rents. (Shane 2003) In
line with the definition above, also Sarasvathy, Venkataraman, Dew, & Velamuri (2003)
propose a definition of entrepreneurial opportunities, where the belief in profit is central:
Entrepreneurial opportunity consists of (1) new idea/s or invention/s that may or may not
lead to the achievement of one or more economic ends that become possible through those
ideas or inventions; and (2) beliefs about things favorable to the achievement of those ends
(Sarasvathy et al. 2003).
Based on the research insights presented above it is clear that there is no current
consensus concerning the exact meaning of the entrepreneurial opportunity concept.
However, based on the definitions offered in existing literature we can conclude that some
unifying themes exist; many researchers share the innovation-emphasis evident initially in
the writings of Kirzner (1979) and Schumpeter (1934b) (See also McMullen et al. 2007). To
distinguish from “non-entrepreneurial” opportunities, some researchers have also added the
element of starting a firm. Ultimately, however, the firm is started with the purpose of
introducing a new good or service (McMullen et al. 2007). For the purposes of this study,
entrepreneurial opportunity is defined as the possibility to introduce innovative (rather than
imitative) goods or services to a marketplace through starting a firm or through the
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significant improvement of an existing venture (Inspired especially by the definitions of
Gaglio 2004, 534, Singh 2000, 23, and Mueller 2007, 356).
If this is the definition given to an entrepreneurial opportunity, then the logical next
question is how are these opportunities discovered and turned into real – and sometimes
profitable – products or services in the marketplace? As already mentioned in the
introductory chapter, discovering (or recognizing) an entrepreneurial opportunity is a
process (Shane 2000; Fiet 2002; Shane 2003) in which the perception about the presence of
an opportunity is a driving force. This process of recognizing opportunities is discussed next.

How are entrepreneurial opportunities recognized?

Even if there is no consensus in the research community over what exactly constitutes
entrepreneurial opportunities, it would be hard to find a scholar in economics or
management who would challenge the argument that entrepreneurial opportunities are
important (McMullen et al. 2007). Given the importance of opportunities, the next big
questions are who, when, and how recognizes those opportunities? As expected, there are no
unambiguous answers to these questions either. For one, the philosophical nature of the
opportunity itself (over which there is obviously no agreement in the research community)
has implications on how that very opportunity is recognized. Second, even if we decide on
the nature of the opportunity, establishing boundaries around whatever constitutes
“recognition” is still challenging. Is recognition limited to the kind of “Eureka” experience
described, for example, in Gaglio’s work? Or is opportunity recognition a process that spans
over time, as many would suggest (Shane 2000; Fiet 2002; Shane 2003; Park 2005)? And
how active or passive is the role of an alert entrepreneur in the process that brings
opportunities from the philosophical world of ideas to the everyday world of business?

19

Technology entrepreneurs can use the knowledge accumulated in science as their raw
material for thinking up new products and services. Vision and entrepreneurial talent are
required to formulate commercially viable ideas for products and services from this stock of
fundamental knowledge. Knowledge can be considered an input, together with
entrepreneurial vision and effort, in the generation of potential new products (Sanders 2007)
(p. 349).

Discovery, development, and exploitation

Whether entrepreneurial opportunities are discovered, recognized, or developed is a
matter of debate between entrepreneurship researchers (Alvarez and Barney 2007).
Discovery. Shane (2003, p. 42) stresses that opportunities may exist as objective realities
even though their discovery may require a creative act by the entrepreneur. A shortcoming of
the conceptualization of opportunity discovery in Austrian economics (Hayek 1945; Kirzner
1979, 1997; Denrell et al. 2003) – the tradition followed by Shane - is the prevailing view of
opportunity discovery as a discrete event. Many of the examples given concerning a
discovery of an opportunity for profit deal with simple arbitrage gains, presented as discrete
events (Sanz-Velasco and Magnusson 2003). While the Austrian perspective may be radical
and challenging within the discourse on economics, it does not take into account the
development efforts that an entrepreneur makes to create value over and beyond arbitrage in
an uncertain setting.
Development. According to Ardichvili, Cardozo, & Ray (2003), while elements of
opportunities may be “out there” waiting to be recognized, opportunities are first and
foremost made, not found. Careful investigation of and sensitivity to market needs as well as
an ability to spot suboptimal deployment of resources may help an entrepreneur to develop
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an opportunity. This development may or may not result in the formation of a business.
Either way, the role of an entrepreneur or a team is not a passive one; opportunity
development also involves entrepreneurs’ creative work. (Ardichvili et al. 2003)
A consensus regarding the discovery vs. development arguments can be found in the
work of Sarasvathy et al. (2003), who distinguish between three types of entrepreneurial
opportunity. Each type of opportunity is related to a distinct view of market coordination in
economics (Buenstorf 2007) (See Table 3). Opportunity recognition is linked to the tradition
of neoclassical economics in that recognition of opportunities is sufficient if both demand
and supply factors “exist rather obviously” (Sarasvathy et al. 2003). In this case, the
entrepreneurial venture exploits already existing markets with already existing technologies.
Arbitrage and franchising are given as examples of these kinds of opportunities. If either
demand or supply factors are absent in the market prior to the entrepreneurial activity, then
this activity is characterized as opportunity discovery (Sarasvathy et al. 2003). Opportunities
may also be actively created by the entrepreneur herself. According to Sarasvathy et al.
(2003), this happens when neither demand nor supply exists prior to the entrepreneurial
venture, and both sides of the market have to be created.
It is worthwhile to note that the Companys & McMullen (2007) description of the sources
of economic opportunity described earlier is similar to the conceptualization of
entrepreneurial opportunities in the intersection of technology supply and market demand
(Sarasvathy et al. 2003).
If novelty is an essential characteristic of an entrepreneurial opportunity as suggested
based on the summary of Table 1, then one can argue that arbitrage opportunities (allocative
view) are not inherently entrepreneurial. They are, indeed, economic opportunities, but not
entrepreneurial opportunities since they are based on existing knowledge in the existing
markets.
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Table 3: Comparing the three views of entrepreneurial opportunity

Method

Domain of application

Allocative view

Discovery view

Creative view

Opportunities

Opportunities

Opportunities

“recognized” through

“discovered” through

“created” through

deductive processes

inductive processes

abductive processes

When both supply and

Only one or the other

When both supply and

demand are known

(supply or demand)

demand are unknown

known
Focus

Focus on system

Focus on process

Focus on decisions

Assumptions about

Complete information

Complete information at

Only partial

information

available at both

the aggregate level, but

information even at

aggregate and individual

distributed imperfectly

the aggregate level,

levels

among individual agents

and ignorance is key
to opportunity creation

Source: Sarasvathy et al. 2003.
Many biotechnological inventions as well as the inventions studied by Christensen and
Bower (1996) and Christensen (1997) help to solve user problems for which only limited or
no solutions have been available in the past. Hence, we come to the domain of the
“discovery view” (Sarasvathy et al. 2003) in that either supply or demand is unknown. For
example, at the outset many medical biotechnology inventions can be applied for the
development of cures and / or diagnostics for a variety of medical conditions (Renko 2006a).
Once these technologies are patented, their areas of commercial application are defined.
After this, the creativity in the opportunity process has to be directed towards developing
demand (customers) rather than supply (technology). Essentially, entrepreneurial
opportunities can be discovered based on a technological innovation (Schumpeter 1934b;
Drucker 1985), in which case the supply of technology is known and demand is unknown
(Sarasvathy et al. 2003) and / or they can be discovered because different market participants
have unequal access to information about the market conditions (customers, markets, and
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ways to serve markets) (Kirzner 1973; Shane 2000, 2003), in which case the demand in the
market is known to some, but the supply has to be developed.
These two sides of opportunity recognition process are illustrated in Figure 1, which has
been adapted from Blenker et al. (2005) and Sarasvathy et al. (2003).

Demand is given.
Supply must
be adjusted
or created. (E.g.
Christensen & Bower
1996; Christensen
1997; Takayama &
Watanabe 2002)

Both supply
and demand
must be
simultaneously
created

Supply is given.
Demand must
be adjusted
or created.
(E.g. Shane 2000)

Development or
creation

Discovery

Discovery

Schumpeterian opportunities
Kirznerian opportunities

Figure 1: Supply, demand, and the nature of entrepreneurial opportunities.
Even though Sarasvathy et al. (2003) suggest a specific meaning for the term
“opportunity recognition” that distinguishes it from opportunity development/creation and
discovery, most entrepreneurship researchers have used the term opportunity recognition as
a rather general word pair, often synonymous to discovery or creation. In the context of the
current research, recognizing an entrepreneurial opportunity is perceiving a possibility to
introduce innovative (rather than imitative) goods or services to a marketplace through (a)
the founding and formation of a new venture, or (b) the significant improvement of an
existing venture (Singh 2000; Gaglio 2004). Because recognition only entails perception, it
follows that exploitation of an opportunity is a separate activity (Choi and Shepherd 2004).
Inspired by March (1991), Choi and Shepherd (2004, 377) define opportunity exploitation as

23

“those activities and investments committed to gain returns from the new product arising
from the opportunity through the building of efficient business systems for full-scale
operations”. In the context of this research, the exploitation of an opportunity refers to those
activities committed to (a) the founding and formation of a new venture, or (b) the
significant improvement of an existing venture in order to introduce innovative (rather than
imitative) goods or services to marketplace.
Whether conceptualized as discovery or development, opportunity recognition (OpR) is
one of the central areas of entrepreneurial research (Teach et al. 1989; Gaglio and Taub
1992; Bhave 1994; Gaglio 1997; Kirzner 1997; Shane 2000; Shane and Venkataraman 2000;
Gaglio and Katz 2001; Hills and Singh 2004; Pech and Cameron 2006; Alvarez and Barney
2007; Shepherd, McMullen and Jennings 2007). In general, two approaches to the study of
entrepreneurial opportunity recognition can be identified in existing literature. First, there are
those researchers that have studied the “black box” of opportunity recognition. Most of these
studies have adopted a cognitive approach in order to understand “How do entrepreneurs
think, reason, and behave such that they create value and wealth through the identification
and implementation of market opportunities?” (Mitchell et al. 2007). Still, other researchers
have tried to divide the “black box” of entrepreneurial opportunity recognition into
components that describe the overall process. Second, there are those studies that have,
instead of cognitive aspects or components, focused on the inputs that go to the opportunity
recognition process.
In the following, literature on the cognitive approach is summarized first, after which
some key typologies of the opportunity recognition process are described. However, neither
the cognitive approach nor the modeling approach to opportunity recognition really helps in
answering the research questions that were presented above. Even though these parts of the
literature review set the scene for understanding entrepreneurial opportunity recognition,
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neither approach informs us about the mechanisms through which different forms of
knowledge contribute to entrepreneurial opportunities. Hence, a major part of the literature
review that follows is devoted to describing research on the sources of entrepreneurial
opportunities, that is, the knowledge inputs that go into the opportunity recognition process.
This literature is directly related to the research questions of this study. However, let us first
take a look at those streams of literature that view opportunity recognition from a cognitive
perspective.

Cognitive approach

Mitchell et al. (2007) identify four different categories in which research on
entrepreneurial cognition has contributed to the understanding of identification and
implementation of opportunities: (1) The use of heuristic-based logic; (2) perceptual
processes/entrepreneurial alertness; (3) the entrepreneurial information processing-based
expertise approach; and (4) the effectuation approach.
The heuristic-based logic approach argues that individuals and situations do vary in the
extent to which these decision shortcuts - called heuristics - are used. Furthermore,
entrepreneurial decision making is thought to be at least partially subjective and based on
informal processes and experience (Busenitz and Barney 1997). Based on this logic, one
would suggest that entrepreneurs may regularly find themselves in situations that tend to
maximize the potential impact of a more heuristic-based logic (Alvarez and Busenitz 2001).
Situations like this include complex entrepreneurial decisions. The decisions that lead to the
recognition of innovative opportunities may require significant leaps in thinking, leading to
innovative ideas that are not always very linear and factually based. A heuristic-based logic
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often enables entrepreneurs to make sense of uncertain and complex situations more quickly
and, relative to more orthodox approaches to decision making, perhaps expedite opportunity
recognition (Baron 2007; Mitchell et al. 2007).
Perceptual processes and entrepreneurial alertness have had a growing presence in
entrepreneurship research in the last decade. Perceiving and interpreting information, and
reaching some unique conclusions about entrepreneurial opportunities, seem to involve some
unique mental processes (Mitchell et al. 2007). Gaglio & Katz (2001) argue that
entrepreneurial alertness is very plausible, testable, and relevant as a model of the cognitive
dynamics driving the opportunity-identification process. Krueger (1993) suggests that
entrepreneurial intentions should derive from feasibility and desirability perceptions of an
individual, plus a propensity to act on opportunities. He finds empirical support for a link
between positive prior entrepreneurship-related experiences and perceived feasibility of
entrepreneurship. Intentions-based models are also tested by Krueger, Reilly & Carsrud
(2000). Mitchell et al. (2007) summarize that some frameworks involving alertness and
perceived connections hold much potential for understanding the discovery of new
opportunities.
Entrepreneurial expertise approach suggests that expert information processing theory can
explain why some (i.e. experienced entrepreneurs) can use information significantly better
than nonexperts / nonentrepreneurs to come up with business opportunities. (Busenitz and
Lau 1996; Mitchell, Smith, Seawright and Morse 2000). Finally, Sarasvathy’s (2001b)
“effectuation” approach suggests that thinking and action proceed together in an attempt to
create one of several possible outcomes. Effectuation assumes that entrepreneurs can utilize
the means at their disposal to influence their future without having to predict it (Sarasvathy
2001b). From an opportunity recognition perspective, this approach suggests that
entrepreneurs make decisions not based on definite goals they set based on analyzing
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markets as given, but rather based on the means they have available for their use. They play
by ear and adapt their decisions based on feedback from customers and other stakeholders.
An important factor in decision making is risk and / or uncertainty. Entrepreneurs, according
to Sarasvathy, can tolerate high levels of uncertainty.

Stage approach

Researchers have tried to understand the entrepreneurial opportunity recognition process
by dividing it into various stages or components. Some key contributions in this area are
described in the following. It should be noted that most of these typologies assume that the
creation of a new organization as a central action of the opportunity recognition process.
As Gaglio & Taub (1992) point out, most researchers describe opportunity recognition as
a linear process. For example, Long & McMullan’s (1984) creative structuring process
includes four conceptual elements that may relate to the pursuit of new business
opportunities: Pre-vision, Point of Vision, Opportunity Elaboration, and Decision to
Proceed. The findings from Manion, Hills, Lumpkin, & Shrader (2000) do provide partial
support for this four-stage model that is useful in understanding the opportunity recognition
process. Gaglio & Taub (1992) summarize existing literature on the typical opportunity
recognition process as having four major steps: (1) the Pre-recognition Stew, (2) the Eureka!
Experience, (3) the Development of the Idea, and (4) the Decision to Proceed. However, like
many other researchers that have studied entrepreneurial opportunities, Gaglio and Taub
(1992) do not explicitly define what entrepreneurial opportunities are. One can assume that
the forth stage, “Decision to Proceed”, refers to establishing a new venture. Still, without a
more specific alignment of the domain of these opportunities, it could also be interpreted as
a decision to proceed with a business idea within an existing organization or even, as
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referred to in the research paper, painters’ definitions of their artistic opportunities and the
pursuit of these opportunities (Gaglio and Taub 1992). Gaglio & Taub (1992) categorization
reflects OpR as a cognitive process. Gaglio’s work has since progressed towards a more
comprehensive model of OpR (Figure 2) (Gaglio 2004) (p. 536).

Knowledge
about status
quo
- industry,
market,
society
rules of the
game
- how
things can
be related
- causal
chains
- existing
means-end
framework

Things
appear to
be usual,
expected
Market
situation
or event

Ignore
Something
unusual,
unexpected
or
anomalous

Alertness chronic schema
What’s really going on
here?
- veridical perception
- veridical interpretation

Discount

How does
it affect
industry,
market,
society, etc.

Maintain
status quo
or existing
means-end
framework
Allocate
resources
using MiniMax rule

Break
status quo
or existing
means-end
framework

Continue
as is

Imitative
opportunities

Incremental
opportunities

Innovative
opportunities

Figure 2: Alertness and the opportunity identification process

The “opportunity outcomes” on the right hand side of the Figure 2 above (Gaglio, 2004)
have striking similarities with the mainstream innovation research. The distinction between
refining and improving an existing design and introducing a new concept that departs in a
significant way from past practice is a central theme in the existing literature on technical
innovation (Freeman 1982; Clark and Henderson 1990). Incremental innovation draws from
no dramatically new science and introduces relatively minor changes to the existing products
(Tushman and Anderson 1986; Clark and Henderson 1990). Radical innovation, in contrast,
is based on new scientific / technological knowledge and often opens up whole new markets,
creates industries, and gives rise to potential novel, improved applications (Clark and
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Henderson 1990). Within innovation literature, especially radical innovations have been
proposed to create great difficulties for established firms (Tushman and Anderson 1986) and
can be the basis for the successful entry of new firms.
Even though the process of opportunity recognition shares many similarities with
innovation processes, the two streams of literature have developed rather independently of
each other. For example, Gaglio (2004) does not refer to any research results regarding
innovations and innovation processes outside of entrepreneurship literature. Overall,
entrepreneurship researchers seldom make use of the technology and innovation
management literature, and vice versa. To some extent, this is probably due to the different
levels of analysis in the two research streams; innovations have typically been studied within
the context of established organizations, whereas individuals and new firm formation have
been in the heart of entrepreneurship research (Lumpkin and Lichtenstein 2005). However,
because of the similarity of the two constructs, entrepreneurial opportunities and
innovations, there are certainly opportunities for cross-fertilization between the two literature
streams that have – so far – gone unnoticed by researchers.
Similarities between opportunity recognition processes and innovation processes can be
illustrated, for example, by analyzing the results of the Minnesota Innovation Research
Program. In a structured attempt to understand innovation processes in existing
organizations, the Minnesota Innovation Studies provide a valid framework for
understanding innovation. As a part of the research undertaking, developmental phases in
innovation process models were summarized and compared (Schroeder, Ven, Scudder and
Polley 2000). These process models have, by and large, three phases: The Beginning,
Activity phases, and the End (Schroeder et al. 2000). Schroeder et al. (2000, 109-112)
provide an extensive list of various (early) innovation process models, and many of the
models have apparent similarities with the entrepreneurial opportunity recognition models

29

(Long and McMullan 1984; Gaglio and Taub 1992; Gaglio 2004) or the “core process” of
opportunity identification and development (Ardichvili et al. 2003). For example, the early
innovation process model by Usher has the following stages: (1) Perception of the problem:
Recognition of partial or incomplete need satisfaction; (2) Setting the stage: Elements
necessary for the solution are brought together; (3) Act of insight: Essential solution is
found; (4) Critical revision: New relations become understood and worked into context
(Usher 1954). These stages are very similar to the stages in many of the linear opportunity
recognition models.
As illustrated by the definitions of “opportunity” in Table 1, by the similarities between
OpR and innovation process models described above (See also economic opportunities of
Companys & McMullen, 2007), as well as by the opportunity “outcomes” of Gaglio (2004)
(Figure 2), there is significant overlap between the two constructs of entrepreneurial
opportunity and innovation. This conceptual ambiguity is seldom discussed by authors on
either topic, but it does not come as a surprise; Schumpeter wrote about new combinations
and innovations, and it was only later that his writings were “translated” into opportunity
recognition terminology (Buenstorf 2007).
Even though this research is based on entrepreneurship literature and aims to contribute to
the understanding of opportunity recognition in technology intensive environments, it is
important to reflect on the research findings also in the light of innovation literature. This
will be achieved by the use of theoretical triangulation when the results of the empirical
research will be discussed. Triangulation refers to the establishment of validity of
propositions by using a variety of methods (Webb, Campbell, Schwartz and Sechrest 1966).
The four types of triangulation include data triangulation, investigator triangulation, theory
triangulation, and methodological triangulation (Denzin 1978). Theory triangulation refers to
the use of more than one theoretical position in interpreting data. The value of theoretical
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triangulation is that it avoids conducting research in a vacuum, in the absence of some
relevant theoretical perspective. Theory triangulation is most appropriate for the analysis of
areas characterized by high theoretical incoherence (Denzin 1978). Entrepreneurial
opportunity recognition is, indeed, an area where coherence is yet to be achieved, as
illustrated by the wealth of even somewhat contradictory definitions regarding the nature of
these opportunities (See Table 1). Hence, theory triangulation in the form of reflecting
research results not only in the light of entrepreneurship literature but also through insights
from technology & innovation management literature should strengthen the new knowledge
that is to be created in this research.
The opportunity recognition (and innovation) processes described above are linear. A
non-linear – and maybe more comprehensive - categorization is suggested by Ardichvili et
al. (2003), who divide the major factors that influence the process of opportunity recognition
and development into five categories: (1) entrepreneurial alertness; (2) information
asymmetry and prior knowledge; (3) social networks; (4) personality traits, including
optimism, self-efficacy, and creativity; and (5) the type of opportunity itself. This
categorization includes the components that need to be present simultaneously for
opportunity recognition to take place. Even if the whole model proposed by Ardichvili et al.
(2003) is not necessarily linear, their core process has linear elements: Opportunity
development process includes recognition of an opportunity, its evaluation, and
development. An entrepreneur is likely to conduct evaluations several times at different
stages of development, and these evaluations could lead to recognition of additional
opportunities or to adjustments to the initial idea. The “core process” only starts if the
entrepreneur has an above-threshold level of entrepreneurial alertness (Ardichvili et al.
2003).
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In a study of software firms, Teach, Schwartz, & Tarpley (1989) identify four clusters of
entrepreneurs with different OpR processes. The first cluster, the Searchers, did their
homework as part of a deliberate search for opportunities. The second cluster, the Pin
Stripes, were committed to planning and evaluation processes. The third cluster, the
Innocents, developed their software on their own time, outside of their regular work hours.
Finally, the Blue Jeans, envisioned OpR as an accidental process and avoided any type of
formal planning and evaluation.
Basing his ideas on the work of Cyert & March (1963), Bhave (1994) defined two types
of OpR: the externally stimulated OpR, where the decision to start a venture precedes OpR
(i.e., entrepreneurs search for ideas, filter opportunities, develop them, and engage in
elaboration of ideas) and internally stimulated OpR, where entrepreneurs first discover
customer needs or identify problems that need solving and only then decide to create a
venture and become an entrepreneur. These two categories emerged from an exploratory
research: Using an open-ended interview technique, Bhave surveyed 27 New York City
firms in an effort to better understand the venture creation process. These categories
(although under different titles) have subsequently been employed in the empirical data
collection for the Global Entrepreneurship Monitor as well as for the Panel Study of
Entrepreneurial Dynamics.
The linear opportunity recognition model of Christensen, Madsen, & Peterson (1994)
highlights the importance of desirability and feasibility as antecedents to the identification of
the opportunity. The feasibility emphasis is also apparent in the work of Krueger (1993;
2000), as described above. However, unlike Krueger, Christensen, Madsen, and Peterson
(1994) specify individual resources that lead to opportunity recognition. These resources are
separated into four categories, which are both within and outside the control of the
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entrepreneur. Entrepreneurs can control the Firm Specific Factors, Management Behavior,
and Strategic Thinking, while Environmental Factors lie outside their control.
Dorf and Byers (2005) identify the following six stages of acting as a technology
entrepreneur: 1) identifying the opportunity; 2) determining the entrepreneur’s capabilities
and interests; 3) evaluating the opportunity; 4) deciding to act on the opportunity or look
elsewhere; 5) writing a summary of the concept; and 6) testing the summary and the concept
with potential customers and investors. They also distinguish between an opportunity pull
and a capability push (i.e., an opportunity that flows from a capability or resource
availability). In the context of technology based organizations, the terms “market pull” and
“science push” are also used. Science push results from research and scientific discovery in,
for example, physics, medicine, chemistry and biology. New entrepreneurial opportunities
can arise from science push, “hunting” for use as a potential solution to a problem. In the
terminology of Sarasvathy et al. (2003) presented earlier, these kinds of opportunities are
discovered because the supply becomes known, but the demand in the marketplace remains
unknown. Cohen and Levinthal (1989) suggest that in order for a firm to be able to exploit
external technological knowledge, it needs to have the internal skills to understand this
knowledge and its potential uses. This ability to exploit knowledge from external sources is
called absorptive capacity. At the other end of the innovation continuum are markets that
‘pull’ discovery by demanding solutions to specific problems. Optimally, innovation
processes in a technology based firm combine both the market pull and science push to end
up with successful solutions for markets (Rice et al. 2001; Renko, Carsrud, Brannback and
Jalkanen 2005). In the following, these two inputs to the entrepreneurial opportunity
recognition process in technology based fields are discussed separately. First, technology
knowledge is discussed as a critical component in opportunity recognition. After this, the
attention moves to market knowledge.
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Knowledge and opportunity recognition

Chance favors the prepared mind.

- Louis Pasteur

A common theme in much research on opportunity recognition has been the suggestion
that information plays a crucial role in the OpR process. Many different perspectives and
theories converge on the view that in order to identify opportunities, entrepreneurs must
somehow gather, interpret, and apply information about specific industries, technologies,
markets, government policies, and other factors (Ardichvili et al. 2003; Shane 2003; Ozgen
and Baron 2007). Baron (2004), for example, combines the informational approach with a
cognitive approach to OpR in suggesting that opportunity recognition involves cognitive
structures possessed by specific persons–frameworks for organizing and interpreting
information developed through life experience. Cognitive frameworks help individuals to
“connect the dots” between seemingly independent pieces of information, and the patterns
they then perceive in the information may constitute the basis for identifying specific
business opportunities. These assumptions have gained empirical support in the research by
Ozgen and Baron (2007).
At extremes, the opportunities that stem from predominantly technological knowledge
(science push) versus those that are based on idiosyncratic information about customers,
markets, and ways to serve markets (market pull) have very different characteristics. In line
with Shane (2003), we call the “science push” opportunities Schumpeterian and the “market
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pull” opportunities Kirznerian. To contrast the two categories, Table 4 has been borrowed
from Shane (2003) 4 (p. 21).

Table 4: Schumpeterian and Kirznerian opportunities

Schumpeterian vs. Kirznerian Opportunities
Schumpeterian opportunities

Kirznerian opportunities

Disequilibrating
Requires new information
Very innovative
Rare
Involves creation

Equilibrating
Does not require new information
Less innovative
Common
Limited to discovery

Essentially, Kirzner (1973) and Schumpeter (1934b) disagreed over whether the existence
of entrepreneurial opportunities involves the introduction of new information or just
differential access to existing information (Shane 2003). Kirzner’s (1973; 1997) view is that
the existence of opportunities only requires differential access to existing information.
People use the idiosyncratic information that they have to form beliefs about the efficient use
of resources – owned or controlled. Because people’s decision making frameworks are not
always accurate, they make errors (Gaglio and Katz 2001), which, in turn, create
opportunities for others to access and recombine resources in a way that creates
entrepreneurial rents (Alvarez and Busenitz 2001; Alvarez and Barney 2004). Schumpeter’s
(1934a) contrasting view is that new information is important in explaining the existence of
entrepreneurial opportunities. Changes in technology, political forces, regulation, macroeconomic factors and social trends create new information that entrepreneurs use to

4

Some other authors essentially talk about the same division between Kirznerian and Schumpeterian
opportunities when they use the terms opportunity discovery vs. opportunity creation (e.g. Alvarez & Barney
2007; Baron 2007; Miller 2007).
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recombine resources in a more productive manner. In technology intensive markets,
especially the changes in existing technology base can result in the kind of new information
that, in Schumpeter’s view, leads to entrepreneurial opportunity recognition.
A clear-cut distinction between opportunities that are based on new versus existing
information is, in reality, hard to establish. In a review of Shane’s interpretation of
Schumpeterian and Kirznerian opportunities, Buenstorf (2007) arrives at a conclusion that
all opportunities must be created by new knowledge. The crucial difference between
opportunities for arbitrage (Kirznerian) and opportunities for innovation (Schumpeterian) is
the extent to which the existence of an opportunity is signaled by the price system, i.e.
whether or not the new knowledge exists in the market or only outside of markets (Buenstorf
2007). This condition, again, would not in reality distinguish Schumpeterian new knowledge
from Kirznerian new knowledge. Schumpeterian new knowledge is characterized as
something revolutionizing, “new-to-the-world”. By definition, this new knowledge cannot
be accounted for by the price mechanism until the knowledge is disseminated among actors
in the marketplace. The knowledge will not be learned simultaneously by all actors, which
creates the situation of idiosyncratic knowledge in the market. This is characterized as
information asymmetry in the marketplace, and the neoclassical market (price) mechanism
cannot account for information asymmetry (perfect information is assumed instead). So the
conclusion is that neither Schumpeterian new information (new-to-the-world) nor Kirznerian
new information (idiosyncratic in nature) is signaled by the price system.

Technology knowledge

Before technological change leads to new products or markets, entrepreneurs have to
discover the technological opportunities and exploit the new technology. Schumpeter’s
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(1934a, 1934b) approach to entrepreneurship has deeply influenced the history of economic
thought, and is still a major influence. (Blaug 2000; Swedberg 2000) After Schumpeter
(1934b) drew attention to the central role of entrepreneur in the innovation process,
technology entrepreneurship research has emphasized the roles of entrepreneurs in the
process of bringing technologies to markets (Roberts 1991; Klofsten 1997; Kelley and Rice
2001).
Schumpeter does not explicitly feature the opportunity concept. Instead, his point of
departure is the notion of innovation characterized as a new combination. The entrepreneur
is an individual who creates a new combination and pursues it in the market. This happens
possibly - but not necessarily – through forming a new firm. (Dutta and Crossan 2005;
Buenstorf 2007). Schumpeter’s new combinations (opportunities) are discontinuous by
nature (p. 51):
”To produce means to combine materials and forces within our reach. To produce
other things, or the same things by a different method, means to combine these
materials and forces differently. In so far as the ‘new combination’ may in time grow
out of the old by continuous adjustment in small steps, there is certainly change,
possibly growth, but neither a new phenomenon nor development in our sense. In so
far as this is not the case, and the new combinations appear discontinuously, then the
phenomenon characterising development emerges”. (Schumpeter 1934a)
As is illustrated by the focus on new combinations, the central message in Schumpeter’s
writings about entrepreneurship concerns the concept of novelty. Schumpeter repeatedly
pointed that while ordinary economic behavior is more or less automatic in nature, the
entrepreneur always has to think very carefully about what action to take since she is
involved in doing something that is fundamentally new (Swedberg 2000; Dutta and Crossan
2005). Schumpeter’s entrepreneurs utilize novel information on, for example, technology
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and science to figure out how to recombine resources in a more productive way (Shane
2003). Schumpeter’s approach differs from the Kirznerian tradition (to be introduced in
detail in the next section) in that opportunities are not pre-supposed for entrepreneurial
activity to occur, but are created by the innovative entrepreneur herself (Sarasvathy et al.
2003; Buenstorf 2007).
Underutilized or unemployed resources, as well as new capabilities or technologies may
offer possibilities to create and deliver new value for prospective customers, even though the
precise products and services to be offered may be undefined. For example, it took years to
understand and prove the positive effects of penicillin in treating infections in humans, even
though the discovery of penicillin by the Scottish scientist Alexander Fleming happened in
1928. Actually, Fleming was initially convinced that penicillin could not last long enough in
the human body to kill pathogenic bacteria. Not only was the inventor unconvinced, but the
general public could not even dream about the effects of penicillin, even less was there any
kind of “market pull” for this new medicine. .
As the market need for a technology- or science based discovery becomes more precisely
defined in terms of customer benefits and resources become more precisely defined in terms
of potential uses, the opportunity progresses from its elemental form and a business concept
begins to emerge. This concept contains the core notions of how the market need might be
served and the resources deployed. (Ardichvili et al. 2003)
Shane (2003) lists some empirical evidence that demonstrates the relationship between
sources of Schumpeterian opportunities (introduction of new information) and the existence
of those opportunities. Bhide (2000) explained that about half of the founders of fast
growing private companies (from the Inc 500 list) in the US that he interviewed indicated
that they initiated their businesses in response to a change in technology, regulation, or some
other external factor. Blau (1987) found that an increase in the rate of technological change
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led to an increase in the self employment rate in the US. Shane (2001) examined inventions
patented by the Massachusetts Institute of Technology between 1980 and 1996, and found
that more heavily cited patents (a proxy for more new information) were more likely to lead
to firm formation (proxy for entrepreneurial opportunities) than less heavily cited patents.
Figure 3 below summarizes and simplifies the core message of this part of the paper into
a drawing. Entrepreneurial opportunities (or new combinations, as Schumpeter called them)
stem from new knowledge. This new knowledge often comes in the form of new
technologies or new scientific advances. The entrepreneur is an individual who creates an
opportunity (a new combination) and pursues it in the market. This happens possibly - but
not necessarily – through forming a new firm. (Buenstorf 2007). If we think of
Schumpeterian new knowledge as something new to everyone in the marketplace, then the
patent system would help in identifying these new pieces of technological knowledge.

Technology knowledge

Entrepreneur’s
creativity

Entrepreneurial
opportunity
recognized

Figure 3: Technology knowledge as a source of entrepreneurial opportunities

As illustrated by Figure 3, according to the Schumpeterian tradition, opportunities are
recognized as a result of the creativity of an entrepreneur. This assumption of the central role
of creativity contrasts the Kirznerian tradition, which will be discussed in the next section.

Market knowledge

“Some would-be entrepreneurs have a new technology and often mistake it for a solution.
Customers want a solution to their problem and usually do not care what technology is

39

employed. Unfortunately, some believe that entrepreneurship is having a great technological
idea. Entrepreneurship is really about creating a new business that solves a problem.” (Dorf
and Byers, 2005, 25)
More than the other two major schools of thought in entrepreneurship, namely
neoclassical equilibrium theories and psychological theories, Austrian theories emphasize
the role of individuals’ information in seeing entrepreneurial opportunities (Hayek 1945).
Psychological theories propose that entrepreneurship is a function of stable characteristics
possessed by some individuals (McClelland 1961; Begley and Boyd 1987) and neoclassical
economists (Khilstrom and Laffont 1979) have proposed equilibrium theories of
entrepreneurship. Austrian economists believe that a viable theory of market system – and
entrepreneurship – cannot assume equilibrium but must explain how a market achieves
equilibrium starting from disequilibrium initial conditions (Kirzner 1997; Shane 2000).
Disequilibrium enables entrepreneurs to discover market imbalances that offer ways to earn
economic rents provided that entrepreneurs can protect their discoveries from imitation by
others (Fiet 2002). In Austrian economists’ view, existing idiosyncratic information and
knowledge provides the basis for entrepreneurial opportunities.
Austrian economists (Hayek 1945; Kirzner 1997) believe that the possession of
information that is appropriate to a particular opportunity leads to discovering this
opportunity 5 ; people and firms recognize those opportunities related to information that they
already possess (Denrell et al. 2003). Fiet (2002) sees an entrepreneur as a person that is an
investor in specific information. From this, Fiet’s (2002) focus moves on to an attempt to
uncover how entrepreneurs can most efficiently invest in the acquisitions of signals – like
market signals - to uncover valuable venture ideas.
5

Note that the terms like opportunity identification or opportunity discovery, widely used within the Kirznerian
tradition, involve passive search or accidental discovery. The fundamental assumption is that opportunities
exist by themselves in the environment and can be discovered. Also, it is impossible for actors to actively
search for opportunities that cannot be clearly defined ex ante.

40

Shane (2000) finds that three major dimensions of prior knowledge are important to the
process of entrepreneurial discovery in high technology context: prior knowledge of
markets, prior knowledge of ways to serve markets, and prior knowledge of customer
problems. New information about a technology may be complementary with an individual’s
prior information about how particular markets operate; the discovery of an entrepreneurial
opportunity related to a specific technology requires prior information about markets. This
information may be achieved e.g. through previous work in a certain organizational unit
(Aldrich and Wiedenmayer 1993; Shane 2000). Shane’s (2000) in-depth case studies of eight
entrepreneurs / entrepreneurial teams show that in every case, prior knowledge led
entrepreneurs to see the usefulness of a technology 6 in solving different customer problems.
Similar paths were also found in the study of Sarasvathy (2001a). McKelvie & Wiklund
(2004) employ a case study approach to demonstrate that while prior knowledge may be of
great importance, constantly gaining new market knowledge and adapting strategies
according to this new knowledge is essential to the successful discovery and exploitation of
opportunities. Hence, even though their cases demonstrate the importance of idiosyncratic
(market) knowledge, the findings also challenge the Kirznerian assumption that
entrepreneurs

passively

discover

opportunities

and

then

exploit

them.

Instead,

entrepreneurial opportunity discovery and exploitation are closely entwined and exploitation
influences discovery just as discovery influences exploitation (McKelvie and Wiklund
2004). The positive effects of market knowledge in discovering and evaluating opportunities
are, according to McKelvie & Wiklund (2004) due to: a) awareness of customer problems as
sources of potential opportunities; b) the ease of determining the market value of new
technological discoveries or other market changes; and c) increased communicability of tacit
knowledge of new technology between user and end-customer.
6

Three-dimensional printing technology developed at MIT.
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Finally, empirical evidence for the importance of idiosyncratic knowledge in OpR also
comes from the Panel Study of Entrepreneurial Dynamics dataset: In PSED, industry- and
market experience were a source of opportunity for 56 per cent of nascent entrepreneurs
(Hills, Singh, Lumpkin and Baltrušaitytė 2004).
Even though entrepreneurs in the Kirznerian tradition do not deliberately search for
opportunities, they can still be alert to the potential discovery of such opportunities. Kirzner
(1979) defines entrepreneurial alertness as the “ability to notice, without search,
opportunities that have hitherto been overlooked” (Kirzner, 1979: 48). Higher alertness
increases the likelihood of an opportunity being recognized (Gaglio and Katz 2001).
Lumpkin, Hills, and Shrader (2001) maintain that Austrian economics approach is restricted
to exploring Kirzner’s concept of alertness. The Austrian view provides a very limited view
of how opportunity recognition actually happens because it suggests that when market
changes create economic disequilibria, opportunities appear ‘fully formed,’ in essence, and
waiting to be noticed (Lumpkin et al. 2001).
Figure 4 below summarizes the core of Kirznerian opportunity discovery into a simple
model. Entrepreneurial opportunities stem from knowledge that is unevenly distributed
among market participants. Alert individuals are able to discover these knowledge gaps in
the marketplace and exploit them to create economic rents.

Idiosyncratic knowledge
of customer problems,
markets, and ways to
serve markets

Entrepreneur’s
alertness

Entrepreneurial
opportunity
discovered

Figure 4: Market knowledge as a source of entrepreneurial opportunities
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It is clear by now that the Schumpeterian and Kirznerian views of opportunity recognition
are based on different assumptions about the very ontological nature of these opportunities.
In terms of the fundamental “What is?” question, the Kirznerian answer is “exists out there”
and the Schumpeterian answer is in the lines of “created from within”. In the first
perspective the opportunity is out there in the world (markets) - but separated from the
entrepreneur / firm – because he, due to his idiosyncratic knowledge or his particular
constellation of human capital, has no access to the relevant information. In the second
perspective the opportunity is within the entrepreneur (or the firm), who is gifted with a
special ability to perform a conceptual extension. However, the opportunity is separated
from the world - until the entrepreneur transcends the distinction. (Blenker et al. 2005)
Despite these profound differences, other researchers have interpreted the Kirznerian and
Schumpeterian opportunity recognition propositions as complementary rather than
competing. Blaug (2000) actually states that:
“There is a subtle change of emphasis in Kirzner’s discussion of entrepreneurship
from that of Schumpeter’s: Schumpeter always portrayed the entrepreneurinnovator as a disequilibrating force disturbing the previous equilibrium, whereas
Kirzner […] depicts him as seizing upon a disequilibrium situation and working to
restore equilibrium” (p. 84).
Even this subtle difference can, according to Blaug (2000), be mostly accounted for by
the general changes in the state of contemporary economic theory between 1911 (when
Schumpeter first outlined his ideas) and 1973 the publication of Kirzner’s work). The
complementarity of the Schumpeterian and Kirznerian approaches is obvious when we
consider the realities of opportunity recognition in practice, discussed in the following.
Some individuals or organizations are so sensitive to market needs or problems that they
perceive possibilities for new products continuously in any environment. This sensitivity (or
alertness, see e.g. Gaglio & Katz 2001) to problems or possibilities does not necessarily
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extend to generation of ideas for solutions to the problems; not everyone who is good at
asking questions is equally adept at creating answers. Other individuals or organizations may
be particularly sensitive to identifying un- or underemployed resources, such as unused land,
idle production facilities, or unexploited technology or inventions. Having identified such
resources, however, these individuals or firms may not be able to define particular uses or
users for which the resources could create value. Inventors or scientists may generate ideas
for new products and services without regard to the commercial viability of these inventions.
(Ardichvili et al. 2003)
Even though practical examples illustrate that both Schumpeterian and Kirznerian
opportunity recognition are needed (Ardichvili et al. 2003) and even though it has been
stated that the two approaches are only minimally different (Blaug 2000), the reader may
still be skeptical about the combination of Schumpeterian and Kirznerian opportunity
recognition in one model since the economic assumptions (equilibrium vs. disequilibrium) of
the two approaches are at odds (Blaug 2000; Shane 2003). The argument that equilibrium
and disequilibrium cannot simultaneously exist in the marketplace is, without a doubt, a
reasonable one. However, if we add a temporal aspect to our opportunity recognition process
an argument can be made that disequilibrating and equilibrating forces can co-exist in the
same model. This argument is addressed in more detail in the following section of the paper.

Market knowledge, new scientific knowledge and entrepreneurial opportunities

The first research question presented in the beginning of the paper concerns the creation
as well as discovery of entrepreneurial opportunities: What is the role of idiosyncratic
market knowledge and new scientific knowledge in the creation and discovery of technology
based entrepreneurial opportunities? Before moving to the development of a model and
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hypotheses for empirical testing, the arguments made above concerning the idiosyncratic
market knowledge (Kirznerian) and “new combinations” (Schumpeterian) behind new
opportunities is summarized.
Both Schumpeterian and Kirznerian knowledge create entrepreneurial opportunities.
Temporally, however, Schumpeterian opportunities are created prior to Kirznerian
opportunities. First, we can have a technological change which leads to other changes that
alter the value of resources, thus upsetting the equilibrium price for resources. Consider the
invention of polymerase chain reaction (PCR), a biochemistry and molecular biology
technique for enzymatically replicating DNA. PCR created the opportunity to manufacture
and sell DNA based products (e.g. for the detection of hereditary diseases, the identification
of genetic fingerprints, the diagnosis of infectious diseases, and the cloning of genes) in a
scale that was unheard of before. The knowledge of this Schumpeterian opportunity
suggested that the resources used for PCR were mis-priced and could be profitably
recombined into a new form. Hence, the market for resources had moved from an
equilibrium to a state of disequilibrium. This disequilibrium, again, created opportunities
that were of a Kirznerian type. This illustrates how instances of equilibrium and
disequilibrium can exist in the same opportunity creation process (See Figure 5).

Equilibrium market

Technological
change alters the
value of resources

Disequilibrium

Idiosyncratic
information about
the markets creates
Kirznerian
opportunities

Figure 5: Equilibrium, disequilibrium, and entrepreneurial opportunities in time
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Even if the market eventually learns from the entrepreneur, it is the diffusion of that
knowledge and the resulting responses that create much of the disequilibrium (Dickson
1992). The creative forces of entrepreneurs disequilibrate markets whenever they introduce
radical new knowledge to the marketplace. When opportunities arise as a result of the
innovative activity of the potential entrepreneur, the innovator is initially the only one who is
in a position to observe the existence of the opportunity. The introduction of the new
innovation to the marketplace gives rise to disequilibrium, and the new disequilibrium state
gives rise to opportunity discovery by those who are alert and have access to the radical new
knowledge before the rest of the market. Hence, we arrive at a conclusion similar to that of
Holcombe (2003); entrepreneurship creates opportunity for more entrepreneurship, which
leads to economic progress.
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III. MODELS AND HYPOTHESES

Previous pages have outlined two major sources of entrepreneurial opportunities:
Technology knowledge and market knowledge. Few empirical tests of entrepreneurial
opportunities are reported in the existing literature, not least because of the difficulties in
defining and measuring opportunities. Even though we are seeing more conceptual
(theoretical) models that aid in understanding, for example, the cognitive processes of
entrepreneurs (Gaglio and Katz 2001; Ardichvili et al. 2003; Gaglio 2004; Lumpkin and
Lichtenstein 2005; Cohen and Winn 2007), empirical tests of those models are scarce. Even
more so, the studies that have tried to empirically test the role of different types of
knowledge in entrepreneurial opportunity recognition are mostly limited to case evidence
(Shane 2000; McKelvie and Wiklund 2004; Park 2005; Sanz-Velasco 2006) with only a few
exceptions of empirical research with quantitative data (Teach et al. 1989; Choi and
Shepherd 2004; Saemundsson and Dahlstrand 2005). Still, entrepreneurship researchers
agree that entrepreneurial opportunities and recognizing them as one of those critical areas
that distinguishes the study of entrepreneurship from other business disciplines. Hence, the
more comprehensive assessment of the knowledge behind entrepreneurial opportunities
conducted in this research should advance our understanding of entrepreneurial opportunities
in particular and the field of entrepreneurship in general.
Entrepreneurship researchers that have followed the Austrian economics tradition
essentially argue for a linear relationship between the amount of knowledge the individual
has and the amount of entrepreneurial opportunities recognized by the individual, given the
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same level of alertness. Each person’s idiosyncratic prior knowledge creates a “knowledge
corridor” that allows him/her to recognize certain opportunities.
However, elsewhere in the literature researchers have demonstrated that there are
interrelationships between different types of knowledge; possessing one kind of knowledge
may blind sight an entrepreneur or a firm to another type of knowledge. These
interrelationships have best been demonstrated as tradeoffs between technology knowledge
and market knowledge.
In the following, hypotheses are developed regarding the role of market knowledge in
entrepreneurial opportunity recognition and exploitation in a technology intensive
environment. Building on previous literature, these hypotheses specify three different
mechanisms through which market knowledge influences entrepreneurial opportunity
recognition and exploitation. The mechanisms suggested are (1) the moderating role of
market knowledge (positive or negative, depending on the amount of market knowledge) in
the relationship between technology knowledge and entrepreneurial opportunities recognized
in a young venture, (2) the direct effects of market knowledge on the entrepreneurial
opportunities recognized in a young venture, and (3) the positive moderation of market
knowledge in the relationship between entrepreneurial opportunities recognized in a young
venture and the subsequent profit potential of the venture.
Even though individuals initially discover opportunities, they are typically developed in
firms. Recognizing an entrepreneurial opportunity is perceiving a possibility to introduce
innovative (rather than imitative) goods or services to a marketplace through (a) the
founding and formation of a new venture, or (b) the significant improvement of an existing
venture (Gaglio, 2004; Singh, 2000). Because recognition only entails perception, it follows
that exploitation of an opportunity is a separate activity. The exploitation of an opportunity
refers to those activities committed to (a) the founding and formation of a new venture, or
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(b) the significant improvement of an existing venture in order to introduce innovative
(rather than imitative) goods or services to marketplace.
Because undiscovered opportunities are impossible to identify for research purposes, it
follows that we have to look inside existing firms to find opportunities that have been
recognized and are being exploited. This is also the most likely reason for the trend that
recently opportunity recognition has been increasingly linked to organizational context
(Companys & McMullen, 2007; Lumpkin et al., 2005; Park, 2005). Opportunity recognition
is a process (Shane 2000; Fiet 2002; Shane 2003; Park 2005) that can occur both prior to
firm founding and after firm founding throughout the life of the firm (Singh, 2000).

Market knowledge as a moderator between technology knowledge and entrepreneurial
opportunities

As was demonstrated earlier, previous research has established a relationship between
new scientific and technology knowledge and entrepreneurial opportunity recognition (See
Figure 3). Based on the literature summarized in section II, the first hypothesis is as follows:

Hypothesis 1: If all other factors are constant, the greater the degree of technology
knowledge in a new venture the larger the number of entrepreneurial opportunities that will
be recognized.

However, understanding technology and science is not enough for entrepreneurial
opportunity recognition; in order for entrepreneurs to recognize business opportunities they
need to understand markets and customers in addition to technology (Shane 2003). Market
knowledge also contributes to exploitation of opportunities; Saemundsson and Dahlstrand
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(2005) find that firms seeking to exploit opportunities based on new technical knowledge
and existing market knowledge attain substantial growth.
Even though there are few empirical studies that have investigated the market knowledge
- business opportunity link in the entrepreneurship domain, extant research in new product
development (NPD) supports the claim that NPD projects, which rely on carefully defined
customer needs, are more likely to succeed than those that are “only” based on new
technological opportunities (Holt, Geschka and Peterlongo 1984; Cooper 1993). From
marketing research we know that new product opportunities are recognized by firms who
stay close to their customers and markets (Athuene-Gima 1995, 1996; Hurley and Hult
1998). The question then arises, if new opportunities are recognized based on
Schumpeterian, new technology knowledge, what is the role of idiosyncratic market
knowledge in this opportunity recognition process?
When dealing with radically new technology knowledge and developing radically new
products, conventional market knowledge is often of limited utility; many firms do not
incorporate users’ or customers’ opinions in their NPD processes because of the customers’
limited domains of expertise, their inability to articulate their underlying needs, and the
belief that user-developed concepts tend not to be innovative or creative (Leonard-Barton
1995; Leonard-Barton and Rayport 1997; Adams, Day and Dougherty 1998; O’Connor
1998). For example, Im & Workman (2004) found that understanding customers influences
new product novelty significantly but negatively. From their study, it appears that knowing
more about customers is not helpful when it comes to creating truly innovative, novel
products (entrepreneurial opportunities) because customers may not approve novel product
ideas due to their inertia towards existing products in the market.
In their sample of 239 radical innovation projects Thieme and Song (2002) found that
under conditions of increasing market turbulence, the impact of market intelligence
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gathering activities is negatively related to performance in the early stages of the product
development and commercialization process, but steadily progresses towards a positive
relationship as the project advances. When translated into the language of entrepreneurial
opportunity recognition, this finding would suggest that there may be a negative relationship
between market knowledge and recognizing entrepreneurial opportunities, but a positive one
between market knowledge and exploiting those opportunities that have already been
recognized. (Thieme and Song 2002) These results provide evidence that for a successful
completion of the opportunity development process, both the Schumpeterian (science push)
and Kirznerian (market pull) effects have to be in place. However, there is a tradeoff
between the two types of knowledge in that idiosyncratic knowledge about current markets
and customers is “impeding the search for unconventional business opportunities” (Hamel
and Prahalad 1991). Customer and market knowledge is probably pivotal in recognizing
opportunities for arbitrage (Sanz-Velasco and Magnusson 2003; Sarasvathy et al. 2003), but
the creativity that drives radical, Schumpeterian opportunities cannot be achieved through
adapting the majority view (Nemeth 1997).
Christensen and Bower (1996) provide evidence from the computer disk drive industry in
support of their claim that the power of dominant customers contributes to the failure of
leading firms. These firms devote so much attention to customers in high margin segments
that they miss out on technologies that emerge in low margin, niche markets that ultimately
supplant earlier technology. Christensen (1997) subsequently examined a variety of
industries and identified the same pattern. Takayama and Watanabe (2002) conclude that in
the pharmaceutical context, technology knowledge promotes new product development. In
contrast, market knowledge sometimes inhibits this process. In the case of totally new
products, Schumpeterian-style disruptive innovations, successful development is not derived
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from market knowledge creation but is initiated by technology knowledge while “freezing”
market knowledge (Takayama and Watanabe 2002).
Obviously, the simple “more knowledge – more opportunities recognized” kind of
thinking that is currently prevalent in studies of entrepreneurial opportunities seems naïve in
the light of the above-presented research insights from related fields. The mechanisms
through which entrepreneurial opportunities are recognized vary from a discovery of an
arbitrage to the creation of a radical opportunity, and the knowledge foundations of the
different OpR mechanisms are different. Building on the relationship suggested in
hypothesis one for technology intensive new ventures, the next hypotheses propose that
market knowledge moderates the positive relationship between technology knowledge and
entrepreneurial opportunities. However, this moderation is more complex than what is
suggested by the existing research based on Austrian economics. More specifically, in an
organizational context where the level of market knowledge is very low or very high,
technology knowledge is likely to give rise to fewer new entrepreneurial opportunities than
in an organizational context where the amount of market knowledge is moderate. This
follows from the literature review presented above which suggests that the favorable
conditions for radical, technology based opportunities are neither characterized by very
detailed understanding of current markets nor by a total lack of market knowledge.

Hypothesis 1a: If all other factors are constant, when a new venture has a moderate level
of market knowledge, there will be a strong positive relationship between the level of
technological knowledge in the new venture and the recognition of entrepreneurial
opportunities.
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Hypothesis 1b: If all other factors are constant, when a new venture has a low level of
market knowledge, there will be a weak positive relationship between the level of
technological knowledge in the new venture and the recognition of entrepreneurial
opportunities.

Hypothesis 1c: If all other factors are constant, when a new venture has a high level of
market knowledge, there will be a weak positive relationship between the level of
technological knowledge in the new venture and the recognition of entrepreneurial
opportunities.

The direct effect of market knowledge on entrepreneurial opportunities

Even if the most radical new opportunities in technology intensive fields are based on
technological and scientific advances, it does not mean that entrepreneurial opportunities
cannot be discovered based on idiosyncratic market knowledge as outlined in the section II
and summarized in Figure 4 above.
Even if the relationship between market knowledge and entrepreneurial opportunities is
hypothesized to have an inverted U-shape when technology knowledge is the basis of those
opportunities (Hypotheses 1a – 1c), there are also other kinds of opportunities (arbitrage)
that are not based on new technological knowledge. These entrepreneurial opportunities
stem from knowledge that is unevenly distributed among market participants. Alert
individuals are able to discover these knowledge gaps in the marketplace and exploit them to
create economic rents. It should also be noted that the established view within marketing is
that market knowledge affects performance through innovativeness, customer loyalty and
quality (Kirca, Jayachandran and Bearden 2005). As far as innovativeness is a construct
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similar to entrepreneurial opportunities, this stylized fact together with insights from
Austrian economics suggests the following:

Hypothesis 2: If all other factors are constant, the greater the degree of market knowledge
in a new venture the greater the recognition of entrepreneurial opportunities.

According to the existing research on entrepreneurial cognition and the work of Kirzner
(1979), entrepreneurs have to be alert to the potential discovery of opportunities (Gaglio and
Katz 2001; Lumpkin et al. 2001; Baron 2004; Gaglio 2004; Lumpkin et al. 2004). Kirzner
(1979) defines entrepreneurial alertness as the “ability to notice, without search,
opportunities that have hitherto been overlooked” (Kirzner, 1979: 48). Consequently, the
initial empirical investigations of alertness focused on the means by which an individual
might literally “notice without search.” (Gaglio and Katz 2001).
The concept of “corporate entrepreneurship” or “intrapreneurship” has been used in
literature to refer to entrepreneurial attitudes and behaviors within existing organizations. In
general, being intrapreneurial is predicted to have a beneficial effect on revitalization and
performance of firms (Schollhammer 1982; Burgelman 1983). When assessing
entrepreneurship at the organizational level, researchers have typically used measures such
as the firm entrepreneurial orientation or posture (Covin and Slevin 1988, 1989, 1991),
which basically suggest that an entrepreneurial organization, regardless of its size, is exhibits
innovative, proactive, and risk-taking behaviors.
Miller (1983) describes entrepreneurial orientation as one that emphasizes aggressive
innovation, risky projects and a proclivity to pioneer innovations that pre-empt competition.
Covin and Slevin (1989) have developed a scale for the measurement of the three
components of entrepreneurial orientation, namely innovativeness, proactiveness and risk
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taking. Innovativeness reflects a tendency to support new ideas, novelty and creative
processes, thereby departing from established practices and technologies. Proactiveness
refers to a posture of anticipating and acting on future wants and needs in the marketplace,
and risk taking is associated with a willingness to commit large amounts of resources to
projects where the likelihood and cost of failure may be high (Wiklund and Shepherd 2003).
Empirical studies have found that those businesses that adopt a more entrepreneurial
strategic orientation perform better (Zahra 1991; Zahra and Covin 1995; Wiklund 1999;
Wiklund and Shepherd 2005).
Since market knowledge has been suggested to sometimes even inhibit radical
innovativeness (Leonard-Barton 1995; Christensen and Bower 1996; Christensen 1997;
Leonard-Barton and Rayport 1997; O’Connor 1998) it is likely that the relationship outlined
in Hypothesis 2 is moderated by a construct that allows potential entrepreneurs to “think
outside of the box”. In the research on entrepreneurial cognition, this construct has been
alertness, as described above. In the current context, where the opportunities that we observe
are found within organizations, entrepreneurial orientation is suggested to be the moderator.

Hypothesis 2a: If all other factors are constant, when a new venture has a higher level of
entrepreneurial orientation, the relationship between the degree of market knowledge and the
recognition of entrepreneurial opportunities will be enhanced.

Figure 6 illustrates the hypotheses presented above in the form of an a priori model. Both
new technological knowledge (Schumpeterian) and existing market knowledge (Kirznerian)
are essential parts of the proposed opportunity recognition model. In addition to the
constructs incorporated in the model, it should be noted that time (noted with a “t” in the
model) is an essential element. Since especially those opportunities that are based on

55

technological knowledge typically take time to develop, there needs to be a time lag between
the measurement of the knowledge variables and entrepreneurial orientation as predictors on
one hand (t1), and recognized opportunities as a dependent variable on the other hand (t2).

Technology
knowledge (t1)

+ (H1)

Entrepreneurial
opportunities
recognized (t2)

+ (H1a)
- (H1b-c)
+ (H2a) Entrepreneurial
orientation (t1)

Market
knowledge (t1)
+ (H2)

Figure 6: The direct and moderating effects of market knowledge on entrepreneurial
opportunity recognition. Ex ante model.

Opportunities and new venture success

Once opportunities have been recognized, they also need to be exploited for rent
appropriation. As mentioned above in section II, profit potential is an integrated element in
many of the definitions of entrepreneurial opportunity. For example, the Shane and
Venkataraman (2000, 220) definition of entrepreneurial opportunity essentially means that
the “better” the entrepreneurial opportunity, the more substantial its contribution to the
firm’s bottom line performance. Later, both Shane (2003, 18) as well as Sarasvathy et al.
(2003) have proposed definitions of entrepreneurial opportunities, where the belief in profit
is central. This belief in profit is also evident in the concept of entrepreneurial opportunity as
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defined by Singh (2000), Goss (2007), Sanz-Velasco (2006) and Companys & McMullen
(2007).
The profit potential of an opportunity can only be determined in retrospect (Singh 2001).
It is only when the opportunity is being exploited that the entrepreneur knows if the “new
combination” can be introduced and sold at a price higher than the costs (McKelvie and
Wiklund 2004). Because undiscovered opportunities are impossible to identify for research
purposes, it follows that we have to look inside existing firms to find opportunities that have
been recognized and are being exploited. If entrepreneurial opportunities are at least believed
to result in a profit at the outset, it should follow that recognizing more of those
opportunities would have positive economical consequences. Hypothesis 3 follows:

Hypothesis 3: If all other factors are constant, the greater the number of entrepreneurial
opportunities recognized in a new venture the greater the subsequent profit potential.

In the empirical context of biotechnology (especially medical biotechnology), it can take
companies up to fifteen years to progress form the discovery of a new product candidate to
the profitable launch of the product in the marketplace. Consequently, rather than
introducing profitability of the product or the firm as a dependent variable in Hypothesis 3,
the dependent variable is profit potential. Even though more subjective than a pure profit
measure, profit potential can be assessed after a shorter period of time than what it would
take to measure the realized profits from entrepreneurial opportunities. For example,
successful out-licensing of a product candidate from a new venture to a large pharmaceutical
company signals future profit potential of this very product. Also, continuous investments
from venture capitalists in the new venture tell about those external equity investors’ belief
in future profit potential of the venture and its products.
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According to Penrose (1959), firm growth in any single time period is made possible by
opportunities identified by the firms’ entrepreneurs. In order to accomplish growth, the
firms’ managers need to be willing to act upon these opportunities and to obtain the
necessary resources to exploit the plans. Even though the focus of Penrose’s writings is firm
growth, her predictions about the positive consequences of opportunities are in line with the
more recent opportunity literature and Hypothesis 3 presented above.
Market knowledge is one of those necessary resources needed for exploitation of
entrepreneurial opportunities (Chrisman and McMullan 2000). Unlike for established
products, entrepreneurs exploiting new products are likely to face considerable demand
uncertainty (Knight 1921). A repeated finding from research in the field of marketing is that
market knowledge contributes to the success of new products or services in the marketplace.
For example, Veldhuizen, Hultink, & Griffin (2004) find that the acquisition of customer
information in a high-technology context is directly associated with product advantage in the
marketplace. More often, however, it has been argued that market information has to be
disseminated and used within an organization for it to have positive effects on firm
performance (Narver and Slater 1990; Jaworski and Kohli 1993; Baker and Sinkula 1999;
Matsuno and Mentzer 2000; Harris 2001).
Matsuno, Mentzer & Ozsomer (2002) hypothesize that the positive performance impact
of market intelligence generation, dissemination and responsiveness hinges on the firm’s
level of entrepreneurial proclivity (entrepreneurial orientation). They argue that a business
can achieve market orientation’s full performance impact only if the market orientation is
driven by an entrepreneurial spirit and appropriate organizational structures, processes and
incentives. Within a sample of US-based manufacturing companies, Matsuno et al. (2002)
find support for their hypothesis that entrepreneurial proclivity is an antecedent to business
performance, and this effect is mediated by market orientation of the firm.
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Based on data collected from 55 incubator based high technology ventures in the US,
Choi & Shepherd (2004) found that entrepreneurs were more likely to exploit opportunities
when they perceived more knowledge of customer demand for the product. They use
elements of the resource-based view to gain a deeper understanding of entrepreneurs’
decisions to exploit opportunities based upon perceptions of the attributes of the new
products and perceptions on the resources and capabilities required for full-scale operations.
In addition to knowing customer demand, other perceptions that positively influenced
entrepreneur’s decision to exploit opportunities were perceptions of more fully developed
enabling technologies, greater managerial capability, and greater stakeholder support (Choi
and Shepherd 2004).
Based on the existing research findings summarized above, hypothesis 3a follows:

Hypothesis 3a: If all other factors are constant, when a new venture has a high level of
market knowledge the relationship between recognition of entrepreneurial opportunities and
subsequent profit potential will be enhanced.

The relationships proposed in Hypotheses 3 & 3a are illustrated in Figure 7 below. Again,
in addition to the constructs incorporated in the model, time (noted with a “t” in the model)
is an essential element. The positive performance outcomes from entrepreneurial
opportunities take time to develop, so there needs to be a time lag between the measurement
of the recognized opportunities as a predictor and market knowledge as a moderator on one
hand (t1), and profit potenail as a dependent variable on the other hand (t2).
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Entrepreneurial
opportunities
recognized (t1)

+ (H3)

Profit potential (t2)

+ (H3a)
Market
knowledge (t1)

Figure 7: The moderating effect of market knowledge on the relationship between
entrepreneurial opportunities and profit potential. Ex ante model.

In some cases, for example, when a new biotechnology-based product addresses a
completely unmet medical need, no market knowledge may be available but the product may
still become a blockbuster in the marketplace. Hence, the proposed relationship between
product innovations and their market performance is moderated (and not mediated, see e.g.
Matsuno et al. 2002) by market knowledge. However, in a typical case, market knowledge
about an existing market would be available, and this market knowledge should be a strong
moderator of the opportunity – performance relationship.
The following section describes the empirical study completed to test the hypotheses.
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IV. EMPIRICAL STUDY

As illustrated by the literature review, entrepreneurial opportunities that have been
recognized by entrepreneurs are typically developed and exploited within firms. Since
unrecognized opportunities are impossible to identify for research purposes, it follows that
an empirical research on entrepreneurial opportunities has to look into opportunities within a
firm context. Hence, the level of analysis in the current empirical study is a firm.
Based on existing literature (Singh 2000; Gaglio 2004), the definition established for
entrepreneurial opportunity recognition in this research is as follows: Recognizing an
entrepreneurial opportunity is perceiving a possibility to introduce innovative (rather than
imitative) goods or services to a marketplace through (a) the founding and formation of a
new venture, or (b) the significant improvement of an existing venture. In addition, the
literature review demonstrated how a bulk of research on entrepreneurial opportunities treats
opportunity recognition as a process (linear or non-linear). What is more, previous
researchers either explicitly state that profit potential is an integrated characteristic of an
entrepreneurial opportunity, or they implicitly assume that this is the case by studying
opportunities exploited in the form of new business enterprises.
To make the theoretical opportunity concept empirically testable, it is suggested that new
product development process is an example of an entrepreneurial opportunity when:
(1) It is based on new knowledge (not incremental/ continuous innovations),
(2) A new venture is founded to conduct new product development, or the new product
development leads to the significant improvement of an existing venture, and
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(3) It aims at eventually creating a profit (not a necessary outcome but goal).
As mentioned in the introductory part of the paper, the empirical setting of this research is
the global biotechnology industry. More specifically, the focus is on young, new ventures
that have been established to exploit scientific advances in the fields of pharmaceuticals,
diagnostics, medicine and the application of biomaterials for medical purposes.
In order for a product in these fields to be launched in the marketplace, it has to go
through a regulated process of development that typically spans over multiple years (Renko
2006a). Most product opportunities developed in new biotechnology ventures are based on
patented intellectual property, that is, new scientific knowledge. What is more, introducing
incremental innovations to the biotechnology marketplace is typically the domain of
existing, large companies that can fund the continuous product development with sales
income. New ventures in the field of biotechnology are heavily dependent on external equity
financing. These funding sources, typically venture capitalists and business angels, want to
see a potential return on investment in the category of hundreds of percents once the product
reaches the market. Incremental improvements on existing products cannot deliver these
kinds of returns, which means that the products developed in new biotechnology ventures
most likely have to be radical in nature and based on new knowledge (See condition 1
above).
The empirical scope of this research is limited to the ventures that have been founded to
conduct new product development in order to exploit an entrepreneurial opportunity (See
condition 2 above). What is more, the empirical analysis is limited to business organizations,
that is, for-profit ventures (See condition 3 above). Many initial scientific advances in the
field of biotechnology are developed and even exploited within non-profit organizations,
especially university laboratories. However, because profit potential has been established as
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one of the key characteristics of entrepreneurial opportunities in past research, this study
only focuses on commercial new ventures.
Data collection for this research has taken place in two phases (See Figure 8). The first
phase of data collection (in-person interviews) happened between October 2003 and June
2004 (t1). The second phase (mail questionnaire) took place in May – October 2007 (t2).
The development timescales in the field of biotechnology are long. For example, the journey
of a pharmaceutical product from initial discovery of an active compound to the launch of a
drug typically takes 12 to 15 years (Rothaermel and Deeds 2004). In this light, the time lag
of approximately 3.5 years between the first data collection (1) and the second round of data
collection from the same companies (t2) seems justifiable. The different phases of data
collection are illustrated below in Figure 8.
Biotechnology was chosen as the empirical field for this research since, like mentioned in
the introduction, the lengthy and highly regulated R&D processes make it easier to separate
the sources of entrepreneurial opportunities throughout the opportunity recognition process.
Also, biotechnology is a growing field of industrial activity, and the growth companies in
this sector represent firms that are of interest for governments and politicians because of
their high earning potential. The global nature of the biotechnology business and, especially,
the international scope of biotechnology markets – be it global markets for medicines or the
licensing markets for inventions – make it feasible to assume that despite location,
opportunity recognition manifests in the same ways in R&D-intensive biotechnology SMEs.
Having said that, there are national differences on the supply side of biotechnology. The role
of the public sector in supplying the soft infrastructure of innovation support for enterprises
is not uniform from country to country, continent to continent. Critics say that the public
sector is the source of Europe’s innovation gap with the United States because reliance on
public intervention in Europe signifies a major market failure (Cooke 2001). Because of the
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potential influence of institutional setting on the opportunity recognition process, data is
collected from two geographic areas, namely the US and Nordic countries. The results
reported in Renko (2006a) show that, overall, there are no major differences in perceptual
variables between the two continents. However, American firms do get more outside
investments than their Nordic competitors (Ernst&Young 2004; Renko 2006a).

Phase I: Data collected
using the survey
instrument in face-toface interviews with 85
biotechnology startup
CEOs in 2003-2004

Phase II: Follow up
mail/online survey to the
startup CEOs
interviewed in 20032004. (n=42)
May-Oct 2007.

Results from the
longitudinal data
reported in this
dissertation

Publication of results
concerning market
orientation in Renko (2006a)

Figure 8: Phases of empirical data collection
Even prior to phase 1 data collection, a qualitative study was conducted that addressed the
nature of market knowledge, market orientation, and other types of knowledge in young
biotechnology ventures (Renko 2006a, b). This inductive preliminary study helped in
understanding the study phenomena in the empirical context of young biotechnology
ventures and was pivotal for subsequent instrument development. The approach in the
preliminary study was a qualitative one, not one geared towards testing existing hypotheses
(either overtly or unconsciously).
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A quantitative hypothesis testing approach (deductive approach) is applied in the main
empirical study reported here. The purpose of this chapter is to describe the research
instrument and procedures applied for empirical testing of the hypotheses. Towards the end
of the chapter I will also discuss the quality of the empirical study focusing on validity and
reliability.
Since the instrument employed in this study has been used before (Renko 2006a, b), parts
of the description of instrument design and empirical procedures reported in the following
can also be found in Renko (2006a).

Instrument design

The challenge in instrument design for concepts such as market knowledge, technology
knowledge, entrepreneurial opportunities, and entrepreneurial orientation is in finding the
items that are clearly related to the domain construct but at the same time discriminate
between the construct we want to measure and other related but unequal constructs. The
selection of items used to capture each study construct was guided by existing literature as
well as the qualitative preliminary study reported elsewhere (Renko 2006a, b). Table 5
summarizes all the measurements used in hypothesis testing in this study. “Entrepreneurial
opportunities exploited” is not used in hypothesis testing, but the scale was created to test the
discriminant and convergent validity of “entrepreneurial opportunities recognized”.
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Table 5: Constructs and measurements in the empirical study

Hypotheses

Construct

Entrepreneurial
orientation

Variable(s)
Entrepreneurial orientation
Market intelligence generation & dissemination

Market knowledge
H1, 1a, 1b,
1c, H2, 2a

Number of patents (approved)

H3, 3a

--

Profit potential

Entrepreneurial
opportunities exploited

Scale, data source etc.

Continuous
(5-point
Likert)
Continuous
(5-point
Likert)

9-item scale based on Knight (1997).
Scale: Mean of 7 variables selected after measure
refinement.
22-item scale based on Kohli et al. (1993). Scale:
Mean of 22 variables selected after measure
refinement.
Self reported by interviewees, checked against
USPTO database
Self reported by interviewees (%)

Continuous

Technology knowledge
Entrepreneurial
opportunities
recognized

Type

R&D intensity
a) New inventions
b) Therapeutic areas where inventions are useful
c) Domestic patent applications
d) International patent applications

Continuous
Continuous
Continuous
Continuous
Continuous

External equity investments

Continuous

Early sales

Continuous

Out-licensing

Continuous

a) New product introductions to markets
b) New product development projects started
c) End products that are / have been developed
based on the company’s invention(s)

Continuous
Continuous
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Continuous

Self reported by interviewees.
Scale: Mean of the four variables.
Self reported, USD thousands per year
Self reported sales data checked against secondary
sources whenever possible
Self-reported number of technologies sold or
licensed out from the firm.
Self reported by interviewees.
Scale: Sum of the 3 variables.

Operationalization of independent variables

Instead of single-item measurements, methodologists advocate the use of multiple-item
measurements. Single-item measurements are popular because they are quick and easy to
administer to large samples, but single-item measurements cannot provide reliable
measurements of relatively complex constructs. Thus multiple-item measurements have been
the norm for over 50 years (Loo 2002; Shadish, Cook and Campbell 2002). In this study, (1)
market knowledge, (2) entrepreneurial opportunities recognized, and (4) entrepreneurial
orientation are measured by multi-item scales as described in the following. Technology
knowledge is captured through the use of two single-item measurements, and profit potential
is assessed through three single-item measurements. All of these measurements are
described in detail in the following.

Market knowledge.

Measurement development. The measurement of market knowledge in this study relies
primarily on the scales used in the existing literature. Since market knowledge has
predominantly been of interest to marketing scholars, the search for an appropriate scale was
conducted primarily within marketing literature.
Li and Calantone (1998) have measured market knowledge competence, defining the
construct of interest as the processes that generate and integrate market knowledge (p. 14).
However, their 21-item scale for the measurement of market knowledge competence has an
explicit focus on formal processes and knowledge integration between marketing and R&D
departments. Since the qualitative preliminary study had shown that the kinds of firms
focused upon in the current study neither have clearly defined borders between marketing
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and R&D nor rely on purely formal processes in their market intelligence gathering, the Li
and Calantone (1998) scale as such was not deemed suitable for the current study.
Li and Calantone (1998) based their measurement to a large extent on previous measures
on market orientation. Two of the most extensively used measurements of market
orientation are the “MARKOR” scale developed by Kohli, Jaworski and Kumar (1993), and
the “MKTOR” scale developed by Narver and Slater (1990). The scale of Kohli et al. (1993)
focuses on market oriented firm level behaviors, whereas the Narver & Slater (1990) scale
measures market orientation as an element of company culture (Ngai and Ellis 1998).
Deshpandé and Farley (1998) conclude that both scales are reliable and valid, generalize
well internationally, and are similar in terms of validity measurements and correlations with
performance. In this study, two of the three subscales 7 of market orientation developed by
Kohli et al. (1993), namely (1) market intelligence generation and (2) dissemination, form
the basis for a measurement for market knowledge. This measure captures the behaviors of a
firm that are geared towards understanding customers and competitors throughout the
company. The “MARKOR” scale developed by Kohli et al. (1993) has been subsequently
employed in a wealth of empirical studies (Siguaw, Simpson and Baker 1998; Matsuno et al.
2002; Perry and Shao 2002; Kyriakopoulos and Moorman 2004; Kara, Spillan and
DeShields 2005).
Measurement refinement. The 18 intelligence generation and dissemination items from
the measurement by Kohli et al. (1993) were further developed to reflect the current
empirical context, i.e. small, young biotechnology firms. Instead of “business unit” (the
original focus of Kohli et al. 1993) the items were re-worded to reflect the firm. Other
changes to the original scale are outlined in Table 6.

7

These three subscales are market intelligence generation, dissemination within a firm, and firm’s
responsiveness to market intelligence.
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Table 6: Refinement of market knowledge scale.
Scale item in Kohli et al. (1993)
Our company meets customers at least once
a year to find out what
Products / services they will need in the
future.

Individuals from our manufacturing
department interact directly with customers
to learn how to serve them better.

Scale item in this study. (R) denotes a reverse coded item.
Our company meets end customers or potential end customers
of our products at least once a year to find out what their future
needs are.

Comments

Our company meets opinion leaders (e.g. recognized medical
doctors) at least once a year to find out about the future needs of
our end customers.

Potential end customers are included because
most sample firms do not have sales for the
time being. Opinion leaders are included
because, based on the preliminary study, they
were deemed to be important in reflecting end
users’ preferences and needs.

Individuals from our R&D and / or manufacturing department
interact directly with customers to learn how to serve them
better.

R&D is included in addition to manufacturing
because most sample firms do not have
manufacturing.

Our company conducts market research in-house.
Our company does a lot of in-house market
research.

Our company subscribes to industry (market) databases.

Sample firms do not necessarily have
resources to conduct market research in-house
but they may still outsource these services.

Our company outsources market research.
Our company is slow to detect changes in
our customers’ product / service preferences
(R)

Our company is slow to detect changes in our customers’ or
potential customers’ product / service preferences (R)

Potential customers included.
Item deleted. Quality in medical
biotechnology is mostly not determined by
customers but regulators, such as the FDA or
EMEA.

Our company polls customers at least once
a year to assess the quality of our products /
services.
We often talk with or survey those who can
influence our end users’ purchases.

We often talk with or survey those who can influence our end
users’ purchases (e.g. medical doctors)

We collect industry information by informal
means (e.g. lunch with industry friends)
In our company intelligence on our
competitors is generated independently by

We collect industry information by informal means (e.g. lunch
with industry friends)
In our company intelligence on our competitors is generated
independently by several individuals / departments.
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Departmental boundaries are unclear in the
smallest firms.

Scale item in Kohli et al. (1993)
several departments.

Scale item in this study. (R) denotes a reverse coded item.

Our company is slow to detect fundamental
shifts in our industry (e.g. competition,
technology, regulation). (R)

Our company is slow to detect fundamental shifts in our
industry (e.g. competition, technology, regulation). (R)

Our company periodically reviews the
likely effect of changes in our business
environment on customers (e.g. regulation,
competition, technology).

Our company periodically reviews the likely effect of changes
in our business environment on customers (e.g. regulation,
competition, technology).

A lot of informal “hall talk” in this business
unit concerns our competitors’ tactics or
strategies.

A lot of informal “hall talk” in our company concerns our
competitors’ tactics or strategies.

We have interdepartmental meetings at least
once a quarter to discuss market trends and
developments

Marketing personnel in our business unit
spend time discussing customers’ future
needs with other functional departments.

Our company holds regular interdepartmental meetings to
discuss market trends and developments.
Our company holds regular meetings with other companies to
discuss market trends and developments.
Our company’s marketing personnel / business development
personnel spend time discussing customers’ future needs with
the other functions.

Our business unit periodically circulates
documents (e.g. reports, newsletters) that
provide information on our customers.

Our company periodically circulates documents (e.g.
newspapers, e-mail alerts) that provide information on
customers.

When something important happens to a
major customer of market, the whole

When something important happens to customers in our
(potential) markets, the whole company knows about it within a
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Comments

Intelligence dissemination can also take place
between companies.

Small firms are more likely to have business
development personnel before marketing /
sales.

Potential customers included.

Scale item in Kohli et al. (1993)
business unit knows about it within a short
period.
Data on customer satisfaction are
disseminated at all levels in this business
unit on a regular basis.
There is minimal communication between
marketing and manufacturing departments
concerning market developments. (R)
When one department finds out something
important about competitors, it is slow to
alert the other departments. (R)

Scale item in this study. (R) denotes a reverse coded item.
short period.

Comments

Our company disseminates data on customer satisfaction at all
levels in the company on a regular basis.
There is minimal communication between people in this firm
concerning market developments. (R)
There is a lot of market related communication between
individuals in our top management team.
When someone in our firm finds out something important about
the market (e.g. customers, competitors) he / she is slow to share
this information with others. (R)
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Departments not relevant for the smallest
firms; rather, communication blocks arise
between individuals.
Departments not relevant for the smallest
firms; rather, communication blocks arise
between individuals.

After the changes, the final market knowledge scale included 22 items (Cronbach’s alpha
in phase 1 data (n=85) 0.753; in phase 2 data (n=36) 0.877). This indicates that the reliability
of the scale is good (Nunnally 1978) and all the items reflect one underlying construct, i.e.
market knowledge. Interestingly, a meta analysis of Cronbach’s alpha reliabilities in
behavioral research by Peterson (1994) revealed that interviewer administration (here in
phase 1) typically produced lower alpha than did self administration (here phase 2).

Entrepreneurial orientation

Measurement development. The entrepreneurial orientation (EO) measurement used in
this survey is based on Knight’s (1997) 8-item scale for entrepreneurial orientation. It
measures the three components of entrepreneurial orientation, namely innovativeness,
proactiveness and risk taking. Knight’s (1997) scale, again, is a slightly modified version of
Covin and Slevin’s (1989) 9-item scale. To be consistent with the market knowledgemeasurement part of the survey, the EO scale was formulated as a 5-point Likert scale
(Knight’s scale is a 7-point scale), where the two ends of each question “continuum” present
opposites to each other, and higher values stand for more entrepreneurial orientation (See
questionnaire in Appendix 1).
Knight (1997) employs numerous techniques to assess the validity and reliability of the
scale for the measurement of entrepreneurial orientation. All in all, Knight (1997) finds that
the scale performs well with regard to consistency and pattern of factor structure, internal
consistency and convergent, as well as discriminant validity.
Measurement refinement. In this study, one item was added to the Knight (1997) scale:
“How many new lines of products or services does your firm have under research and
development right now?”, the answers ranging from “1” that represents “no new lines of
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products or services” and “5” that stands for “very many new lines of products or services”.
This addition was necessary since most firms included in the current empirical study did not
have any products on the markets at the time of the interview. The reliability measurements
are reported item by item in Table 7. As the Table shows, the items in phase 1 of data
collection behave in a similar way to Knight’s (1997) items: items 6, 7, and 8 have high
item-to-total correlations, whereas items 1, 2, 3, and 5 have lower item-to-total correlations.

Table 7: Entrepreneurial orientation scale reliability, item statistics

Item 8
1. Product lines
2. Product changes
(Product lines under
R&D) 9
3. R&D leadership
4. New techniques
5. Competitive posture
6. Risk-taking proclivity
7. Environmental
boldness
8. Decision-making style
Cronbach’s alpha
N of cases

Current study, phase 1
data, item-to-total
correlation
0.065
0.270
0.336

Current study, phase 2
data, item-to-total
correlation
.525
.318
.604

Knight (1997), itemto-total correlation

0.298
0.432
0.294
0.456
0.363

.491
.466
.321
.243
.366

0.512
0.585
0.455
0.629
0.636

0.453
0.631
85

.107
0.704
29

0.666
0.834
204

0.490
0.560

As shown in Table 7, the 9-item scale for entrepreneurial orientation employed for
hypothesis testing in this study (phase 1 of data collection) has a Cronbach’s alpha of .631.
After an analysis of the item-total statistics of the scale, items one and two were dropped
from the scale. Item one in particular has a poor item-to-total correlation in phase 1, which is
probably due to the fact that most study firms had either not launched any products on the
markets or had only launched a few. After removing the two first items, the resulting 7-item
8

For exact items, see questionnaire in Appendix 1.

9

This item was not in the Knight (1997) scale but was added to the measurement in this study because of the
young age of the study firms.
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scale has a Cronbach’s alpha of .719 (phase 1 data), and the mean value on this scale is used
as a proxy for entrepreneurial orientation in the dependence models.
Overall, the item-to-total correlations in this study are worse than those reported by
Knight (1997). However, as mentioned above, the item-to-total correlation patterns in phase
1 data are similar to Knight’s (1997) study. The most likely explanation for the lower
correlations in this study is the fact that the respondents typically ranked their companies
very high on the entrepreneurial orientation items; by definition, most biotechnology startups
are taking huge risks and have to be proactive and innovative if they wish to recover their
R&D costs one day. The mean value for entrepreneurial orientation in phase 1 of this study
is 3.86, which is also the median value for the scale (5-point Likert scale). The standard
deviation of the scale is 0.608. Knight’s (1997) companies come from medium-sized firms in
the textiles, clothing, electronic goods and electrical parts industries in Canada. Within this
population of firms you are likely to see more variation and also possible co-variation for
entrepreneurial orientation items. Unfortunately, Knight (1997) does not report scale means
or standard deviations for his items.
The Wiklund and Shepherd (2005) study is used here to compare the level of
entrepreneurial orientation of the biotechnology firms included in this sample with the
results from other industries. Wiklund and Shepherd (2005) measure entrepreneurial
orientation using Miller’s (1983) eight items, which also reflect innovativeness,
proactiveness and risk taking, like the items in this study. Each item is measured on a 7-point
Likert scale, and Wiklund and Shepherd (2005) obtain a mean of 28.93 for the summated
scale (standard deviation 6.19). The sample firms of Wiklund and Shepherd (2005) represent
Swedish firms in the following sectors: knowledge-intensive manufacturing, labor-intensive
manufacturing, professional services and retail. The mean value of the Wiklund and
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Shepherd (2005) summated EO scale would translate into a mean of 2.58 10 on a five-point
scale like the one employed in this study. This value is 1.28 points lower (on a five-point
scale) than the sample mean of this study. This indicates that at least compared with the
sample firms of Wiklund and Shepherd (2005), the firms in this study exhibit higher levels
of entrepreneurial orientation.
Interestingly, the item-total statistics of the entrepreneurial orientation in phase 2 data are
quite different from phase 1 data. There are two plausible explanations for this. First, in the
second phase of data collection complete data for the EO scale was only obtained from 29
firms. This low number of cases may affect the numbers reported in Table 7. Second, the
most dramatic change between the two data collection periods concerns the first scale item,
namely “How many new lines of products or services has your firm marketed since 2000”.
The companies that have survived as independent organizations until 2007 and have been
available for data collection in phase 2 have most likely been under pressure from investors
and other stakeholders to get their products to the markets. The mean value in phase 2 data
for this item is 3.39 and median 4, whereas in 2003-2004 (phase 1) the same item had a
mean value of 2.48 and a median of 2. Surviving companies are the ones that have been able
to push products to markets as well as start new, promising product development projects
(Item “How many new lines o f products or services does your firm have under research and
development right now” also shows a dramatic change in the scale statistics, Table 7).
Hence, the relative importance of these items in the EO scale has shifted between phases 1
and 2.

10

[28.93/(7*8)]*5=2.58
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Technology knowledge.

Measurement development. Technological knowledge is mostly an unobservable
construct and researchers need to analyze different indicators, which each offer clues about
the construct without directly measuring it. Here, technology knowledge of a firm is
measured with two items, namely (1) “share of R&D expenses out of total expenses of the
firm 11 ”, and (2) number of patents. Measurements of R&D activity, such as the total amount
of R&D spending and R&D spending divided by total sales, have been used as indicators of
technological capability in previous research (Coombs and Bierly 2001). Nelson and Winter
(1982) suggest that the probability of a firm coming up with an innovation is proportional to
the firm’s R&D spending. At the same time, R&D is regarded as a highly uncertain activity,
and institutional structures supporting innovation are complex and diverse (Nelson and
Winter 1977). R&D spending reflects investment in knowledge, rather than knowledge
itself, and is a questionable proxy because knowledge generation is cumulative. Hence
patents are used as an additional proxy for technology knowledge.
Patents are output measurements of technological knowledge (Coombs and Bierly 2001).
Firms, laboratories and individuals can apply for a patent to protect a new technology, to
signal technological competence, or “to mark technological territory” (Ramani and Looze
2002). In biotechnology, most new technology is protected by patents. The protection of
technology - prevention of copying by competitors - is the typical reason for patenting
innovations, but the positive “signaling” impact of patent applications is also considered to
be particularly strong in the biotechnology sectors (Lemarié, Looze and Mangematin 2000).
Whatever the strategic motivations, a patent can only be granted if the invention has an
industrial use. However, using a firm’s number of patents as a proxy for its technological
11

The more conventional way is to estimate R&D spending as a share of total sales, but since most sample
firms did not have sales at the time of the interview this estimate was not deemed feasible.
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knowledge is problematic for many reasons (Pavitt 1985). Patents differ greatly in their
technical and economic significance, not all types of technological knowledge can be
patented, and patenting strategies - i.e. what to patent, where to patent and how frequently to
patent - vary widely between industries and even between firms in the same industry. To
overcome these problems, researchers have, for example, measured the quality of the patent
by how often others cite it (Coombs and Bierly 2001). Even though R&D spending and
patent counts are both problematic measurements of technology knowledge, using them both
should capture the variation in the sample firms’ technological knowledge base.
In both phase 1 and phase 2 data collection the respondents were asked to estimate the
share of R&D expenses (%) out of the total expenses of their respective firms. They were
also asked to provide information on the patent count of the firm. However, only data from
the first phase of data collection are used as independent variables in the tests of proposed
models. In phase 1, two interviewees (out of 85) refused to give out this information. In
phase 2, two respondents (out of 42) left the patent questions of the questionnaire blank.
Most interviewees were confident in answering the patent questions, but in phase 1 six
interviewees were unsure of the actual counts. These interviewees were asked to check the
numbers after the interview, and all of them replied later with the patent numbers.
Measurement refinement. The United States Patent and Trademark Office’s (USPTO)
publicly available database was searched to verify the patent data given by the interviewees.
However, many of the sample firms have obtained rights to patents that have not actually
been developed by the firms themselves; for example, university spin-offs often have rights
to patents developed by university research groups. Thus the USPTO patent search by
company names is not likely to catch all the patents the interviewees were referring to when
providing patent numbers during the interviews. Still, it is important to check interview data
against a more objective source, and even though those patents that are not assimilated with
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the firm’s name are missed in the search, the resulting numbers should still correlate
positively with the numbers provided by the interviewees. Comparison of patent data from
the interviews with the USPTO patent data (Table 8) reveals that the numbers given by the
interviewees are higher. They commonly reported that the same patents have been approved
or applied for both in the home country as well as internationally, hence no large differences
between “domestic” and “international” patent figures. Table 8 below summarizes the means
and medians for patent data.

Table 8: Comparison of patent data from USPTO and interviewees.

PHASE 2

PHASE 1

USA-based firms

Data from
interviewees:
Number of
domestic patent
approvals
Number of
international patent
approvals
USPTO:
Patents (approved)
under company
name, June 2004.
Data from
interviewees:
Number of
domestic patent
approvals since
June 2004
Number of
international patent
approvals since
June 2004
USPTO:
Patents (approved)
under company
name between June
2004 - Oct 31st
2007.

Finland and Sweden-based firms

Mean

Median

SD

Skew
ness

7

2

10

1.939

7.7

1

23

4

0

5.36

Median

SD

Skew
ness

4.7

2

6.5

2.667

5.881

4.7

2

7

2.436

7.3

2.463

1.46

0

2.5

1.952

2

12

3.256

1.12

0

1.8

1.271

5

0.5

11

3.370

1.31

0.5

1.7

1.023

2.6

0

5.0

2.909

0.86

0

1.5

2.348
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Mean

As indicated by Table 8, the numbers reported by the interviewees are higher than the
numbers obtained from the USPTO. Nevertheless, for the reasons mentioned above, this
does not mean that the interviewees were not truthful when answering the questions about
patents. Because there are no large differences between numbers reported for domestic and
international patents, the correlations between the subjective data and the USPTO data were
calculated for the whole sample, not making a difference between US- based and Nordic
companies. There is a significant positive correlation between the USPTO patent numbers
and the numbers provided by the interviewees. The correlations are listed in Table 9.

Table 9: Correlations between patent data from USPTO and interviewees.

Variables

1

1. PHASE 1: Number of
domestic patent approvals

1

2. PHASE 1: Number of
international patent approvals

.832***

1

.433***

.299***

1

.562***

.511***

.222

1

.539***

.526***

.186

.940***

1

.364***

.157

.746***

.689***

.682***

3. PHASE 1: USPTO patents
(approved) under company
name, May 31st 2004.
4. PHASE 2: Number of
domestic patent approvals
since June 2004
5. PHASE 2: Number of
international patent approvals
since June 2004
6. PHASE 2: USPTO patents
(approved) under company
name between June 2004-Oct
2007

2

3

4

5

6

1

*** Correlation is significant at the 0.01 level (2-tailed)
Despite the positive correlations between the numbers of patents obtained from the
interviewees and from the USPTO, the Wilcoxon Signed-Rank test has a significant p-value
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(p < 0.01) for tests of both domestic and international patents as reported by the interviewees
against the USPTO data. This indicates that the distribution of the patent data obtained from
the USPTO is different to the patent data provided by the interviewees. This is problematic
for the analyses; the USPTO numbers are objective, but, as mentioned earlier, the numbers
given by the managers also include patents for which the very company is not listed as
“assignee” in the patent database. In the case of many young firms, and especially spin-off
firms, ignoring this data would be problematic. Thus, for the analyses, an average of the
number of patents reported by the interviewees and the number of approved patents listed in
the USPTO database was computed from phase 1 data. This mean is used as a proxy for
patents in the analyses.

Operationalization of dependent variables.

The first hypotheses of this study test the effects of market knowledge, technology
knowledge, and entrepreneurial orientation in phase 1 on the number of entrepreneurial
opportunities recognized in phase 2. The latter hypotheses, then, focus on the relationship
between the number of entrepreneurial opportunities recognized by the firm in phase 1 and
the firm’s subsequent profit potential (phase 2). Hence, the dependent variables of interest
are (1) entrepreneurial opportunities recognized; and (2) profit potential.

Entrepreneurial opportunities recognized.

There are few attempts in the existing research to quantitatively measure entrepreneurial
opportunities. For example, Ardichvili et al. (2003) produce a comprehensive theoretical
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model and propositions concerning entrepreneurial opportunities, but remain silent on how
these opportunities (supposedly dependent variables) would exactly be measured.
Baron & Ensley (2006) compare the business opportunity prototypes of novice (firsttime) and repeat (serial) entrepreneurs. They conclude that serial entrepreneurs show greater
agreement than novice entrepreneurs concerning the central attributes or dimensions of the
concept “business opportunity”, and that experienced entrepreneurs include more distinct
dimensions in their opportunities than novice entrepreneurs do (Baron and Ensley 2006). By
studying entrepreneurs who are members of entrepreneurship network organizations Baron
& Ensley (2006) imply that these are the people who have recognized opportunities. They
ask entrepreneurs to “Describe the idea on which your new venture was based,” and “Why
did you feel this was a good idea—one worth pursuing?”. Hence, a new venture idea that
leads to a business startup seems to be the operationalization of a business opportunity for
Baron & Ensley (2006).
Busenitz (1996) does not explicitly state what entrepreneurial opportunities are, but since
his empirical research compares managers in publicly traded large corporations to founders
of new ventures it can be assumed that founders of new ventures have recognized
entrepreneurial opportunities whereas managers in large corporations have not. More
specifically, to qualify as an entrepreneur (and supposedly then having recognized an
entrepreneurial opportunity) an individual should have established a firm. This should have
happened within the past two years or, alternatively, the individual should be planning to
start a second venture within the next five years (Busenitz 1996). Young firms are also the
incarnation of opportunities in the Saemundsson and Dahlstrand (2005) study. Two
measures were used to quantify the newness of market and technical knowledge behind the
opportunity. First, if the new firm had any business relations at start-up with former
employers, the business opportunity was considered to be based on existing market
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knowledge. Second, if the respondent reported that universities or research institutes had
been important at start-up, the business opportunity was considered to be based on new
technical knowledge (Saemundsson and Dahlstrand 2005). These measures are barely
measures of newness of any kind. If anything, they tell about the social network of the
entrepreneur(s) at the time of the business startup.
Shane (2000) focuses on one patented technology, made available through a university
(MIT) technology licensing office. The opportunities - that is, the units of analysis – are
startup activities by eight different entrepreneurs (or teams), geared at commercialization of
this patented technology.
Park (2005) demonstrates opportunity recognition through a case study of an innovative
firm. For Park (2005) entrepreneurial opportunity seems to equal “effective innovation and
resultant market success” (p. 747). However, the construct is not operationalized in more
detail. For Sanz-Velasco (2006), an opportunity must include the following elements: a
definite offer to the customer; a definite customer segment; definite value; a definite revenue
model; accomplished through technology. According to this “operationalization”, a new firm
startup would not demonstrate entrepreneurial opportunity if, for example, it was a nontechnological service business that had not segmented its markets.
Gaglio & Katz (2001) devote extensive discussion to the difficulties of operationalizing
entrepreneurial alertness research. However, they do not make concrete suggestions as to
how entrepreneurial opportunities should be measured. They do warn researchers about the
dangers of confusing opportunities with successful opportunities when conducting research:
“the commonly accepted practice of asking successful entrepreneurs recount how they
“found” their opportunities is problematic for alertness investigators because it allows
respondents to collapse all the stages into one moment” (p. 107).
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Brown, Davidsson & Wiklund (2001) operationalize “opportunity based firm behavior”
by developing and testing a scale. Some of the scale items ask respondents to assess
opportunities in their firms (For example, “We limit the opportunities we pursue on the basis
of our current resources” and “In exploiting opportunities, having the idea is more important
than just having the money”). However, the interpretation of what constitutes an opportunity
or its exploitation seems to be left to the respondents (Brown et al. 2001). The same is true in
the empirical study of Ozgen & Baron (2007), who measure opportunity identification by six
items selected from previous research (Singh, Hills, Hybels and Lumpkin 1999), but they
never explain how the respondents are supposed to interpret the term “opportunity” that
appears in the scale items (Items such as “I can recognize new venture opportunities in
industries where I have no personal experience” and “I have a special alertness or sensitivity
toward new venture opportunities”). (Ozgen and Baron 2007) This latter item was also used
as an item in the alertness scale of Singh (2000, 69), whose sample included 303
entrepreneurs, defined as presidents and/or CEOs of small and young companies. Singh’s
(2000) mail questionnaire included a simple model description of a difference between an
idea and a new venture opportunity, and the respondents were asked to provide information
on the numbers of new ventures ideas, new venture opportunities, and pursued opportunities
over the past year (Singh 2000).
Given the ambiguity surrounding the entrepreneurial opportunity construct, it is not
surprising that only a few researchers, as described above, have tried to turn entrepreneurial
opportunities into measurable units. For those who have tried, new firm startups seem to be
the place where individuals reside after having recognized entrepreneurial opportunities.
Hence, the choice of startup firms in the field of biotechnology as the data source concerning
entrepreneurial opportunities is in line with previous research (Busenitz 1996; Shane 2000;
Singh 2000; Park 2005; Saemundsson and Dahlstrand 2005; Ozgen and Baron 2007).
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In line with the definition established for entrepreneurial opportunities in this research, it
was suggested above that new product development process can be an example of an
entrepreneurial opportunity. To quantify the opportunities recognized by the sample firms
we should look into their product development pipelines to count the number of
opportunities. In order to understand the variables chosen to reflect entrepreneurial
opportunities in the current empirical context the reader should have a general understanding
of new product development processes in biotechnology. In the development pipeline typical
for biotechnology products, the projects evolve from discovery (invention) and scientific
development via clinical development and commercialization. The development from
invention and preclinical testing to a commercialized product typically takes 12-15 years for
biomedical products. One aspect related to the complexity of the biotechnology innovation
process is that there is not normally a one-to-one relationship between a specific scientific
discovery and a certain industrial application. Any given biotech invention may be used in a
variety of applications and industries (McKelvey, Rickne and Laage-Hellman 2004), and
often firms have to select which one of the many potential commercialization avenues they
want to pursue for any one invention. Small R&D firms are typically heavily dependent on
the success of their lead development projects. In biotechnology, the huge costs of R&D
effectively limit the number of projects that can be run within one firm. Failures in the lead
projects can break the whole company, whereas success in them can attract investors and
speed up the development process. Signaling the science- and technology oriented business
models typical for biotechnology firms, managerial tasks in these firms reflect science,
product development, business development and the few administrative functions necessary
to keep any organization running. (Renko 2006a)
Figure

9 below illustrates

the

product

development

pipeline

of

a

typical

biopharmaceutical company and how the items in questionnaire section E (Items E1-E9 in
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the figure) capture different parts of the pipeline (See Appendix 1 for questionnaire).
Question E1 asks about the number of “new inventions for which the firm has filed domestic
or international patent application(s)”. The fact that patent has been applied for implies that
there is possible industrial use. However, as illustrated in Figure 9, these inventions are still
far from being commercialized. As mentioned earlier, some inventions can be developed
towards a variety of commercial applications. Still, some firms may choose to focus on one
business area only and all their inventions may be targeted towards one usage area. Hence, it
is important to know the number of “therapeutic areas where these inventions are useful
(your own estimate)”, item E2 in the questionnaire (could not be placed in Figure 9). Some
inventions may be abandoned without pursuing them further for commercial purposes.
Hence, item E3 is needed to capture the extent of the firm’s pipeline as well as those
inventions that originate from the focal firm but are developed in a partner firm of some
kind: “End products that are / have been developed based on this/these inventions in your
firm or your partners”. Items E4-E7 ask about patent protection that has been applied for or
granted to a firm’s inventions. Both domestic and international patent applications and
approvals are captured; even though it has turned out that the US is the primary patenting
location for those firms wishing to launch products to international distribution, there are
still firms that pursue more local patenting strategies as well. Item E8 captures the end of the
development pipeline: “New product introductions to the markets”, whereas item E9 asks
about the entrepreneurial opportunities that move from having been identified (invention) to
a stage where the company invests in their development towards commercialization: “New
product development projects started”. Note that this item differs from E3 in that a firm may
have started numerous development projects (high value in E9) but may have abandoned
many of them before they ever reach the markets (low value in E3).
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E1

Discovery
(2-10 years)

E4/5
E9

Preclinical

Preclinical Testing
E6/7
Laboratory and animal testing
Phase I
20-80 healthy volunteers used to determine
safety and dosage
Phase II
100-300 patients used to look for
efficacy and side effects
Phase III
1000-5000 patiens used to monitor
Clinical
adverse reactions to long-term use
Regulatory Review/Approval

E8
Additional Postmarketing
Testing Phase IV
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Figure 9: Biopharmaceutical product development pipeline and questionnaire items E1-E9

Having defined entrepreneurial opportunity recognition as perceiving a possibility to
introduce innovative (rather than imitative) goods or services to a marketplace through (a)
the founding and formation of a new venture, or (b) the significant improvement of an
existing venture, it follows that recognized entrepreneurial opportunities in biotechnology
ventures have the following characteristics:
-

novel (invention),

-

patentable (potential industrial use)

-

lead to a significant improvement of the venture.

Hence, the following four items were selected as scale items for “Entrepreneurial
opportunity recognition”:
-

number of new inventions for which the firm has filed domestic or international
patent application(s);
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-

number of therapeutic areas where these inventions are useful;

-

number of domestic patent applications; and

-

number of international patent applications (The same application submitted to
multiple countries counts as one).

The inventions captured by these questions in phase 1 of data collection should reflect the
ideas that got the company started in the first place. Hence, they have essentially led to the
founding and formation of a new venture. In phase 2 the respondents were asked to provide
numbers since June 2004 only. It is assumed that these inventions then have a potential to
lead to significant improvement of an existing venture. Especially those that have potential
use in multiple therapeutic areas can be valuable since a firm can license out development
rights to those indications it does not pursue in house.
The 4-item scale has a Cronbach’s alpha reliability value of .664 in phase 1 data. In phase
2 data, the corresponding value is .882.
Entrepreneurial opportunities exploited 12 . Because the definition of opportunity
recognition only entails perception, it follows that exploitation of an opportunity is a
separate activity. As defined earlier, the exploitation of an opportunity refers to those
activities committed to (a) the founding and formation of a new venture, or (b) the
significant improvement of an existing venture in order to introduce innovative (rather than
imitative) goods or services to marketplace (See also Choi and Shepherd 2004). Since the
units of analysis in this research are independent, young ventures that have already been
established, the current study focuses on the “significant improvement of an existing venture
in order to introduce innovative goods to the marketplace”.

12

This construct is only operationalized to show the discriminant and convergent validity of “entrepreneurial
opportunities recognized”. This variable will not be used in the hypothesis testing.
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Choi & Shepherd (2004) study opportunity exploitation and measure entrepreneurs’
engagement in exploitation as their likelihood

to commence “immediate full-scale

operations on the product or service arising from the opportunity, where full-scale operation
is the scale required to ship the first product for revenues […] - not market testing” (p. 385)
(Likert scale items for various scenarios). This translates to an “operationalization” of an
opportunity as something that can be anchored in a product or service.
A common indicator of expertise in the biopharmaceutical industry is the number of
drugs in development or in the “pipeline”. The strength of a firm’s pipeline is considered an
important indicator of a company’s future cash flows, and the number of products under
development by a biotechnology firm has a direct relationship to firm financial performance
(DeCarolis and Deeds 1999).
The measurement of entrepreneurial opportunity exploitation in this study includes the
following continuous items: (1) New product introductions to markets, (2) New product
development projects started, and (3) End products that are / have been developed based on
the company’s invention(s). A composite measurement (sum) of these three items is used.
This measurement combines the new firm context of opportunities (Busenitz 1996; Shane
2000; Singh 2000; Park 2005; Saemundsson and Dahlstrand 2005; Ozgen and Baron 2007)
with innovativeness (Park 2005; Sanz-Velasco 2006) and product- or service relatedness
(Choi and Shepherd 2004) of these opportunities. The three-item scale has a Cronbach’s
alpha value of 0.882 in phase 2 data.

Profit potential.

How to assess company performance in biotechnology? Conventional internal
performance evaluation is based on comparable and well-accepted measurements, which are
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also backward looking (Cumby and Conrod 2001). In the pharmaceutical industry, sales,
profits, customer base, or the richness of the R&D pipeline are commonly used as
performance indicators. However, for most biotechnology companies that have no products
on the markets yet, these measurements are irrelevant. When asked about the development
stage of their lead products, 48.8 per cent of the respondents of the empirical study indicated
that their firms either marketed their own lead product or had a partner company taking care
of this task at the time of data collection. This means that more than half of the sample firms
(at both phase 1 and phase 2) had not yet launched their lead product. One could have
assumed that the share of companies with products on the markets would have been larger in
2007 than in 2003-2004 but this was not the case. At both times, 51.2 per cent of
respondents represented firms with no products on markets.
Essentially, business performance can be investigated by both subjective (e.g., selfreported) and objective (e.g., market share, sales, profit) measurements. However, even
some “objective” financial data is subject to managerial decisions such as evaluation of
investments and assets, reporting of liabilities and costing (Rodriguez Cano, Carrillat and
Jaramillo 2004). The difficulty in obtaining objective data contributes to the wide use of
subjective measurements (Dawes 1999; Harris 2001). Especially for the kinds of small and
young (mostly private) firms included in the sample for this study, objective information is
not readily available. Rather, managers, especially in the US-based companies, tend to
disclose as little financial information as possible. Thus performance in this study is
measured through items reported by the respondents that capture the profit potential of the
venture.
Early sales. Growth in sales (sales growth rate) is a traditional accounting measurement
of a firm’s performance widely used in the entrepreneurship literature (Lumpkin and Dess
1996). In this study the respondents were asked whether or not their firm currently sells

89

products. If the answer was yes, they were further asked to provide information on the way
the product(s) is / are marketed: licensing agreement / own distribution and sales / selling
through a partner company (non-licensing agreement). Furthermore, these respondents were
asked to provide objective (numeric) information about sales turnover for 2001 and 2002
financial years (phase 1) as well as 2005 and 2006 financial years (phase 2). If the
respondent answered “No” to the question “Do you currently sell products?”, he/she was not
asked about sales figures; instead, there was a question whether the firm is planning to reach
end markets through a licensing agreement / own distribution and sales / selling through a
partner company (non-licensing agreement) in the future.
Self reported sales data was checked against data obtained from secondary sources
whenever secondary data was available. Secondary sales data was obtained from the
following databases: Hoover’s, Inc 13 , FIB (Finnish Biotechnology Index), The Swedish
Biotech Industry Guide 14 , and Thomson-Gale, Business & Company Resource Center. The
correlations between primary and secondary sales data are reported in Table 10. The
correlations between the self reported figures and those obtained from secondary sources are
comfortably high, all significant at p<.05. Based on sales data obtained in interviews in
phase 1 and survey data collected from respondents in 2007, sales growth in USD was
calculated for 15 companies. In addition, it was possible to calculate sales growth for an
additional 16 companies based on sales data obtained from secondary sources.
Consequently, sales growth variable (%) is available for 31 companies. This sales growth
serves as a dependent variable in the tests of hypotheses 3 and 3a. In addition, absolute sales

13

Hoover’s offers proprietary business information and features a database of information on more than 12
million corporations and organizations.
14

http://biotech.idg.se/industryguide
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numbers from 2006 will be used in the analyses since those numbers are available for 44
firms.

Table 10: Primary and secondary sales data
Correlations (n in parentheses)
N

1

2

3

4

5

6

Phase 2

Phase 1

1. Self reported
36
1
sales data 2001
2. Self reported
37
.965***
1
sales data 2002
(36)
3.
Secondary
36
.631***
.747***
1
sales data 2004 15
(19)
(19)
21
.569***
.949***
.998***
1
4. Self reported
sales data 2005
(14)
(14)
(11)
5. Self reported
22
.459*
.902***
.996***
.990***
1
sales data 2006
(15)
(15)
(12)
(21)
6.
Secondary
34
.521**
.581**
.923***
.853***
.877***
1
sales data 2005
(15)
(15)
(26)
(10)
(11)
or 2006
*** Correlation is significant at the 0.01 level (2-tailed); ** Correlation is significant at the 0.05 level (2tailed); * Correlation is significant at the 0.1 level (2-tailed)

Equity investments. Limited internal funds and lack of sales income typical of young
firms in markets for technology combined with the imperfections of capital markets suggest
that external equity financing is crucially important for these firms (Carpenter and Petersen
2002). In the venture capitalists’ view, the expectation of high financial returns is mainly
correlated with the size and growth of markets targeted by the young innovative firm, and
the radical nature of innovation (Tyebjee and Bruno 1984). In the US in particular, the role
of venture capitalists in backing up promising technology ventures is a phenomenon that has
received a wealth of attention in research studies of these firms (See e.g. Amit, Brander and
Zott 1998; Gompers and Lerner 2001; Hellmann and Puri 2002). A recent study of German
biotechnology firms by Champenois, Engel and Heneric (2006) emphasizes the importance
15

Very few data points would have been available from secondary sources for years prior to 2004. This is
probably due to the very young age of most firms when interviewed for phase 1 data collection.
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of venture capital finance as a source of funding for biotechnology firms developing new
products and technologies in the therapeutic and diagnostic fields. Forty-two per cent of the
“high risk” sample firms of Champenois et al. (2006) received early stage venture capital.
Remembering that only a proportion of startup firms that search for venture capital
investments actually receive funds, it is clear that venture capital is a crucially important
phenomenon for biotechnology startups.
In the interviews conducted for the phase 1 as well as in the phase 2 questionnaire the
respondents were asked to provide information on the capital invested in their firm up to the
time of the interview. Seventy interviewees actually provided this information in phase 1 and
thirty three in phase 2. The Pearson correlation coefficient between phase 1 and phase 2 data
is .905 (Significant at p<.01). Since these young companies are not required to provide
information about their sources of capital to the public, secondary data to confirm these
numbers are not readily available. For currency conversions in phase 1, USD 1 = EUR 0.9 =
SEK 8. For currency conversions in phase 2, USD 1 = EUR 0.74 = SEK 6.8 16 . In the
analyses, the amount of capital invested in the firm divided by firm age is used.
Outlicensing. A third proxy used to signal profit potential in this study is the number of
technologies the firm has licensed out. The number of product candidates licensed out to
other companies tells about the future profit potential of these products. Small, young
biotechnology firms may adopt different commercialization routes for their product
opportunities: either take their technology direct to the market as a final product or channel it
through large established companies that will then apply their know-how and resources to
commercialize it (Pfirrmann 1999; Costa, Fontes and Heitor 2004). The deals between
smaller, upstream inventors and larger, downstream marketers are typically structured as
licensing agreements, and profit potential together with functional complementarity are the
16

This conversion rate was used for all financial information gathered in phase 2 primary data collection.
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driving forces behind such agreements (McCutchen and Swamidass 2004). In comparison
with other industries, biotechnology has the highest absolute number of strategic alliances
(Hagedoorn, 1993), involving mainly licensing agreements. Using a secondary database,
Kollmer & Dowling (2004) identify

360 North American biopharmaceutical firms as

licensors out of a total population of 421 biopharmaceutical firms in the North America in
1999 17 (86%). In this study, the questions about the number of technologies the firm had
sold or licensed out to other companies were added between phases 1 and 2, so licensing
data is only available at phase 2. Out of the 42 companies for which data were obtained in
phase 2, twenty-two had licensed out or sold at least one technology during the firm’s
existence. Out of the 14 biopharmaceutical companies from which data were collected in
phase 2, eleven had been involved in such technology transfer as a seller / licensor (79%). A
sum of the number of technologies the firm has licensed out or sold out since the beginning
of 2004 is used in the analyses.
Control variables. The use of control variables is limited by the small number of cases
(n=42) from which data were obtained in phase 2. Introducing many control variables to the
dependence models would bring down the degrees of freedom. It might be that the results of
the tests are somewhat different for different types of biotechnology firms (medical device /
technological platforms/ diagnostics / drug discovery & development), for example.
However, introducing dummy industry sector controls to the models would be detrimental
for the degrees of freedom in the models. Three control variables have been selected for all
the models. First, firm location is used as a control variable. The dummy variable for
location (1 = USA, 0= Finland or Sweden) is used as a control variable in all statistical
analyses. In addition, firm age and firm size (number of employees) are used as controls. The

17

Number based on the Biotechnology Guide USA.
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age of the firm is measured as the number of years between the year of the firm’s formation
(self-reported) and the year of phase 1 data collection.

Design of the survey process

The primary empirical data for this study have been collected from young, independent
biotechnology ventures in Finland, Sweden, Pennsylvania, Florida and California. Different
institutional systems for new venture finance and innovation commercialization (US vs.
Scandinavia) may account for variation in the profit potential and innovativeness of new
firms. However, even though attention will be paid to differences rising across the various
geographic regions when conducting the analyses, comparisons and finding similarities /
differences between areas is not the purpose of this research.
Market knowledge in a science driven field. Sheen (2003, 268) has not been the only one
to state that “success in the pharmaceutical industry depends, perhaps more than in any other
industry sector, on scientific research”. However, even though the development process of a
new drug or other kind of medical product is extremely long, knowledge intensive and
costly, in the end the process aims at selling the output to end users. The deliberate decision
to focus on medical biotechnology companies in this research – hence, mostly on
pharmaceutical firms - is based on the understanding of the specific, science-driven nature of
the industry. Biotechnology is a representative field of the functioning of markets for
technology (Arora, Fosfuri and Gambardella 2001). The research results revealed by the
study on the market knowledge of small biotechnology firms illustrate this phenomenon in a
field that is considered extremely science and technology driven.
Primary data collection. The basic difficulty with quantitative research approaches to the
biotechnology field lies in the fact that biotechnology is not an industrial sector but a

94

technological area. Modern biotechnology has many product dimensions, different
underlying knowledge bases and wide fields of application. According to Brink et al. (2004,
31-32), the main data sources for existing economic research in the field of biotechnology
include:
•

trade data classified by product group;

•

specialized surveys of firms engaged in some form of biotechnology production

•

surveys of ‘technology use’ at the firm level;

•

scientific publications’ data;

•

patent data, either United States Patent and Trademark Office or European Patent
Office;

•

R&D data covering expenditure and personnel;

•

databases on specific topics, such as alliances, venture capital, firms and so on.

Market

knowledge,

technology

knowledge,

entrepreneurial

orientation

and

entrepreneurial opportunities are organizational phenomena To study these phenomena
based on secondary data would certainly not capture the essence of them. Even though
secondary data on, e.g., market intelligence generation through firms’ subscription to various
databases could be available, the only way to collect firm level data on the independent
variables altogether is either through empirical observation of firms, or through interviewing
/ surveying key individuals. In this empirical study, the latter approach is put into action.
Biotechnology in Finland and Sweden. In both Finland and Sweden the private capital
market has undergone a change during the last decade. More venture capital has become
available for innovative firms in their early development phase, especially for firms within
biotechnology or information technology (Nilsson 2001). This has been an important driver
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for new firm formation; numerous new biotechnology firms have been formed in both
Finland and Sweden since the beginning of the 1990s (Renko et al. 2005; Renko 2006a).
However, public funding also plays an important role in the early stages of a firm, especially
because it is “soft” money and the inventor still owns his/her idea. There are several public
actors in both Finland and Sweden that provide funding to early-stage high-technology
firms. Both the Swedish and the Finnish system are characterized by close cooperation
between academia, clinical practice and basic, pre-clinical and clinical fields. (Renko 2006a)
Biotechnology in the US. USA provides a good environment for biotechnology firms to
flourish, which is clearly illustrated by the funds invested in biotechnology R&D; 70 per
cent of biotechnology R&D takes place in the US. In 1992 there were 1,231 companies in
the biotechnology business in the US, in 2001 1,457 companies, and in 2006 1,452
companies (Ernst&Young 2002; Kermani and Bonacossa 2003; Ernst&Young 2007) In
2006, these 1,452 companies combined raised over USD 20,300 million from the financing
community, out of which USD 944 million came from initial public offerings (an increase of
51% over 2005) (Ernst&Young 2007). US-based biotechnology companies like Genentech,
Amgen, Biogen, Chiron and Genzyme have brought biotechnology-based drugs to markets
over the past twenty years.
51 US metropolitan areas have been identified as biotechnology areas, and they can be
further grouped into four general categories based on the relative amount of biotechnology
activity in each. Nine metropolitan areas (Boston, Los Angeles, New York, Philadelphia,
Raleigh-Durham, San Diego, San Francisco, Seattle and Washington/Baltimore) stand out as
biotechnology centers because they have above-average levels of biotechnology research
activity and biotechnology commercialization. Four metro areas can be characterized as
biotech research centers with limited commercial activity. Twenty-eight metro areas have
median levels of biotech research and commercialization, and within this group there are two
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metropolitan areas from the state of Florida, namely Miami—Fort Lauderdale, FL, and
Tampa—St. Petersburg—Clearwater, FL. Ten metro areas have no significant biotech
activities taking place (Cortright and Mayer 2002).
The US data collected for this research comes from companies in South Florida,
Pennsylvania (Philadelphia area), and the Bay Area in California. The key aspects of
biotechnology in each area are briefly highlighted in the following.
Florida. In terms of population, Florida is the fourth largest US state and it is third in
consumption of pharmaceutical products. A boost to biotechnology in Florida has been on
the way ever since the beginning of the new century. A California-based non-profit research
institute, the Scripps Research Institute, has fueled growth by opening its second facility in
Jupiter, FL (Abrams 2004). According to data compiled by the University of Florida’s Sid
Martin Biotechnology Incubator, more than half of Florida’s current 134 biotech and
biomedical device companies have been founded in 2001-2007. Within Florida, the top three
regions with the greatest concentration of biotech and bio-medical device companies are:
The Southeastern region with 46, the North Central Region with 37, and the Tampa Bay
region with 30 companies. Most companies are privately owned with fewer than 20
employees. (BiotechBusinessWeek 2007).
Philadelphia Area. The Philadelphia medical district, with its large pharmaceutical firms,
was established by the mid-1950s. Over the past two decades, the area has experienced a
shift from a traditional drug and pharmaceutical base into biotechnology as a result of
several interrelated elements, such as the concentration of academic, medical and researchoriented institutions; the presence of large pharmaceutical companies; the availability of
capital; and the coordinated support of government and private organizations. The three-state
area around Philadelphia, including eastern Pennsylvania, New Jersey and Delaware,
accounts for about 80 per cent of the production of pharmaceuticals in the US (Llobrera,
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Meyer and Nammacher 2000; Santomero 2002). At the same time, biotechnology has a
strong foothold: Investments in biotechnology in the Philadelphia area more than doubled in
2006, to $349.2 million (Loyd 2007).
San Francisco Bay Area. The San Francisco Bay Area is an intellectual center with three
world-class universities - the University of California, Berkley; the University of California,
San Francisco; and Stanford University, Palo Alto - fueling biotech innovation. Many of the
first biotech companies in the United States emerged in the Bay Area in the early 1980s,
including Genentech, Chiron and Cetus. The area also benefits from a permissive regulatory
infrastructure. For example, Stanford University announced the formation of an institute to
study stem cells and human cloning in 2002 despite national pressure against the exploration
or use of the technologies. In per capita concentration of life scientists, San Francisco ranks
second in the world (after Boston) with about 3,100 life scientists. In terms of biotech
patents, the San Francisco area is clearly a hotbed of activity, with almost 1,300 patent
registrations in 2000 compared with less than 850 in Boston (Bergeron and Chan 2004).

Sample

The sample of this study includes a total of 85 biotechnology firms in the USA, Finland
and Sweden in phase 1 (2003-2004). Forty-two (42) of these firms also participated in phase
2 (2007).
Population. The target population of the survey is the small and medium-sized
independent medical biotechnology companies in Finland, Sweden, San Francisco Bay Area,
Philadelphia area and South Florida. These areas were chosen so that firms from different
institutional environments (Nordic and American) would be included. Furthermore, some
areas have long roots in biotechnology (like Bay Area and Pennsylvania), others have
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experienced a dominance of large pharmaceutical companies in the past (Sweden), and some
areas have only witnessed rapid growth in the biotechnology field over the past decade
(Finland and South Florida).
Sampling method. Random sampling ensures that the answers from a sample approximate
to what we would have got had we asked everyone in the population (Shadish et al. 2002).
Random sampling was used in this study to make the sample similar to the population.
Sampling criteria. The sample was stratified using the following criteria: (a) corporate
governance (independent firms), (b) employment size class maximum of 250 people
following the European Union’s cutoff for small and medium-sized enterprises, (c) industrial
sector: active in R&D in human therapeutics (drug discovery & development), diagnostics,
medical devices, and / or technology research that helps in developing the aforementioned
classes of products, and (d) product-orientedness (i.e. even if firms provide services as a part
of their business model, their main lines of business are about researching and developing
physical products).
Sampling frame. The random sample of companies included in this research was derived
from

the

industry

databases

of

BioFlorida

(www.bioflorida.org),

Pennsylvania

Biotechnology Association (www.pabiotech.org), Biotechnology Industry Organization
(www.bio.org) member directory of Californian companies, Directory of Finnish
biotechnology companies (www.finbio.net), and “The Swedish Biotech Industry Guide”
(http://biotech.idg.se/industryguide/).
Data collection method, phase 1. In order to collect valid and comprehensive data from
the sample firms face-to-face interviews were conducted with the CEO (in some cases the
business development manager or founder) of each sample firm in phase 1. This was
important for a number of reasons. First, in addition to a structured questionnaire, the phase
1 survey instrument included questions that were open ended and the analysis of which
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would be qualitative. Second, face-to-face contact gave the respondents a possibility to ask
for clarification if they did not understand some questions. Third, a personal visit and data
collection minimized the amount of missing data.
The interviewees were told about the general purpose of the research before the
interviews, but they were not shown the questionnaires. In the actual interview the session
started with questions about company demographics, after which open-ended questions were
presented. It was important to ask the open-ended questions before the interviewees filled in
the standardized scales so that the answers to the open-ended questions would not be biased
by the scale items. Overall, the questionnaire worked well and the personal interview
approach resulted in a minimal amount of missing data. Table 11 below summarizes the
positions of phase 1 interviewees (n=85). More detailed response patterns by region will be
described shortly.

Table 11: Position of interviewees, phase 1
Position
CEO
Founder
CEO and Founder
Vice President, Bus. Dev.
Total

N
48
2
19
16
85

Percentage
57
2
22
19
100

Phase 1 data collection with the survey instrument took place between October 2003 and
June 2004. In 2003 and 2004 the biotechnology industry worldwide rebounded from the
depressed stock market conditions of 2001 and 2002. Increasingly, pharmaceutical and
medical device companies were converging with health care providers. The number of
publicly traded biotech companies declined slightly in 2003 to 611 from 619 in 2002, but
these companies earned 17% more in revenues and hired more workers, boosting
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employment by 9% while reducing R&D spending by 16% and improving their net loss by
65% (Ernst&Young 2004).
Data collection method, phase 2. The purpose of the phase 2 data collection effort was to
follow up with the firms first interviewed in phase 1. Phase 2 data collection started in May
2007 by secondary data collection from online sources to determine the status of each firm
and original respondent. Sixty of the original 85 firms were still operating as independent
businesses. In 43 of these 60 firms the interviewee from phase 1 was still in the same
position as in 2003-2004 or had even been promoted. In these 43 cases, phase 2
questionnaire was mailed to this individual. In the remaining 17 cases the new company
CEO received the questionnaire. Mail survey was employed in phase 2 data collection
because it allowed a maximum amount of information to be collected from a maximum
number of geographically dispersed firms in a minimum amount of time. The survey
questionnaire was identical to the structured interview guide that had been used in phase 1
except that items on technology licensing were added for phase 2 and some questions were
re-organized.
Before sending out the survey questionnaire, an executive summary of phase 1 research
results was mailed to all respondents. The actual questionnaire with an introductory letter
followed two weeks after the executive summary. To increase the response rate of the mail
survey, a postcard reminder as well as two additional copies of the mail questionnaire were
mailed to the respondents within specified time intervals after the initial mailing of the
questionnaire as suggested by Dillman (1991). Dillman (1991) also summarizes a number of
other techniques that have been proven to increase response rates in mail surveys. The
following techniques were employed in phase 2 to increase the mail survey response rate: (1)
ordering questions to assure that interesting ones related to the topic described in the cover
letter come first; (2) printing the questionnaire in a booklet format with a topically neutral
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cover; (3) use of four carefully spaced mailings, including a postcard follow-up one week
after the original mailing, a replacement questionnaire and cover letter informing the
recipient the questionnaire has not yet been received four weeks after the original mailing,
and a second replacement questionnaire and cover letter approximately seven weeks after the
first mailing; (4) individually printed, addressed, and signed letters; (5) addresses printed
onto envelopes rather than on address labels; (6) use of smaller than usual business
stationery to reduce costs and make the entire request appear smaller and easier to comply
with; (7) cover letter content that includes descriptions of the study’s social usefulness and
why the respondent is important; (8) explanation of how respondent confidentiality is
protected, and (9) folding of outgoing materials in a way that contrasts with advertising mail.
(Dillman 1991)
Phase 2 data collection with the survey instrument took place between May and October
2007. Over the past years the product pipelines of the global biotechnology companies have
been strengthening, their financial performance improving, and the field has seen
consolidation between companies with complementary product pipelines. The number of
publicly traded biotech companies in the world reached 710 in 2006 (compared to 611 in
2003) and these – as well as private biotechnology companies – are increasingly profitable,
indicating the increasing maturity of the biotechnology sector. In 2006 the global
biotechnology industry registered strong revenue growth across all leading biotechnology
regions of the world; 13 % in the US and in Europe and 22 % in Canada, and the industry
also made some advances toward overall profitability (Ernst&Young 2007).
Response patterns. BioFlorida is an organization that promotes the biotechnology
industry in the state. Its goals include providing an infrastructure for companies, research
community - both private and governmental - and others to exchange information and ideas
(networking), providing and promoting education and other programs to assist biotechnology
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companies and attracting financial resources for BioFlorida members. At the start of phase 1
data collection in 2003, BioFlorida listed 160 companies active in biotechnology in Florida.
The companies were assessed for the sampling criteria, and the CEOs 18 of the firms (28) that
fulfilled the sampling criteria of this research were sent an e-mail and asked about their
interest to be included in phase 1 research (personal interview). Twenty-two managers
answered and with 19 of them it was possible to set a time for a face-to-face interview. All
these interviews were conducted in the end of 2003. By May 2007, beginning of phase 2
data collection, seven of the firms interviewed for phase 1 had either been acquired or
merged (4 firms) or had ceased to exist without information on what happened to the firm (3
firms) 19 . Out of the twelve firms that were still in operation as independent firms in May
2007, phase 2 survey data were received from five firms. In all five firms the respondent was
the same person as in phase 1 data collection.
In a similar way, the Pennsylvania Biotechnology Association listed 170 firms in May
2003. Again, these companies were assessed for their characteristics and those that fulfilled
the criteria of this research were approached by e-mail (43 companies). In Pennsylvania it
was possible to set times for 14 interviews with managers of firms in the Delaware Valley
area. One of these interviews turned out to be unusable because the interviewee – even
though very willing to discuss trends in biotechnology in general – was not able to answer
the questions presented. He kept on talking about issues related to the questions presented,
but within the one-and-a-half hours spent with him, only about 5 per cent of the whole
questionnaire got filled in. Thus, the phase 1 sample from Pennsylvania comprises 13 firms.
18

Company CEO was always approached first and in most cases he / she also served as the respondent.
Because the firms are young and small, often this CEO had also started the firm. In some cases (larger firms)
the CEO appointed a business development manager to be interviewed for the study.
19

Assessment of company status in May 2007 was based on data available on companies’ websites, from their
operators, from interviewees of phase 1 whenever they could be reached, and from online press archives, such
as LexisNexis.
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By May 2007, one of these firms had disappeared and 2 had been acquired. From the 10
Philadelphia-area based firms approached in phase 2 data collection, nine provided data.
Eight phase 2 respondents here were the same individuals as in phase 1 interviews. In one
company the CEO had changed and the new CEO filled in the questionnaire in phase 2.
Of the 256 firms listed by the Biotechnology Industry Organization in California in early
2004, 78 were evaluated as suitable for the study based on sampling criteria, and they were
contacted. Of these firms, phase 1 interviews were conducted in 26 Bay Area firms. By May
2007, six of these firms had gone through a merger or had been acquired and two firms had
ceased to exist altogether. Of the remaining 18 Bay Area firms that were approached for data
collection in phase 2, ten firms participated. In all ten firms phase 2 respondents were the
same individuals as the phase 1 interviewees.
In Finland the Finnish Biotechnology Industry Association listed a total of 128 firms in
the country in the beginning of 2004. Of these, 28 firms were evaluated as suitable for this
study. They were approached either by phone or by e-mail in January – February 2004, and
20 managers agreed to a phase 1 face-to-face interview. In May 2007 14 of these firms still
existed as independent companies; four had been acquired / merged and two had closed their
operations. In Finland, phase 2 data were received from thirteen firms. In five firms the
respondent had changed form phase 1.
Finally, in Sweden phase 1 data collection was completed within a five-day period in the
Gothenburg – Linköping area. Based on the directory used, 34 biotechnology companies
were active in the area at the time of the phase 1 interviews, and of them, 16 were deemed
suitable for this study. Of these 16 firms approached, interviews were conducted in seven
firms in phase 1. Six of these firms were still in operation in May 2007; one firm had been
acquired. Phase 2 data were received from five Swedish respondents, four of whom had also
been informants in phase 1.
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It should be pointed out that the phase 1 data collection in Sweden as well as in
Pennsylvania was carried out within a very short period of time (five days in Sweden in
February 2004, seven days in Philadelphia area in Pennsylvania in October 2003).
Consequently, because of the busy schedules of the managers, some of those willing to be
interviewed could not be included in the sample. In Finland the data collection was
completed over the months of January and February 2004, in South Florida in NovemberDecember 2003, and in the San Francisco Bay Area in April-June 2004.

Description of the survey response

Non-response bias is a potential problem in any sample survey; non-response error
represents a failure to obtain information from some parts of the population. Specifically,
non-response is a problem if those included in the sample differ systematically from those
who did not respond (Armstrong and Overton 1977). Figure 10 presents the response
analysis of the study.
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Sample frame
CA
PA
FL
SE
FI

78
43
28
16
28

Total 193
firms

25 do not exist
as independent
firms anymore

50 declined to
participate

49 no reply

8 not possible to
schedule
interview
because of time
conflicts

Phase 1: 107
firms did not
participate

8 declined to
participate

10 no reply

94 agreed to
participate

86 interviews
conducted,
85 usable
interviews. The
effective
response rate in
Phase 1 of data
collection is (86 /
193*100%) =
45%

Phase 1, completed in 2003-2004

42 provided data.
The effective
response rate in
Phase 2 of data
collection is (42 /
(85-25)*100%) =
70%

Phase 2, completed in 2007

Figure 10: Response patterns in the empirical study
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The phase 1 response rate of 45% is rather good, especially considering that a onehour commitment was needed from the CEO of the company. The only incentive given
for participation was access to research results. The actual length of the phase 1
interviews varied between 40 minutes and a bit over two hours. Most interviews,
however, lasted for about one hour.
In some of the 49 firms that did not respond the interview request possibly never
reached the CEO of the firm. Often, the e-mail addresses of CEOs were not available
and e-mails to the general company addresses (info@company.com) seldom resulted in
replies. Telephone calls reached the managers’ secretaries, and despite their promises,
the managers seldom called back.
The phase 2 response rate of 70% is in line with the response rates summarizes in
Dillman (1991) for other mail surveys that have employed similar steps in carrying out
a survey. The response rate of 70% was only achieved after multiple rounds of mailings
as described earlier. In many cases, the respondents were also contacted by phone and
encouraged to respond. Those managers who said they couldn’t answer because of the
length of the questionnaire were encouraged to fill in at least those parts of the
questionnaire that collect data for the dependent variables of the study. Because of this,
phase 2 data contain many more missing values than phase 1 data. For example, values
for entrepreneurial opportunity recognition in phase 2 are available from all 42
respondents, but market knowledge in phase 2 is only available for 36 cases (85 cases in
phase 1) and entrepreneurial orientation in phase 2 for 35 cases.
One method for estimating non-response bias is to compare results from a survey
with known values of the population (Armstrong and Overton 1977). To assess non-
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response bias, Table 12 describes the company age of the phase 1 sample firms (n=85)
and non-respondents (n= 107) area by area. The purpose of the table is to show that
respondents do not significantly differ from non-respondents. The data is based on the
companies’ websites; for firms in the sample, information provided on the website was
confirmed in the interview, whereas for non-respondents, the data is based on website
information only. All of these firms in each area were contacted, and those who did not
respond to the inquiry about their willingness to be interviewed for the research or
responded negatively are classified as non-respondents.
Table 12 reveals that in South Florida and Finland the sample firms are, on average,
older than the non-respondents. In the three other locations the sample firms are
younger than the non-respondents. However, only in the Bay Area of California does
the difference in age between the two groups turn out to be significant (t-test p-value <
0.05). There are two possible explanations for this. First, it may be that in some cases –
despite numerous trials – attempts to contact the CEOs of larger firms did not go
through. For example, in larger firms the managers’ secretaries may scan the managers’
e-mails, in which case interview invitations could have been deleted without the actual
managers ever seeing them. Furthermore, when contacting companies by phone, in
larger firms managers’ secretaries - instead of the managers themselves – typically
answered. Even though the secretaries often promised to forward the interview request
to the manager in question, this may not always have been the reality. In smaller firms
the manager herself was often reached by phone. Another possible explanation is that
larger firm managers are busier and do not have time for research interviews. In fact,
many of those who turned down the interview invitation said that they were too busy to
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devote time to the study. One more speculation is that larger firms often have
“professional” managers, whereas smaller firms are typically run by scientists who have
been PhD students themselves. It may be that these ex-PhD students sympathized with a
PhD student and were more willing to agree to be interviewed.

Table 12: Age of sample firms and non-respondents 20

Firm Age
Mean

S.D.

Non-respondents 21
Mean
S.D

South Florida, USA

7.47 (n=19)

5.40

7.00 (n=9)

7.38

Pennsylvania, USA

5.61 (n=13)

4.39

7.41 (n=29)

6.68

3.50** (n=26)

2.94

5.38** (n=52)

4.02

5.14 (n=7)

1.86

7.00 (n=9)

8.46

6.45 (n=20)

3.78

4.75 (n=8)

3.70

Sample firms

Bay Area, Northern
California, USA
Sweden, Gothenburg
Area
Finland

**= Significant at p < .05

Chi-square tests were conducted to analyze if there were significant differences
between respondents and non-respondents in terms of industry sectors. The only
significant difference between the sample firms and the non-respondents can be
observed for diagnostics firms in Pennsylvania. There, the count for diagnostic firms in
20

Because of the small n in many categories the results should be interpreted with caution.

21

Non-respondent here means that the company was determined to fulfill the criteria to be included in the
sample and the company was contacted to ask for interview appointment, but either the company never
responded or the response was negative.
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the sample is zero, whereas there are four non-respondents that are diagnostics firms.
Even though the difference is significant (p<0.05), the overall count of diagnostics firms
is very small and selection bias is hard to prove.
Finally, companies that participated in both phase 1 and phase 2 data collection
(n=42) were compared to those that participated in phase 1 but were non-respondents in
2007 (n=18). An independent samples t-test revealed that the two groups of companies
are not significantly different from each other with regard to any of the variables chosen
for the analysis (firm age, number of employees, amount of sales, number of patents,
and level of market knowledge).

Quality of the study - testing, checking and validation procedures

The first ten interviews in phase 1 also served as a pilot test for the questionnaire that
was later also used in phase 2. Because the final questionnaire was developed based on
a preliminary, qualitative study as well as the extant literature, it was expected that not
many changes would be necessary after the pilot testing. In the pilot testing stage, i.e.
during the first ten interviews, the respondents were asked to pay extra careful attention
to the formulation of the questions and give feedback on any possible problems or
challenges. The feedback and the actions taken are summarized in Appendix 2.
Even though minor changes were made to the questionnaire based on the pilot testing
(see Appendix 2), the changes were not of such dramatic nature that they would have
justified dropping all or some of the first ten interviews (pilot testing) from the sample.
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Consequently, the interviews that served as pilot tests for the questionnaire remained in
the final sample.

Single-respondent bias

There is considerable debate concerning the effect of leaders on organizational
outcomes. At one extreme, Perrow (1970) argued that “leadership” approaches to
organizational analysis represent a form of psychological reductionism and understate
the effect of systemic influences on organizational outcomes. At the other end,
however, there is evidence that suggests that the characteristics of key organizational
actors cannot be ignored when studying organizations. For example, those who allocate
organizational resources also influence innovation adoption (Hage and Dewar 1973).
Especially in small firms, the characteristics and skills of the entrepreneur-manager
influence all aspects of business.
A common problem in researching small firms is that secondary, objective data on
these firms is not readily available. Most firms in the current sample are very small and
they do not publish their financial information. Thus, the only way to assess company
financials, for example, is to ask the managers. Controlling the accuracy of the
information they provide is difficult. In this study, in addition to asking the managers
about their firms’ performance, multiple company databases were searched through in
order to find objective numbers that could be compared to those given by the managers.
Demographic data is readily available from multiple sources for the public companies in
the sample (n=12 in phase 1), and it matches very well the numbers given by the
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interviewees. However, only scarce data is provided by secondary sources for the
private biotechnology companies; sales information is the piece of information most
commonly available. Thus sales data were collected from secondary databases for as
many sample firms as possible. The correlations between these secondary data and the
data provided by the respondents were reported earlier in Table 10. Overall, the positive
correlations between primary and secondary sales data were comfortably high.
Consequently, based on the sales data there seems to be no reason to suspect that the
respondents have been giving biased information. The Wilcoxon Signed-Rank test was
also employed to detect differences in the distributions of sales as reported by the
interviewees and the sales data obtained from secondary sources. The 2-tailed p-value
for this test was non-significant (p = 0.121); the distribution of sales obtained from
secondary sources is not different from the sales data provided by the respondents.
In research where measurements of different variables are collected from the same
respondents and an attempt is made to interpret any correlations between those
variables, common method variance can be a problem that biases the research results
(Campbell and Fiske 1959). Because the measurements come from the same source, any
“defect” in that source contaminates both measurements, presumably in the same
fashion and in the same direction. Because the variables of this study were obtained
from a single key informant per firm, a possible common method bias was assessed
using the Harman one-factor test (Podsakoff and Organ 1986). Because of the relatively
small number of cases in the dataset (n=85), the factor analysis had to be limited to
selected sets of variables at a time. Hence I selected eight variables at a time for factor
analysis. The variables were selected from different constructs that the questionnaire
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was desired to tap in order to detect possible common method bias. Altogether, three
sets of eight variables were chosen for factor analysis. For each set of variables
analyzed, the results of the principal components analysis revealed three factors with
eigenvalues greater than 1.0. These results (even with limited sets of variables at a time)
seem to indicate that there is no one general factor in the unrotated factor structure.
Hence common method bias should not be a great concern.
In seven firms the phase 2 respondent is a different person than phase 1 respondent.
If the respondents’ answers to the survey questions reflected their own personal
attributes rather than those of their organizations, the estimates obtained from these
different respondents for constructs like market knowledge and entrepreneurial
orientation would be more dissimilar to phase 1 estimates than in the case of the same
respondent in both phases. An independent samples t-test was used to analyze whether
these differences were significant. For the same respondent in phase 1 and phase 2, the
average absolute difference in market knowledge mean between phase 1 and phase 2 is
.489 (n=30). This is not significantly different (p= .628) from companies where phase 2
respondent was different from phase 1 respondent: Average difference in market
knowledge mean .560 (n=6). Similarly, for the same respondent in phase 1 and phase 2,
the average absolute difference in entrepreneurial orientation mean between phase 1 and
phase 2 is .440 (n=29). This is not significantly different (p= .760) from companies
where phase 2 respondent was different from phase 1 respondent: Average difference in
entrepreneurial orientation mean .405 (n=6). Even if the small number of cases in the
group where the respondent of phase 2 is different from phase 1 respondent makes the t-
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test results somewhat unreliable, these findings still provide some comforting evidence
about the absence of single respondent bias.

Validity and reliability of the measurements

Valid measurement is a prerequisite for the successful study of concepts. Constructs
such as knowledge, attitudes and behavior cannot be directly and perfectly measured
with one item. Validity refers to the degree to which an instrument is truly measuring
the construct it is supposed to measure (Peter 1981).
Cook and Campbell (1979) divide validity into four related components: statistical
conclusion validity, internal validity, construct validity and external validity. Each one
of these is discussed in the following.

Statistical conclusion validity

Statistical conclusion validity refers to the appropriate use of statistics to infer
whether the presumed independent and dependent variables co-vary and – if they do –
how strongly do they co-vary. We can incorrectly conclude that cause and effect covary when they do not (type I error) or incorrectly conclude that they do not co-vary
when they actually do (type II error) (Shadish et al. 2002). In this study, the most severe
threat to statistical conclusion validity arises from the use of a rather small sample
(n=42) of firms. However, it is worthwhile mentioning that a number of important
contributions to literature on the effects of market knowledge and market orientation
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have been based on similarly small samples. The sample of Appiah-Adu (1998)
included 74 firms, Caruana, Ramaseshan and Ewing (1998) 84 organizations, Dawes
(2000) 93 organizations, Deshpandé and Farley (1998) 82 organizations, Langerak
(2001) 72 firms, Ngai and Ellis (1998) 73 firms, Pelham and Wilson (1996) 68
organizations, and that of Slater and Narver (2000) 53 firms.
Despite the small dataset, longitudinal research design improves the validity of the
study. A small sample size would be very problematic in a study where new scales
would be developed for the measurement of various constructs. However, in this study
established scales are used for the measurement of latent constructs as described earlier
to avoid this problem. What is more, the phase 1 face-to-face data collection increased
the internal as well as the construct validity of the research as will be described below.
Given the limited resources of one researcher, using such a personal data collection
method to access more than 85 firms in phase 1 would have required more time and
money than was available. Thus, the sample size was partly compromised in order to be
able to collect data that would satisfy the internal validity and construct validity
requirements.
Shadish et al. (2002) suggest a number of strategies to increase the statistical validity
of a research. In this study, as reliable measurements as possible were chosen for the
variables of interest. Whenever possible, measurements were chosen that had shown
high reliability in previous studies, because a conclusion about co-variation may be
inaccurate if either variable is measured unreliably (Nunnally and Bernstein 1994).
Also, restricting variables to a narrow range was avoided; in the statistical analyses
continuous variables were not dichotomized. What is more, the fact that the units of
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analysis, and, more importantly, respondents, represent a relatively homogenous group
of companies in terms of firm demographics should increase the statistical conclusion
validity. The more the units in a study are heterogeneous within conditions on a
variable, the greater will be the standard deviations on that variable (and on any others
correlated with it). With regard to statistical conclusion validity, Bouckenooghe, De
Clercq, Willem, & Buelens (2007) note that 40 per cent of the published
entrepreneurship research in recent years has used only one dependent variable in a
study. In the current study, statistical conclusion validity should be improved through
the use of multiple dependent variables. Finally, to increase statistical conclusion
validity as accurate effect size estimation as possible is sought. Before conducting the
statistical analyses the data were scanned for potential outliers that would cause the
distribution to depart from normality.

Internal validity

Internal validity refers to inferences about whether observed co-variation between A
and B reflects a causal relationship between A and B in the form in which the variables
were measured (Shadish et al. 2002). In a cross sectional study, we should be concerned
about ambiguous temporal precedence. Current research in the field of entrepreneurship
is mostly cross-sectional in nature, which should raise concerns about potential reverse
causality between variables (Bouckenooghe et al. 2007). In this research, careful
attention was paid to the research design in order to ensure that the observed
relationships reflect the directionality of the co-variation between the variables under
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study. Data on independent variables were collected about 3.5 years before the data on
dependent variables.
Systematic differences in respondent characteristics from those of the population of
interest can also cause the observed effect. The key feature of such a selection bias is a
confounding of observed effects with population differences (Shadish et al. 2002). For
example, if the market knowledge in a young biotechnology firm is largely determined
by the quality of the management team, and if the firms included in the current sample
systematically represent firms that were established by teams of PhDs and serial
entrepreneurs (high quality teams), we should be concerned about the internal validity
of the results. In this case it would be possible that significant relationships between, for
example, a firm’s level of market knowledge and the money invested in the firm could
be a result of a confound effect of the firm’s management team.
Comparing sample characteristics to population characteristics was carried out when
discussing the non-response bias above. Overall, the sample seems to be representative
of the population, i.e. medical biotechnology SMEs in Finland, Sweden, South Florida,
Pennsylvania and San Francisco Bay Area. However, one more important concern
related to internal validity is the operationalization of variables of interest; do the
measurements employed in the empirical study really reflect the underlying constructs,
like market orientation? This question also relates to construct validity and is discussed
in the following.
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Construct validity

Construct validity is the most salient indicator of measurement validity. It is
commonly regarded as consisting of two aspects: convergent and discriminant validity.
Convergent validity is the degree to which multiple independent attempts to measure
the same construct are in agreement. Hence, it is also related to scale reliability, which
will be discussed later. Discriminant validity is the extent to which measurements of
two or more different constructs are distinct (Peter 1981; Bagozzi, Yi and Phillips
1991). Exploratory factor analysis and principal component analysis (PCA) are typical
ways to analyze the initial construct validity and underlying dimensions of scales.
However, these analyses are extremely sensitive to small sample sizes like the one in
this study. Hence construct validity is assessed via means other than PCA and factor
analysis.
The measurements of market intelligence generation and dissemination (used here as
a proxy for market knowledge) were originally developed by Kohli et al. (1993) based
on previous, qualitative work by Kohli & Jaworski (1990). Since then, the scale has
been used and its reliability tested in numerous empirical studies and various industry
contexts (Siguaw et al. 1998; Matsuno et al. 2002; Perry and Shao 2002; Kyriakopoulos
and Moorman 2004; Kara et al. 2005). Similarly, the entrepreneurial orientation scale
used here was originally developed and tested by Knight (1997) based on Covin &
Slevin (1989). Patents and R&D intensity as well as outcome measures such as sales
and capital invested are widely used measures as well. The only measurement employed
in this study that has few predecessors in existing research is the measurement for
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entrepreneurial opportunities recognized. As described earlier, this measurement in the
current study was developed keeping the industry context in mind. Conceptually,
exploited and recognized opportunities are two separate constructs and, hence, they
should not share variance. To check this in the empirical dataset, a measurement for
exploited opportunities was developed. Table 13 below shows the correlation
coefficients between exploited and recognized opportunity measures in this study for
both phase 1 and phase 2 data. High positive correlations in the dark-shaded areas
provide evidence of convergent validity; measurements of the same construct with the
same instrument at two points of time (approximately 3.5 years apart) indicate
consistency. Non-significant correlations in the lighter shaded areas, again, should
provide evidence of discriminant validity. With the exception of highly significant
positive correlation between items 1 and 3 (Table 13) they do.

Table 13: Correlations between recognized and exploited opportunities
Variables
1. Entrepreneurial
opportunities recognized,
phase 1 (log)
2. Entrepreneurial
opportunities recognized,
phase 2 (log)
3. Entrepreneurial
opportunities exploited, phase
1 (log)
4. Entrepreneurial
opportunities exploited, phase
2 (log)

Mean

SD

1

2

3

1.92

1.26

1

1.54

1.28

.753***

1

2.07

.91

.354***

.232

1

2.16

1.18

.233

.237

.317*

4

1

*** Correlation is significant at the 0.01 level (2-tailed); ** Correlation is significant at the 0.05 level (2tailed); * Correlation is significant at the 0.1 level (2-tailed). N = 85 for phase 1, n = 42 for phase 2.
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In the current study, business philosophy items, used by Harris (2001; 2002) and
adapted from Deng and Dart (1994) and Peterson (1989), were used to check the
construct validity of the market knowledge scale. These items are supposed to measure
the sales, production, customer, stakeholder, and technology focus 22 of the organization
(for actual items, see questionnaire in Appendix 1). Table 14 lists the correlations
(Pearson) between business philosophy and the composite market knowledge
measurement (mean) calculated for each firm. As expected, there is a significant
positive correlation between the market knowledge measurement and customer focus
(0.244) (evidence of convergent validity). Correlations between market knowledge and
business philosophy items other than customer focus turned out to be insignificant
(evidence of discriminant validity).

Table 14: Correlations between market knowledge and business philosophy
Variables

Mean

SD

1

2

3

4

5

1. Business philosophy,
production focus

2.95

1.30

1

2. Business philosophy,
sales focus

3.87

1.14

.355***

1

3. Business philosophy,
customer focus

4.01

.963

.039

.309***

1

4. Business philosophy,
stakeholder focus

3.62

1.06

.231**

.257**

.146

1

5. Business philosophy,
technology focus

4.37

.889

.193*

.275**

.051

.327***

1

6. Market knowledge

3.79

.462

-.172

-.025

.244**

.089

-.097

6

1

*** Correlation is significant at the 0.01 level (2-tailed); ** Correlation is significant at the 0.05 level (2tailed); * Correlation is significant at the 0.1 level (2-tailed). All items measured in phase 1 (n=85).
22

Items for production, sales, customer and stakeholder focus were formulated similarly to previous
studies, and the item for technology focus was formulated specifically for this study.
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As a conclusion, the construct validity of the key measurements of the empirical
study appears to be solid.

External validity

External validity concerns inferences about the extent a causal relationship holds
over varying conditions, like variations in people, settings and outcomes (Shadish et al.
2002, 83). Thus the question of external validity is essentially a question of
generalizability. Shadish et al. (2002, 87-90) distinguish between five different threats
to external validity. Of those five, the relevant threats in this study concern the
interaction of the causal relationships with units (i.e. firms being studied), with
outcomes (i.e. the kinds of performance measurements employed in this study) and with
settings (e.g. medical biotechnology industry).
The threat of interaction of the observed causal relationship(s) with the units of the
study can be avoided through random sampling. The sampling procedures of this study
were described in detail earlier, and they aimed at guaranteeing a random sample of the
population, i.e. of the small and medium-sized independent medical biotechnology
companies in Finland, Sweden, San Francisco Bay Area, Philadelphia area and South
Florida. Random sampling – within the limits of sampling error – guarantees that the
average relationships observed in the sample are the same as (1) the average
relationships that would have been observed in any other random sample of companies
from the same population, and (2) the average relationships that would have been
observed across all other firms in that population which were not in the original random
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sample. Thus random sampling should eliminate possible interactions between the
causal relationship(s) observed and the class of firms who are studied versus the class of
firms who are not studied.
As described earlier, markets for biotechnology are global in nature. However,
because of the different institutional settings in, e.g., the USA versus Europe,
companies’ approach to stakeholders such as venture capitalists or governmental
organizations may vary. It is possible that in differing country settings types of
knowledge manifest differently in young biotechnology firms and, furthermore, their
consequences on entrepreneurial opportunities and profit potential could differ. This
potential importance of physical location led to the deliberate decision to sample firms
in five locations on two continents. This has benefits for external validity. It allows tests
of the interaction between the relationships observed between the variables of interest
and firm location in the study data. If an interaction is detected (i.e. if firm location
moderates the firms’ knowledge levels and their contribution to opportunity recognition
or profit potential), this is prima facie evidence of limited external validity across
geographical locations (Shadish et al. 2002).
The careful selection of dependent variables that was described earlier should reduce
the possible threat that the detected causal relationships actually interact with the
outcomes (i.e. the kinds of dependent variables employed in this study). Also, a number
of different measurements are used to capture profit potential, and entrepreneurial
opportunity recognition is measured with a scale of multiple items. These actions
should further reduce the threat of interaction of study findings with the chosen
dependent variables.
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Generalizations to other firms should – as always – be made cautiously, but there is
no reason to suspect that the findings of the study are systematically biased and / or
non-representative of the target population.

Face validity

An instrument is said to have face validity if it “looks like” it is going to measure
what it is supposed to measure. At the end of each phase 1 interview the interviewee
was asked to comment on the interview; what did he / she think about the relevance of
the questions asked? Was there something that was not asked even though he / she
thought it was an important aspect of market orientation? Overall, the interviewees were
satisfied with the interview experience and many of them commented that the issues
covered in the questions were very important in their everyday work. However, some of
the interviewees mentioned that rather than business issues they were more preoccupied
with advancing technological development. Some of the most insightful comments by
the interviewees about the relevance and quality of the questions asked are listed below:

“Marketing being commonsense, a lot of questions here are about reacting quickly.”
”Answers to your questions are different for different products. When I was
answering I had this one specific product in mind, but if I had thought of another
product my answers would have been different.”
“Why do you need to have a scale from 1 to 5 for questions that are clearly yes / no
questions?”
”What does this word ”periodically” mean really? I don’t think it matches the
thinking of a dynamic company.”
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“Cultural desires. They are missing from the questions. In some countries doctors
want something that is not acceptable in other markets. Country-based changes in
products.”
“Very few early stage companies are interacting directly with patients, it is a
stepwise process. But the data is already important in the early stages. We picked small
indications because they require smaller clinical trials.”
Based on the feedback received from interviewees in phase 1 as well as the few
comments written on the questionnaires by phase 2 respondents it can be concluded that
most respondents felt that the questions asked were relevant for their firms’ strategies
and operations.

Reliability

Reliability is a matter of internal consistency; the degree to which the instruments are
free from error and thereby yield consistently accurate measurements of the construct of
interest (Churchill 1979; Peter 1979). The most popular method for assessing
measurement reliability in cross sectional research is Cronbach's alpha (Cronbach
1951). Cronbach's alpha summarizes the extent to which a set of items are interrelated
with each other (Churchill 1979; Peter 1979). Cronbach’s alpha is formulated as:
k
⎛
⎜ ∑ δ i2
⎛ k ⎞⎜
α =⎜
⎟⎜1 − i 2
1
k
−
δt
⎝
⎠
⎜
⎝

⎞
⎟
⎟
⎟
⎟
⎠

where k = number of items in the scale; δ t2 = total variance of the scale, and δ i2 =
variance of item i.
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Table 15 shows the values of Cronbach’s alpha for the scales used in the empirical
study for both phases of data collection. Only values from the phases on grey
backgrounds in Table 15 were used in analyses. Naturally, no reliability coefficients can
be computed for variables measured on a unidimensional scale consisting of a single
question. Skewed distribution toward socially desirable responses is a common problem
with self-response measurements. Since the distribution is skewed for practically all
items on the scales, it was not possible to eliminate a subset of them. Because these
variables are important for the analyses, they were retained and used in further
statistical analyses. Because the original distribution of the “entrepreneurial
opportunities recognized” scale was not normal, a log-transformed value of the scale
was used in analyses.

Table 15: Scale reliabilities

Scale (number of
items)

Mean

Phase 1 (n=85)
SD
Cronbach’s α

Mean

Phase 2 (n=42)
SD
Cronbach’s α

Market knowledge (22)

3.79

.462

.753

3.60

.581

.877

Entrepreneurial
orientation (7)

3.86

.608

.719

3.88

.547

.633

Entrepreneurial
opportunities
recognized (4), mean

15.77

33.95

.664

10.13

15.69

.882

Nunnally (1978) and Churchill (1979) suggest that for a reliable scale, Cronbach’s
alpha should be over 0.7. Here, the alpha coefficients range from 0.664 to 0.877,
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indicating sufficient reliabilities. Since data from 42 companies are available at two
points of time (phase 1 and phase 2), reliability of measures was also assessed using
test-retest analysis. These results are reported below in Table 16.

Table 16: Test-retest correlations and mean differences

N

r

Correlations
r2
Sig.

Mean

Paired differences
t
df Sig.(2tailed)

Pair 1

Market
knowledge

36

.426

0.181

.010

.168

1.75

35

.089

Pair 2

Entrepreneurial
orientation

35

.486

0.236

.003

.024

.286

34

.777

Pair 3

Entrepreneurial
opportunities
recognized (log
transformed)

39

.753

0.567

.000

-.241

-1.77 38

.085

Results of the test-retest study are presented in Table 16. Considering all three scales,
the lower R-square (for market knowledge) is .181, the highest one (for entrepreneurial
opportunities recognized) reaches .567. None of the t-tests are significant at p < 0.05,
but two are significant at p < 0.10, indicating that the distribution of values for market
knowledge and entrepreneurial opportunities recognized are somewhat different for
phase 1 vs. phase 2 data. In summary, the significant positive correlations (all at p =
0.01 or lower) and non-significant or only marginally significant (at p < 0.085 or
higher) paired t-test values for the four scales are comforting.
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Data analysis

Multiple linear regression

Multiple linear regression analysis is a tool for assessing the relationship between
one dependent variable and a number of independent variables. The technique is used to
test models that help to predict the dependent variable based on the (known) values of
the independent variables (Hair, Anderson, Tatham and Black 1995). The resulting
model indicates the relative contribution (weight) of each independent variable on the
dependent variable. Multiple linear regression is used to test Hypotheses 1-4. The basic
multiple regression model has the following form:
Yˆ = b0 x0 + b1 x1 + ... + bn x n

In the equation above, Y is the dependent variable (for example, entrepreneurial
opportunities recognized), b0 a constant, xn an independent variable and bn the relative
weight of that variable. The main assumptions for using multiple linear regression are
normality of the variables, homoscedasticity (i.e. equality of variance) and
independence of the independent variables.
Given the moderating relationships within the research models, a second analysis
technique that was initially considered was structural equation modeling. However, this
technique was ruled out due to the sample size of the database.
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Normality and homoscedasticity in regression analysis

In this research the normality of the variables was tested by assessing the normality
of distribution graphically with the help of normal probability plots. This procedure is
widely used and recommended by experts (Hair et al. 1995). The findings of each
assessment were additionally verified by means of the Kolmogorov-Smirnov test for
normality.
The homoscedasticity of the variables is tested using Levene’s test. This test is
robust against departures from normality and thus particularly recommended (Hair et al.
1995). Variance-stabilizing transformations were applied in order to achieve equal
variances in cases where heteroscedasticity was present.

Independence of predictor variables

In true experiments, typical for the natural sciences, it is often possible to control the
introduction of independent variables. In such a case the overall importance of each
factor (for example, the proportion of the Y variance it accounts for) can be
unambiguously determined since its orthogonality with the other factors assures that its
effects on Y cannot overlap with the effects of the others (Cohen and Cohen 1983). This
is seldom the case in behavioral research and the social sciences. The presence of
multicollinearity between independent variables has a substantial effect on the results of
a regression analysis; it complicates determining the contribution of each single
variable. A common strategy for detecting multicollinearity is the calculation of the
tolerance value or its inverse, the variance inflation factor (VIF). The smaller the
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tolerance value, the higher the multicollinearity. When running the regression analyses,
VIF values are calculated to assess multicollinearity.
In addition to the assumptions mentioned above, the existence of outliers – cases that
have large residual values – influences the result of the regression analysis (Belsey, Kuh
and Welsch 1980). When residuals are standardized by dividing them by their standard
deviation, a residual that is as much as three (or, certainly, four) of these units in
absolute size is reasonably considered an outlier (Cohen and Cohen 1983). As a
regression equation minimizes the squared residuals, an outlier not only makes a
relatively large contribution to the variance (thus reducing R2 of the model) but also
exerts a disproportionately strong pull on the regression. Outliers are, therefore,
particularly bothersome when they are all or predominantly of the same sign.
Outliers can incur the suspicion that they arose from some causal process different
from that operating on the bulk of the data, usually an error in recording or data input.
In the case of outliers in the dataset used in this dataset study, multiple checks of
original data documentations were made to confirm that the outliers did not result from
mistakes in data input. Typically, this was not the case. There were a few outlier values
for some of the variables (See Table 17) but, as suggested by Cohen & Cohen (1983),
these outliers were left alone because they were few and no error could be assumed.
Table 17 summarizes the key characteristics of original data. To test normality,
Kolmogorov-Smirnov tests were completed, and skewness values were computed for
each variable. Box plots were analyzed in order to detect outliers.
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Table 17: Data characteristics (original data)

n

Mean

Min/
Max values

S.D.

85

6.07

0/57

9.68

1/2

2.672

**

80

60.46

0/100

30.10

0/0

-.553

ns

Market knowledge (scale mean)

85

3.792

2.7/4.8

.462

0/0

-.341

ns

Entrepreneurial orientation (scale mean)

85

3.863

1.71/5

.608

2/0

-.655

ns

USA vs Scandinavia

85

.68

0/1

.468

--

-.798

ns

Firm age (years)

85

6.09

0/17

3.841

0/0

.898

ns

Number of employees

85

37.62

1/250

50.57

1/1

2.822

**

83

15.77

0/257

33.95

5/2

5.229

**

42

10.13

0/76.25

15.7

0/2

3.289

**

33

5489

0/38875

8202

0/1

2.456

**

Annual sales turnover 2006, USD thousands

44

13819

0/250000

45041

2/3

4.643

**

Sales growth between phase 1 and phase 2

31

4070

-100/58000

11430

0/4

3.956

**

Technology licensing & sales

40

1.45

0/14

2.552

1/1

3.386

**

Variable

Phase 1

Patents, mean of USPTO and reported
domestic approved patents
Share of R&D expenses (%) of all the
expenses of the firm

Phase 2

Skewness

KolmogorovSmirnov test
for normality
(**significant
at p<.05)

Number of
moderate /
extreme outliers

Entrepreneurial opportunities recognized
(mean of 4 item scale)
Entrepreneurial opportunities recognized
(mean of 4 item scale)
Capital raised by the firm, USD thousands per
year
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Based on tests for normality (Table 17) and the skewness values, the following
transformations were completed for the variables in the analysis to assure normality
(Table 18).

Phase 2

Phase 1

Table 18: Data transformations

Skewness of the
original variable

Transformation

Skewness after
transformation

Number of employees, current

2.822

Logarithm
LG10(X)

.019

Patents, mean of USPTO and
reported domestic approved patents

2.672

Logarithm
LG10(X)

.155

Entrepreneurial opportunities
recognized (mean of 4 item scale)

5.229

Logarithm
LG10(X)

.239

Entrepreneurial opportunities
recognized (mean of 4 item scale)

3.289

Logarithm
LG10(X)

.135

Capital raised by the firm, USD
thousands per year

2.456

Logarithm
LG10(X)

-.501

Annual sales turnover 2006, USD
thousands

4.643

Logarithm
LG10(X)

.799

Sales growth between phase 1 and
phase 2

3.956

Logarithm
LG10(X)

.313

Technology licensing & sales

3.386

Logarithm
LG10(X)

.754

After these transformations the variables were tested for normality and linearity again.
High significance values (p>.05) of the tests for normality indicate that the distribution of
the data does not differ significantly from a normal distribution after the transformations.
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V. RESULTS

The results of the empirical study are presented in the following. These results are
based on the data collected on the independent variables in phase 1 (2003-2004) and data
collected on dependent variables in phase 2 (2007). Since the instrument employed in this
study has been used before (Renko 2006a, b), parts of the description of sample firms
reported in the following can also be found in Renko (2006a).

Description of sample firms

Of the total of 85 interviews in phase 1, 58 were conducted in the US. The remaining
27 were divided between Finnish (n=20) and Swedish (n=7) companies. In Finland, the
sample companies are located in the three major cities, namely Helsinki, Turku and
Tampere. In Sweden, all seven companies are located in the Gothenburg area. Table 19
below illustrates the distribution of survey responses in phase 1 and phase 2 by
geographic region. The lowest follow-up (phase 2) response rate was obtained in South
Florida (42%) and the highest in Finland (93%). This partly reflects the differing levels of
success in reaching managers by phone. Scandinavian managers typically answered their
phones themselves, whereas US- based managers did not. Once reached by phone, many
were willing to help and respond. However, in those (numerous) US companies where
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the assistant / secretary of the manager in question decided that the survey was not worth
the manager’s time, it was impossible to get a response.

Table 19: Survey response by geographic region

Phase 1

Firm location

Finland
Sweden
Bay area, CA
Pennsylvania
South Florida
TOTAL

Between phase 1
and phase 2

Phase 2

Original N
in phase 1

Quit or
no
record

Merged /
acquired

Effective
N 2007

20
7
26
13
19
85

2
0
2
1
3
8

4
1
6
2
4
17

14
6
18
10
12
60

Reply
by mail

Reply
after
phone
inquiry

Effective
response
rate phase 2

4
4
3
7
5
23

9
1
7
2
0
19

93%
83%
56%
90%
42%
70%

Using company status in phase 2 as a “dependent variable”, an attempt was made to
distinguish those companies that were still in operation from those that had ceased to
exist or had merged or been acquired by other firms. Even though specific hypotheses
were not formulated with regard to the expectations of company status, it would be
logical to assume, based on existing literature in entrepreneurship as well as marketing,
that firms that had initially recognized more opportunities and had higher levels of
market knowledge, technology knowledge, as well as entrepreneurial orientation would
be the ones that survive. Also, based on the literature on liabilities of newness
(Stinchcombe 1965), one would assume older organizations to have better chances of
survival than new ones.
Table 20 lists the correlations between the three company status variables in phase 2
and selected independent variables in phase 1. The number of cases in each status
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category is as follows: Ongoing business = 60; merged or acquired (M&A) = 17; quit/no
records = 8. The strongest correlation is between market knowledge at phase 1 and the
M&A outcome in phase 2 (correlation coefficient .347, significant at p < .01). Market
knowledge is also significantly but negatively (p < .05) related to subsequent “quit/ no
records” category. This negative effect could have been expected based on the marketing
literature that emphasizes the positive performance and survival effects of market
knowledge and market oriented company culture (Kohli et al. 1993; Narver, Slater and
MacLachlan 2004; Mavondo, Chimhanzi and Stewart 2005), but the positive association
between market knowledge and ending up acquired or merged is not captured in the
existing empirical literature on market orientation or market knowledge. In the current
biotechnology environment, where opportunities for investors’ successful exit through an
initial public offering are few (Ernst&Young 2007), M&As offer an alternative exit
strategy and improved liquidity. Other financial objectives that can be achieved through a
M&A are increased shareholder base as well as improved opportunities to access new
sources of capital. The funds of larger institutional investors are only available to those
companies that first fulfill the sizable requirements for “minimum” market capitalization.
(McBeath and Bacha 2001) Assuming that involvement in a merger or acquisition is a
positive development, the marketing literature that has linked market knowledge to
positive firm level outcomes could explain this relationship. However, if the acquisition
or merger is a result of the firm losing its viability as a standalone business, the
relationship becomes harder to explain.
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Table 20: Correlations for selected phase 1 variables and company status in phase 2

Phase 2

Phase 1
Variables

Patents

R&D
intensity

Ongoing
business
Company
merged or
acquired

-.122
(69)

Quit / No records

Market
knowledge

Phase 2

Entrepren.
orientation

Location,
USA

-.061 (80) -.146 (85)

.134 (85)

-.052 (85)

.138
(69)

.081 (80)

.347** (85)

-.047 (85)

.025 (85)

-.004
(69)

-.016 (80) -.248* (85)

-.146 (85)

.047 (85)

Age

Size

Entrepreneurial
opp. recognized

Ongoing
business

Merged /
acquired

Quit /No
records

.036
(85)
.097
(85)
.076
(85)

-.028
(85)

-.053 (80)

1

.219*
(85)

.241* (80)

-.775**
(85)

1

-.256*
(85)

-.240* (80)

-.499**
(85)

-.161 (85) 1

Market knowledge, phase 1

4 .50

4.11
4 .00

3.75

3 .50

3.44

3 .00
0 .0

1 .0

2 .0

Company status, phase 2

Figure 11: Error bars showing 95% confidence interval of mean for
market knowledge by phase 2 status category

Entrepreneurial opportunities recognized, phase 1 (log)

*Correlation is significant at the 0.05 level (2-tailed). ** Correlation is significant at the 0.01 level (2-tailed). N in parentheses.

4 .00

3 .00

2.52
2 .00

1 .00

1.87

1.02

0 .00

0 .0

1 .0

2 .0

Company status, phase 2

Figure 12: Error bars showing 95% confidence interval of mean for
opportunities recognized by phase 2 status category
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Table 20 also shows how entrepreneurial opportunity recognition is related to the
outcome statuses in a way that is similar to market knowledge. However, even if these
correlations are significant at p < .05, they are not as substantial as the market knowledge
– status correlations. Figure 11 and Figure 12 further illustrate the differences between
the three status groups at phase 2 with regard to market knowledge and entrepreneurial
opportunities recognized at phase 1 (0= quit, 1= M&A, 2=ongoing business). Figure 11
shows how the middle category (M&A) is significantly different from the two other
categories using the 95% confidence intervals of market knowledge mean. Figure 12,
again, shows how the status categories with regard to opportunities recognized have
different means but still overlapping confidence intervals. Thus, evidence for the
discriminating power of market knowledge is quite convincing, whereas the relationship
between opportunities recognized and subsequent firm status remains inconclusive. The
non-significant correlations between firm age and outcome statuses suggest that there is
no evidence of liability of newness in this sample. The correlations between firm size and
M&A (correlation coefficient .219, significant at p < .05) and firm size and firm death
(correlation coefficient -.256, significant at p < .05) suggest that there is some evidence
of the liability of smallness in this sample. The latter (negative) correlation clearly points
towards the liability of smallness argument: Disadvantages of scale or a generally lower
talent of the management in small firms may contribute to their disproportionately high
dissolution rate (Strotmann 2007). However, the lack of a link between firm survival and
larger firm size somewhat dilutes the strength of this argument. Again, the positive and
significant relationship between M&A and firm size is somewhat surprising, but may be
indicative of a certain critical mass required for a firm to be an interesting acquisition
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target or a potential merger partner. Even if not the main focus of this study, these
relationships between firm-level attributes and subsequent survival of the firm provide
some interesting speculations for future research.
Next, some characteristics of those firms that participated in both data collection
phases are described. Tables that illustrate the descriptive statistics of the sample firms
are provided in Appendix 3. Some key features of these Tables as well as descriptive
numbers presented earlier in Table 17 are discussed in the following.
With regard to the positions of the interviewees in their respective organizations, 69 of
the 85 phase 1 interviewees were CEOs or founders, or both CEOs and founders of their
respective firms. The remaining 16 interviewees held managerial positions in business
development. These interviewees typically represent larger firms in the sample. The
distribution of respondent positions remained very similar in phase 2 data.
In terms of business focus, most of the sample firms (n=33 in phase 1) provide
technological tools and platforms in biotechnology. Some of these firms have a
secondary line of business where they develop their own proprietary drugs or devices; 29
firms indicated drug discovery and development as their main activity and 16 firms
represent the field of medical devices. One firm was categorized as a “fully integrated
pharmaceutical company”, but in the following analyses that include “field of business”
as a variable this one firm is included in the “drug discovery and development” category.
Finally, six of the sample firms indicated “diagnostics” as their main field of business.
About half of the phase 1 sample firms, i.e. 42 companies, did not have sales income
at the time of the interview. Nineteen of these firms had their most advanced product at
the preclinical development stage, for six firms this lead product was in early stage

137

clinical development, and 16 firms had no sales yet but had a product in late stage clinical
development 23 . Of the 43 firms that were selling their product(s) at the time of the phase
1 interview, 24 marketed the product(s) themselves and 16 firms had their products on
markets through some kind of a licensing or third-party distribution agreement. Four
firms could not provide information on the development phase of their most advanced
product. One could assume that over the study time lag period (between phase 1 and
phase 2, approximately 3.5 years) more companies would move to stages that indicate
product launch. Somewhat surprisingly, this is not the case; the distribution of firms in
each stage of lead product development remained unchanged between phases 1 and 2.
There are two likely explanations for this. First, biotechnology product development is a
long process that takes even decades. Even the 3.5 year time lag may be too short for
companies to make significant progress from one stage of clinical trials to another, for
example. Second, a more plausible explanation can be that as firms make progress
towards markets and grow, they also become more bureaucratic. Getting survey
responses in phase 2 was especially challenging in larger organizations, which may be
reflected in the fact that the distribution of firms in each stage of product development
remained unchanged between phases 1 and 2. However, the mean firm size of the sample
firms (number of employees reported by respondents) grew from 38 in phase 1 to 51 in
phase 2.
The average sample firm was six years old at phase 1, and most firms were very young
at that time; 88 per cent of the sample firms were 10 years old or younger when first
23

Not all sample firms follow the standard clinical development path in the product development.
However, the respondent of firms that do not follow this standard path to FDA approval and marketing
typically had no difficulties in assessing and placing their firms’ lead product at a relevant stage along this
standard pharmaceutical product development timeline.
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interviewed. On average, 60 per cent of all company expenses were categorized under the
umbrella of “R&D expenses”. However, for 40 per cent of the sample firms this figure
(i.e. the share of R&D expenses out of total expenses of the firm) was 80 per cent or
more.
Even though the average for capital raised by sample firms is 5.5 million USD per
firm per year, this figure varies remarkably from one firm to another; 45.5 per cent of the
firms had – by 2007 – only attracted USD one million /year or less, whereas 8 of the
thirty-three phase 2 study firms that reported capital investments had gathered more than
USD 10 million per year.
The majority (n=59) of the sample firms in phase 1 (85) have been started by teams
rather than individuals. Forty-one firms have started as independent ventures, 25
interviewees categorized their firms as university spin-offs, and 17 as industrial spin-offs
from another company. Altogether, 12 sample firms (14%) were publicly traded at the
time of the phase 1 interviews, and 5 firms (12%) were publicly held at the time of phase
2 data collection. Finally, 30 firms out of 85 - 26 in the US and four in Finland or Sweden
- have been started by a serial entrepreneur. These data (a dummy variable of yes / no for
previous start-up by the same entrepreneur) are not self-reported by the respondents but
were gathered based on publicly available information, mostly online. This information
was available for 79 firms. Most firms report their managers’ biographies on their
website, and if an entrepreneur has previously started another technology firm, this
information would be mentioned in the biography.
A test of means for the key firm demographic variables and the variables used in the
regression analyses in the USA-based and Finland- or Sweden-based sample firms was
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conducted and the results are depicted in Table 21. The null (H0) and alternate (Ha)
hypotheses are as follows:
H0: MUSA = MNOR
Ha: MUSA ≠ MNOR
Where MUSA: Mean score for a given factor in the USA-based firms and MNOR: Mean
score for a given factor in the Nordic (Finland & Sweden) firms.

Table 21: T-test for differences in variables, USA vs. Nordic firms

USA firms

Nordic firms

Mean

s.d.

Mean

s.d.

1.35

1.36

.853

1.29

63.3

28.4

54.8

32.9

Market knowledge (scale mean)

3.80

.480

3.77

.433

Entrepreneurial orientation (scale mean)

3.97

.612

3.63

.538 **

Firm age (years)

5.62

3.97

7.11

3.40 *

Number of employees (log)

3.10

1.27

2.82

.842

Entrepreneurial opportunities recognized
(mean of 4 item scale) (log)

2.10

1.30

1.55

1.11 *

Entrepreneurial opportunities recognized
(mean of 4 item scale) (log)

2.03

1.20

.889

1.09 ***

Capital raised by the firm, USD thousands
per year (log)

7.89

1.93

7.23

1.58

Annual sales turnover 2006, USD thousands
(log)

8.19

1.66

7.62

1.32

Sales growth between phase 1 and phase 2
(log)

6.96

2.65

4.18

1.30 ***

Technology licensing & sales (log)

.774

.838

.701

.686

Phase 2, USA firms n=24,
Nordic firms n=18

Phase 1, USA firms n=58, Nordic
firms n=27

Variable
Patents, mean of USPTO and reported
domestic approved patents (log)
Share of R&D expenses (%) of all the
expenses of the firm

t-Values for
Differences
in Means

*** Significant at the 0.01 level; ** Significant at the 0.05 level; * Significant at the 0.10 level
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As indicated by Table 21, the null hypothesis is rejected for entrepreneurial orientation
and marginally for firm age and “entrepreneurial opportunities recognized” in phase 1
data. The US-based firms exhibit higher levels of entrepreneurial orientation, whereas the
Nordic sample firms are, on average, somewhat older and have recognized fewer
entrepreneurial opportunities than American firms. In phase 2 data the null hypothesis is
rejected for “entrepreneurial opportunities recognized” and sales growth. US-based firms
have higher means both for sales growth and entrepreneurial opportunity recognition than
their Nordic counterparts. However, especially in phase 2 data the group sizes are rather
small (24 US-based firms and 18 Nordic firms), so the results should be interpreted with
some caution.

Tests of hypotheses

The characteristics of the variables used in the tests of hypotheses are in Table 22. The
correlations between study variables are presented in Table 23. It is interesting to note
that out of the two technology knowledge variables, R&D intensity shares a significant
positive correlation with entrepreneurial opportunities recognized at phase 2, whereas the
correlation between patents and opportunity recognition is not significant at p < .05. Also
market knowledge and entrepreneurial orientation at phase 1 are significantly and
positively related to opportunity recognition in phase 2. With regard to the variables that
measure profit potential, capital investments in a firm correlate significantly and
positively with the firm’s earlier patent count, market knowledge as well as the number
of opportunities recognized. For sales-related variables there is only one interesting
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correlation to report, namely that between market knowledge in phase 1 and sales
turnover in 2006. Patents as well as market knowledge also correlate positively and
significantly with subsequent technology licensing & technology sales.
The correlations between independent variables in Table 23 do not raise much concern
about multicollinearity. However, the VIF multicollinearity statistic is calculated for each
variable in each model. All of these values were far below the cut-off value of ten
(Freund and Wilson 1998), indicating no multicollinearity problems.

Table 22: Data characteristics

n

Mean

Min/
Max values

S.D.

69

1.18

-.69/4.04

1.35

80

60.46

0/100

30.10

Market knowledge (scale mean)

85

3.792

2.7/4.8

.462

Entrepreneurial orientation (scale mean)

85

3.863

1.71/5

.608

Location, USA

85

.68

0/1

.468

Firm age (years)

85

6.09

0/17

3.841

Number of employees (log)

85

2.99

0/5.52

1.15

80

1.92

-1.39/5.55

1.26

42

1.54

-.70/4.33

1.28

29

7.64

3.22/10.57

1.80

42

7.97

5.3/12.43

1.54

24

5.92

1.93/10.97

2.60

20

.747

0/2.46

.762

Variable

Phase 2

Phase 1

Patents, mean of USPTO and reported
domestic approved patents (log)
Share of R&D expenses (%) of all the
expenses of the firm

Entrepreneurial opportunities recognized
(mean of 4 item scale) (log)
Entrepreneurial opportunities recognized
(mean of 4 item scale) (log)
Capital raised by the firm, USD thousands per
year (log)
Annual sales turnover 2006, USD thousands
(log)
Sales growth between phase 1 and phase 2
(log)
Technology licensing & sales (log)
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Table 23: Pearson correlations for dependent and independent variables in the regression analysis

Variables

1

1. Patents (log)

1

2. Share of R&D expenses
3. Market knowledge

Phase 1

4. Entrepreneurial orientation
5. Location, USA

Phase 2

6. Firm age

.17
(66)
.27*
(69)
-.09
(69)
.17
(69)
.17
(69)

2

3

4

5

6

7

8

9

10

11

12

13

1
.11
(80)
.35**
(80)
.14
(80)
-.33**
(80)

1
.29**
(85)
.03
(85)
-.15
(85)

1
.26*
(85)
-.21
(85)

1
-.18
(85)

1

7. Firm size (number of
employees) (log)

.38**
(69)

-.07
(80)

.24*
(85)

-.02
(85)

.10
(85)

.22*
(85)

1

8. Entrepreneurial opp.
recognized (phase 1) (log)

.39**
(67)

.28*
(77)

.23*
(80)

.26*
(80)

.21
(80)

-.06
(80)

.40**
(80)

1

9. Entrepreneurial opp.
recognized (phase 2)

.28
(32)

.37*
(40)

.32*
(42)

.53**
(42)

.45**
(42)

-.20
(42)

.42**
(42)

.75**
(39)

1

10. Capital raised/ year

.57**
(22)

.30
(29)

.54**
(29)

.34
(29)

.18
(29)

-.10
(29)

.60**
(29)

.62**
(29)

.68**
(29)

1

11.Annual sales turnover
(2006)

.15
(37)

-.23
(40)

.38*
(42)

-.02
(42)

.18
(42)

.19
(42)

.62**
(42)

.04
(40)

.10
(24)

.34
(16)

1

12. Sales growth

.16
(22)

.12
(22)

-.00
(24)

-.16
(24)

.53**
(24)

-.59**
(24)

.34
(24)

.35
(23)

.54*
(14)

.54 (8)

.16
(23)

1

13. Technology licensing &
sales

.62*
(16)

-.09
(20)

.69**
(20)

-.03
(20)

.04
(20)

.32
(20)

.37
(20)

.19
(20)

.42
(20)

.49
(14)

.28
(14)

-.05
(6)

* Correlation is significant at the 0.05 level (2-tailed). ** Correlation is significant at the 0.01 level (2-tailed). N in parentheses.
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1

Factors behind entrepreneurial opportunity recognition

The relationships predicted in study hypotheses are assessed through a regression
analysis. At the first step, control variables for firm location, size and age are introduced
to the models. At the following steps, the factors predicted to influence the outcome
variable are introduced to the models one at a time. Standardized beta-coefficients are
reported in the regression tables that follow. The models also include constant terms not
included in the tables.
The analysis started by investigating the relationship between technology knowledge,
market knowledge, and subsequent opportunities recognized in a biotechnology venture
as proposed in Hypotheses 1 and 1a-1c. All independent variables come from phase 1
data (2003-2004) and the dependent variable was measured at phase 2 (2007). In Model
A1 (Table 24), only control variables of firm location, size and age are introduced to the
analysis. Model A1 shows that 37 per cent (Adjusted R-square) of the variance in
entrepreneurial opportunities recognized is explained. The importance of firm size as a
predictor of entrepreneurial opportunities recognized is logical, since larger organizations
have more resources, brains, and capabilities that aid in opportunity recognition.
At the next step after the control model, the technology knowledge variables of patent
count and R&D investment intensity were separately added to the model (Models A2 and
A3). Patent count turned out to be a marginally significant predictor of subsequent
opportunity recognition, and the model has an adjusted R-square value of 0.44. R&D
intensity is not significant. As a conclusion, partial support (in the case of patents as a
proxy for technology knowledge) is found for Hypothesis 1: If all other factors are
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constant, the greater the degree of technology knowledge in a new venture the larger the
number of entrepreneurial opportunities that will be recognized.

Table 24: Regression results. Dependent variable: Entrepreneurial opportunities
recognized (phase 2, log).
Control
variable

Main effect variables

Interaction

Model
A1

Model
A2

Model
A3

Model
A4

Model
A5

Model
A6

Location,
USA

.451***

.467***

.451***

.467***

.473***

.453***

Firm age

-.219

-.235

-.132

-.235

-.251*

-.232

Firm size
(log)

.347**

.299**

.394***

.299**

.270*

.293**

Patents (log)

.278*

Share of
R&D
expenses (%)
Market
knowledge
Patents x
market
knowledge

.223
.162
.278*

.175
.287**

R-square

.434

.508

.484

.493

.534

.513

Adjusted Rsquare

.373

.435

.425

.432

.444

.441

(A2-A1)
.074*

(A3-A1)
.050

(A4-A1)
.061*

(A5-A1)
.100*

(A6-A5)
-.021

6.970***

8.207***

6.970***

5.955***

7.104***

Change in Rsquare
F-value

7.143***

Durbin-Watson 2.150
2.056
2.007
2.056
1.966
*** Significance p< 0.01, ** Significance p< 0.05, * Significance p< 0.1

145

2.059

Hypotheses 1a-1c predict that the relationship between technology knowledge and
entrepreneurial opportunity recognition is contingent upon the amount of market
knowledge that the organization has. To examine this moderation effect, the plan was to
divide the sample into three groups according to market knowledge scores using a threeway split into groups of equal size and to then run separate regressions for the three
groups. Unfortunately, only 42 cases in total are available for regression analysis, and
dividing this sample into smaller categories would jeopardize the statistical power of any
quantitative analysis.
To assess the moderation, a product term (patents x market knowledge) was
computed. R&D intensity was omitted at this stage since it did not show significant
effects (Model A3). A moderation (an interaction effect) only exists if the interaction
term gives a significant contribution over and above the direct effects of the independent
variables (here, technology knowledge and market knowledge).A hierarchical regression
analysis (Table 24) reveals that strictly speaking, market knowledge does not moderate
the relationship between technology knowledge and opportunity recognition since model
A6 (with the product term) actually has a lower R-square value than model A5 (with the
main effects from market knowledge and technology knowledge). However, given the
low number of cases (only 32 in models A5 and A6) it is hard to draw conclusions form
these models, especially model A5 with five independent variables. The facts that the
product term (standardized β .287) in model A6 is significant at p < .05 and the model
has a significantly higher R-square value than the control model (A1) can be interpreted
as weak evidence of a moderated relationship.
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To assess this interaction in more detail, sample firms were divided into three groups
of equal size (low, medium & high) both based on their market knowledge scores and
patent scores. An interaction plot (Figure 13) illustrates the nature of the relationship
between patents and market knowledge in influencing entrepreneurial opportunities
recognized.

Estimated Marginal Means of Entrepreneurial opportunities recognized (log)
(n=42)
4.00

Technology knowledge
(log patents)
Low
Medium
High

Estimated Marginal Means

3.00

2.00

1.00

0.00

-1.00
Low

Medium

High

Market knowledge

Figure 13: The interaction of market knowledge and technology knowledge (patents)
in influencing entrepreneurial opportunities recognized.
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Hypotheses 1a-1c predicted that the relationship between technology knowledge and
entrepreneurial opportunity recognition would be strongest at moderate levels of market
knowledge and weaker at very high or very low levels of market knowledge. Based on
Figure 13, however, this is not the case. The clearly defined relationship of low levels of
technology knowledge leading to low numbers of opportunities recognized, medium
levels of technology knowledge leading to medium numbers of opportunities recognized,
and high levels of technology knowledge leading to high number of opportunities
recognized is only present when the amount of market knowledge is high (right hand side
of Figure 13). Hence, no support is found for hypotheses 1a-1c. However, a moderating
effect of market knowledge on the relationship between technology knowledge and
entrepreneurial opportunity recognition is detected (See Table 24 and Figure 13). Based
on the detected relationship a proposition for future research suggests that a positive
linear relationship between technology knowledge and entrepreneurial opportunity
recognition only exists when a firm also has a high level of market knowledge.
Despite the low number of cases, the models presented in Table 24 seem to be robust;
the directions of effects (negative / positive) and relative magnitudes of independent
variables’ effects remain similar in Models A1 through A6 (Table 24). When the number
of observations is small (n=42) and the number of predictors is large, it is expected that
there will be a greater difference between R-square and adjusted R-square compared with
a situation when the number of observations is larger compared with the number of
predictors.
Based on model A4 in Table 24 it can be concluded that there is evidence that
supports hypothesis 2: If all other factors are constant, the greater the degree of market
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knowledge in a new venture the greater the recognition of entrepreneurial opportunities.
Hypothesis 2a predicts that if all other factors are constant, when a new venture has a
higher level of entrepreneurial orientation, the relationship between the degree of market
knowledge and the recognition of entrepreneurial opportunities will be enhanced. The test
of this hypothesis is presented in Table 25.

Table 25: Regression results, part 2. Dependent variable: Entrepreneurial opportunities
recognized (phase 2, log).
Control
variable

Main effect variables

Interaction

Model
B1

Model
B2

Model
B3

Model
B4

Model
B5

Location, USA

.451***

.467***

.277**

.301**

.318**

Firm age

-.219

-.235

-.137

-.154

-.161

Firm size (log)

.347**

.299**

.420***

.383***

.384***

Market
knowledge
Entrepreneurial
orientation
Market
knowledge x
Entrepreneurial
orientation

.278*

.175
.320**

.268*
.345***

R-square

.434

.493

.509

.524

.523

Adjusted Rsquare

.373

.432

.443

.459

.472

(B2-B1)
.061*

(B3-B1)
.075**

(B4-B1)
.09**

(B5-B4)
-.01

6.970***

9.160***

7.917***

10.151***

Change in Rsquare
F-value

7.143***

Durbin-Watson
2.150
2.056
2.155
2.000
1.975
*** Significance p< 0.01, ** Significance p< 0.05, * Significance p< 0.1
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Both market knowledge and entrepreneurial orientation have independent, significant
effects on subsequent entrepreneurial opportunities recognized, as revealed by models
B2-B4 in Table 25. The product of market knowledge and entrepreneurial orientation is
used to assess the interactive relationship. Again, looking at the interaction model B5,
strictly speaking, entrepreneurial orientation does not moderate the relationship between
market knowledge and opportunity recognition since model B5 (with the product term)
actually has a lower R-square value than model B4 (with the main effects from market
knowledge and entrepreneurial orientation). However, the adjusted R-square of the
interaction model is higher than that of any of the other models in Table 25. The facts that
the product term (standardized β .345) in model B5 is significant at p < .01 and the model
has a significantly higher R-square value than the control model (B1) can, again, be
interpreted as weak evidence of a moderated relationship.
Again, to assess this interaction in more detail, sample firms were divided into three
groups of equal size (low, medium & high) both based on their market knowledge scores
and entrepreneurial orientation scores. Figure 14 below illustrates the interactive
relationship. According to hypothesis 2a we would expect to see that the positive linear
relationship between market knowledge and opportunity recognition should be stronger at
higher levels of entrepreneurial orientation. This is true for those firms that have high or
low levels of market knowledge; the slope of the regression line gets steeper when
moving from low-medium entrepreneurial orientation to medium-high entrepreneurial
orientation. Hence, there is some support for hypothesis 2a. However, a more striking
feature in Figure 14 is the importance of entrepreneurial orientation especially for those
firms who have medium levels of market knowledge. A firm that is about average in
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terms of its market knowledge scores poorly in opportunity recognition when its
entrepreneurial orientation is low. Nevertheless, Figure 14 suggests that under a high
level of entrepreneurial orientation the same firm recognizes more entrepreneurial
opportunities than other firms who have higher levels of market knowledge. This is an
interesting finding and will be further discussed in the “Discussion” section.

Estimated Marginal Means of Entrepreneurial opportunities recognized (log)
(n=42)
Market knowledge
Low
Medium
High

Estimated Marginal Means

3.00

2.00

1.00

0.00
Low

Medium

High

Entrepreneurial orientation

Figure 14: The interaction of entrepreneurial orientation and market knowledge in
influencing entrepreneurial opportunities recognized.
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Factors behind profit potential

An attempt to measure a young firm’s profit potential is, indeed, a challenging task.
As mentioned earlier, in this study the proxies adopted for a firm’s profit potential
include (1) sales growth; (2) sales turnover in 2006; (3) equity investments in the firm;
and (4) selling and licensing out technologies. In the following, each one of these
dependent variables is analyzed separately.
Similar to the regression models presented above, each analysis starts with a model
(C1, D1, E1, and F1) that only includes the three control variables. At the next stages (24) main effects of entrepreneurial opportunities recognized and market knowledge (phase
1 data) are included in the models. Finally, at the last (5th) stage, an interaction term is
introduced to the models as a test of hypothesis 3a, which predicts that if all other factors
are constant, when a new venture has a high level of market knowledge the relationship
between recognition of entrepreneurial opportunities and subsequent profit potential will
be enhanced.
The adjusted R square values in these models vary from less than ten per cent (for
technology licensing and sales as a dependent variable) to over fifty per cent. The results
are discussed in more detail in the following.
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Table 26: Regression results for firm profit potential (phase 2).
Dependent variable: Sales growth % (log)
Control
variables

Main effect variables

Dependent variable: Sales turnover in 2006 (log)

Interaction

Control
variables

Main effect variables

Interaction

Model
C1

Model
C2

Model
C3

Model
C4

Model
C5

Model
D1

Model
D2

Model
D3

Model
D4

Model D5

Location, USA

.234

.232

.159

.161

.235

-.136

-.091

-.058

-.057

-.105

Firm age

-.557***

-.554***

-.602***

-.597***

-.562***

-.058

-.103

.042

-.022

-.096

Firm size (log)

.264

.261

.324

.324

.272

.709***

.767***

.583***

.675***

.757***

Entrepreneurial
opp. recognized
(log)
Market
knowledge

.008

.001
-.120

-.192

-.114

Entre opp.
recognized (log)
x market
knowledge

-.151
.298**

.277**

-.018

-.139

R-square

.530

.530

.548

.540

.530

.414

.442

.491

.512

.428

Adjusted Rsquare

.456

.426

.452

.404

.426

.366

.379

.423

.441

.363

C2-C1
0.000

C3-C1
.018

C4-C1
.010

C5-C4
-.100

D2-D1
.0280

D3-D1
.077**

D4-D1
.098**

D5-D4
-.084

5.074***

5.748***

3.987***

5.078***

8.493***

6.943***

8.208***

7.142***

6.557***

2.395

2.360

2.425

2.419

2.378

Change in Rsquare
F-value

7.140***

Durbin-Watson
1.654
1.475
1.689
1.565
1.498
*** Significance p< 0.01, ** Significance p< 0.05, * Significance p< 0.1
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Table 27: Regression results for firm profit potential (phase 2) continued
Dependent variable: Equity investments in the firm (log)
Control
variables

Main effect variables

Dependent variable: Technology licensing and sales (log)

Interaction

Control
variables

Main effect variables

Interaction

Model E1

Model E2

Model
E3

Model E4

Model E5

Model F1

Model F2

Model F3

Model F4

Model F5

Location, USA

.086

-.018

.077

-.014

-.041

.129

.144

-.021

.000

.100

Firm age

-.151

-.151

-.158

-.158

-.147

.252

.247

.105

.097

.259

Firm size (log)

.619***

.416**

.519***

.346**

.387**

.290

.334

.018

.079

.216

Entrepreneurial
opp. recognized
(log)
Market
knowledge

.400**

.357**
.414***

-.067

.385***

Entre opp.
recognized (log)
x market
knowledge

-.094
.653***

.657**

.463**

.108

R-square

.400

.507

.561

.645

.542

.192

.194

.491

.496

.198

Adjusted Rsquare

.328

.425

.488

.568

.466

.04

.02

.355

.316

.04

E2-E1
.107**

E3-E1
.161***

E4-E1
.245***

E5-E4
-.103

F2-F1
.002

F3-F1
.299***

F4-F1
.304**

F5-F4
-.298

6.180***

7.673***

8.369***

7.103***

1.265

.904

3.617**

2.753*

.924

1.605

1.572

1.191

1.151

1.638

Change in Rsquare
F-value

5.565***

Durbin-Watson
2.023
1.796
2.120
1.909
1.756
*** Significance p< 0.01, ** Significance p< 0.05, * Significance p< 0.1
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Hypothesis 3 predicts that if all other factors are constant, the greater the number of
entrepreneurial opportunities recognized in a new venture the greater the subsequent
profit potential. Out of the four profit potential measurements used (See Table 26 and
Table 27), hypothesis three is only supported in the case of equity investments in the
firm. Hence, hypothesis three only receives partial support from the empirical data.
The only variable that has a significant (negative) effect of sales growth is firm age;
the younger the firm, the faster its sales growth. This makes sense since many of the
younger sample firms started from non-existent or very low sales at the time of the first
data collection. With regard to predictors of sales turnover in 2006 (models D1-D5),
larger firms obviously have higher sales turnover. Interestingly, also market knowledge
contributes significantly and positively to higher sales turnover. This should be expected
in the light of existing marketing literature, where understanding of markets and
customers has been linked to superior firm performance (Jaworski and Kohli 1993;
Appiah-Adu and Ranchhod 1998; Matsuno et al. 2002). The (non)-finding that the
variable “entrepreneurial opportunities recognized” does not influence either one of the
selected sales measures is most likely a consequence of the fact that the biotechnology
product development cycles expand years, even decades. Even the 3.5 year time lag of
this study is too short for ideas to make their ways to markets. For many firms current
sales turnover is created by products and services that have been launched while the
company is still waiting for its most promising products to reach the markets.
The only variable that is significantly related to a firm’s technology sales & licensing
in the regression models (F3-F4) is market knowledge. As far as technology licensing and
sales are considered another form of bringing a firm’s products to markets, the
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importance of market knowledge in this process should not be surprising. Instead of
aiming at developing ideas all the way to complete products, many biotechnology firms
choose to license out or sell rights to their inventions, and in this process the
understanding of potential licensees, end markets and as well as end customers is
important. One would expect the number of opportunities recognized to be positively
related to the number of technologies the firm licenses out in the following years. There
are two possible reasons for why this is not the case. First, it is likely that out of all the
opportunities recognized, only some have potential to generate significant revenues in the
marketplace. Given the transaction costs and principal-agent problems associated with
technology transfer (Caves, Crookell and Killing 1983; Gallini and Wright 1990), it can
be assumed that only the most promising new product ideas can be licensed out or sold to
other companies. Hence, establishing a link between opportunities recognized and
technology licensing may require a set of observations much larger than the current
dataset, and even then the linkage might be weak in statistical terms. Alternatively, we
would need a way to measure the value of each recognized opportunity, after which we
could hypothesize that the link between opportunity recognition and technology licensing
exists only in the case of the most valuable opportunities. Second, even though
commonplace in biotechnology, technology licensing may still not be a preferred
business model for many firms. This is evident in the respondents’ answers to the
questions about their business models: Out of those 23 sample firms that already had
products on the markets in 2007, licensing had been the primary method to bring
products to the markets only in the case of one firm. Out of those nineteen firms that did
not have products on the markets in 2007, half (eight) were hoping to be able to use
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licensing as a method for commercialization in the future. Hence, there are obviously
many firms that opt for business models other than technology licensing or sales. The
reasons vary, but may include the nature of the idea itself, difficulties in determining the
scope of the license, the issue of derivatives and to what extent the material can be
modified and still belong to the licensor, tricky and sometimes risky calculations of
royalties, as well as government regulations, warranties and disclaimers (Fowlston 1988).
The results with regard to capital investments (models E1-E5 in Table 27) are quite
interesting. In control model E1 firm size is the only significant predictor of capital
investments. This is logical since the larger firms need sizable investments to keep their
research and development moving forward. In a cross-section of data from phase 1 only,
US-based firms seemed to attract significantly more capital than Scandinavian firms
(Renko 2006a), which was supported by empirical evidence from other sources. For
example, the average biotechnology deal size in Europe in 2003 was € 1.04 Million,
whereas in the U.S. it was € 9.55 Million (PriceWaterhouseCoopers 2005). However, in
the longitudinal dataset reported in Table 27 firm location (US vs. Northern Europe) is
not a significant predictor of capital investments, which is somewhat surprising given the
common assumption that risk capital is easier to access in the US. It looks like over time,
those firms that survive the early years do have equal access to outside equity regardless
of their location. The fact that the early finding about the importance of location (Renko
2006a) is not repeated in the longitudinal dataset may also be a reflection of the
institutional environments that are different in the US vs. Scandinavia. US-based startups
are heavily dependent on angel- and venture capital investments from early on, whereas
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in Scandinavia governments have created funding opportunities (such as TEKES 24 in
Finland and VINNOVA 25 in Sweden) for innovative new ventures that spare them form
having to access private investors at the earliest stages of firm development. Hence, a
snapshot of very young biotechnology firms (Renko 2006a) reflects how the US-based
ventures have been gathering more equity capital, whereas over time the difference
between Nordic and American firms levels off as also Nordic firms move from the
domain of government sponsored product development to dependence on venture capital.
Both entrepreneurial opportunities recognized and market knowledge turned out to be
significant predictors of capital invested in a firm per year (Table 27) in the main effects
models, and the models have adjusted R-square values ranging from .425 to .568. The
interaction model (E5) has a lower R-square value than the model with the main effects,
which suggests that the interaction does not explain additional variance over and above
what is being explained by the main effects. However, the interaction was plotted in a
way similar to Figure 13 and Figure 14. The patterns of interaction were very subtle.
Given the limited number of cases (only 29 cases for the regression analysis on capital
investments) as well as the fact that the main effects together produced a stronger model
(E5) the interaction is not discussed further. Thus, even if the data supports hypothesis 3
in the case of capital investments as a proxy for profit potential, there is no support for
hypothesis 3a, which predicted that a high level of market knowledge would enhance the
relationship between recognition of entrepreneurial opportunities and subsequent profit
potential.
24

Tekes, the Finnish Funding Agency for Technology and Innovation, www.tekes.fi
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Tyebjee and Bruno (1984) analyzed the investment decisions of venture capitalists and
came to the conclusion that the two constructs of “market attractiveness” and “product
differentiation” determined the returns expected by the investors. Market attractiveness
consists of market size, growth and access to customers, and product differentiation
includes uniqueness, patents, technical edge and profit margin. In light of this, it is not
surprising that both the opportunity recognition and market knowledge variables turned
out to be significant predictors of capital invested.
Overall, all the models produced in the regression analysis seem to be robust; the
directions of effects (negative / positive) and relative magnitudes of independent
variables’ effects remain similar in Models A1 through F5.

Summary of results

Table 28 summarizes the results of the empirical study as far as the hypotheses are
concerned. These results will be reflected in light of the existing literature in the final
chapter of this thesis. As Table 28 indicates, of the total of 8 hypotheses, the empirical
data supported four (including partial support for some hypotheses). None of the three
moderation hypotheses for entrepreneurial opportunity recognition are supported (H1a-c),
but in the case of H1c there is evidence that supports the opposite hypothesis.
Furthermore, even if H3a is not supported, market knowledge does influence profit
potential. This effect is not a moderating effect but an independent main effect instead.
The implications of these findings are discussed in the following section.
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Table 28: Results by hypothesis
Hypotheses

Support

Hypothesis 1: If all other factors are constant, the greater the
degree of technology knowledge in a new venture the larger the
number of entrepreneurial opportunities that will be recognized.

Partial support (marginal).
Support for patents as a proxy for
technology knowledge, not for
R&D expenditure.

Hypothesis 1a: If all other factors are constant, when a new
venture has a moderate level of market knowledge, there will be a
strong positive relationship between the level of technological
knowledge in the new venture and the recognition of
entrepreneurial opportunities.

Not supported.

Hypothesis 1b: If all other factors are constant, when a new
venture has a low level of market knowledge, there will be a
weak positive relationship between the level of technological
knowledge in the new venture and the recognition of
entrepreneurial opportunities.

Not supported.

Hypothesis 1c: If all other factors are constant, when a new
venture has a high level of market knowledge, there will be a
weak positive relationship between the level of technological
knowledge in the new venture and the recognition of
entrepreneurial opportunities.

Support for the opposite
hypothesis. When a new venture
has a high level of market
knowledge, there is a strong
positive relationship between the
level of technological knowledge in
the new venture and the recognition
of entrepreneurial opportunities.

Hypothesis 2: If all other factors are constant, the greater the
degree of market knowledge in a new venture the greater the
recognition of entrepreneurial opportunities.

Marginal support (at p < .10)

Hypothesis 2a: If all other factors are constant, when a new
venture has a higher level of entrepreneurial orientation, the
relationship between the degree of market knowledge and the
recognition of entrepreneurial opportunities will be enhanced.

Supported.

Hypothesis 3: If all other factors are constant, the greater the
number of entrepreneurial opportunities recognized in a new
venture the greater the subsequent profit potential.

Partial support. Supported for one
out of four profit potential
measures.

Hypothesis 3a: If all other factors are constant, when a new
venture has a high level of market knowledge the relationship
between recognition of entrepreneurial opportunities and
subsequent profit potential will be enhanced.

Not supported. Market knowledge
influences capital investments, sales
turnover, and technology licensing
but the effect is independent of
opportunities recognized.
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VI. DISCUSSION AND CONCLUSIONS

This study was designed to answer two critical questions about the nature and origins
of entrepreneurial opportunities: What is the role of idiosyncratic market knowledge and
new scientific knowledge in the creation and discovery of technology based
entrepreneurial opportunities? And how does market knowledge contribute to the
exploitation of technology based entrepreneurial opportunities? Following a literature
review, specific hypotheses (refutable assertions) were developed regarding the role of
market knowledge in entrepreneurial opportunity recognition and exploitation. These
hypotheses specify three different mechanisms through which market knowledge was
expected to influence entrepreneurial opportunity recognition and exploitation. The
mechanisms suggested are (1) the moderating role of market knowledge in the
relationship between technology knowledge and entrepreneurial opportunities recognized
in a young venture, (2) the direct positive effects of market knowledge on the
entrepreneurial opportunities recognized in a young venture, and (3) the positive
moderation of market knowledge in the relationship between entrepreneurial
opportunities recognized in a young venture and the subsequent profit potential of the
venture.
The research questions have now been addressed in the light of the established
literature on entrepreneurial opportunities. Also, 85 biotechnology ventures have been
consulted in the process of answering the questions, and 42 of these firms have provided
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longitudinal data that has been used to empirically test the hypotheses. The purpose of
this final chapter is to discuss the main findings of the study and make the theoretical and
managerial contributions of the research explicit. The section starts with a summary of
the answers to the two research questions, after which the theoretical and managerial
contributions of the research are assessed in more detail.

The role of market knowledge and technology knowledge in the recognition of
entrepreneurial opportunities

To understand the knowledge-based antecedents of opportunity recognition in a
technology intensive environment, a quantitative, hypothetico-deductive research
approach was adopted. This approach is different from a bulk of entrepreneurial
opportunity recognition literature, which has been either conceptual (Christensen et al.
1994; Busenitz 1996; Gaglio and Katz 2001; Eckhardt and Shane 2003; Baron 2004;
Gaglio 2004; De Carolis and Saparito 2006; Buenstorf 2007; Casson and Wadeson 2007)
or qualitative (Shane 2000; McKelvie and Wiklund 2004; Park 2005; Sanz-Velasco
2006) in nature.
Based on a review of previous literature, three key components were identified behind
entrepreneurial opportunity recognition. First, according to the followers of the
Kirznerian tradition, idiosyncratic market knowledge enables opportunity recognition.
Second, according to the Schumpeterian tradition, new combinations emerge from new
knowledge. In technology intensive markets this new knowledge is typically of a
scientific or technological nature. Third, previous research that was summarized in the
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literature review section has emphasized the importance of entrepreneurial alertness in
opportunity recognition. In the context of existing organizations, the construct of
entrepreneurial orientation captures the essence of this alertness.
To summarize the findings of the empirical study with regard to the antecedents of
opportunity recognition, technology knowledge that is captured in the form of patents
does, indeed, contribute to subsequent opportunity recognition. In addition to being
evidence of the importance of Schumpeterian-type “new knowledge” in opportunity
recognition process, this finding can also be regarded as evidence of the existence of
absorptive capacity in these firms. Based on Cohen and Levinthal’s (1990) definition,
“absorptive capacity is the ability to recognize external information, assimilate this
information, and apply it to commercial ends” (p. 128). Research activity in a firm has a
dual role of generating new knowledge and enhancing a firm’s ability to absorb new
knowledge generated by others (Cohen and Levinthal 1989, 1990). The more
entrepreneurs and their firms have previously absorbed in terms of technology
knowledge, the greater their absorptive capacity. Hence, also absorptive capacity
hypotheses would expect to see a link between a firm’s patenting activity (as a proxy for
technology knowledge) and its subsequent capability to recognize entrepreneurial
opportunities (See also Alvarez and Busenitz 2001).
Outside of opportunity recognition literature, the influence that a firm’s past patenting
activity has on its subsequent opportunity recognition can also be reflected in the light of
organizational path dependency arguments. Technological path dependencies, caused by
technological choices, lock the firm in or out of certain technological trajectories (Dosi
1988). Since no information was obtained with regard to the specific technological details
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of sample firms’ patents, it is not possible to conclude anything about the exact
technological paths followed by the firms. However, what can be said is that the past
amount of technology knowledge has an impact on future inventions originating from the
firm; more technology knowledge in the firm leads to more numerous new inventions.
Even a young firm’s history seems to be an antecedent to its current capabilities (Helfat
and Raubitschek 2000).
The data analysis has shown that the influence of technology knowledge on
opportunity recognition is moderated by market knowledge in that the positive linear
relationship between technology knowledge and entrepreneurial opportunity recognition
only exists when a firm also has a high level of market knowledge. This finding
contradicts much of the previous literature, which has suggested that when dealing with
radically new technology knowledge and developing radically new products – like the
sample ventures are doing - conventional market knowledge would be of limited utility;
customers have limited domains of expertise and may be unable to articulate their
underlying needs (Hamel and Prahalad 1991; Leonard-Barton 1995; Leonard-Barton and
Rayport 1997; Adams et al. 1998; O’Connor 1998; Takayama and Watanabe 2002; Im
and Workman 2004). Instead, the finding about the interaction of market knowledge and
technology knowledge emphasizes that a mere understanding of technology and science
is not enough for entrepreneurial opportunity recognition. In order for entrepreneurs or
entrepreneurial firms to recognize business opportunities they need to understand markets
and customers in addition to technology (Shane 2003). New product opportunities are
predominantly recognized by firms who stay close to their customers and markets
(Athuene-Gima 1995, 1996; Hurley and Hult 1998) and possess high levels of technology
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knowledge. It should be pointed out that even if this importance of market knowledge for
opportunity recognition has been established in previous conceptual and qualitative
studies, the current study is the first more quantitative analysis of the moderating effect of
technology- and market knowledge on entrepreneurial opportunity recognition.
In addition to its moderating effect, market knowledge also has an independent, direct
positive effect on opportunities recognized. Since market knowledge has been proposed
as an antecedent of opportunity recognition especially in the case of discovery of an
external opportunity (Kirzner 1997; Shane 2003) rather than creation of a new
opportunity (Ardichvili et al. 2003; Sarasvathy et al. 2003; Alvarez and Barney 2007),
this significant but weaker relationship is not unexpected. Rather than simply discovering
opportunities, biotechnology ventures often face considerably ambiguity in both markets
and technologies, and create (or develop) the opportunities they pursue (Sarasvathy et al.
2003).
Because of the growing presence of perceptual processes and entrepreneurial alertness
in entrepreneurship research, entrepreneurial orientation was tested as a moderator
between market knowledge and opportunities recognized. Kirzner (1979; 1980) maintains
that the crucial difference between opportunity finders and non-finders can be found in
their relative assessment of the market event or situation. Entrepreneurs, being more alert,
perceive reality more accurately and are better at inferring the likely implications and
consequences. Based on a review of Kirzner’s contributions, Gaglio & Katz (2001)
suggest that an entrepreneurially alert individual or entrepreneur must perceive the
market environment correctly (veridical perception); identify the true driving forces and
critical factors; and infer the real relational dynamics among these elements (veridical
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interpretation) (p. 97). In the context of existing firms, entrepreneurial orientation
captures the essence of a firm’s alertness to new opportunities in the environment.
Entrepreneurial orientation stands for a company culture and behavior that emphasizes
innovativeness, proactiveness and risk-taking (Covin and Slevin 1991). Innovativeness
reflects a tendency to support new ideas, novelty, experimentation, and creative processes
(Lumpkin and Dess 1996). Proactiveness refers to a posture of anticipating and acting on
future wants and needs in the marketplace before competitors do (Lumpkin and Dess
1996). With such a forward-looking perspective, proactive firms are expected to
capitalize on emerging opportunities (Wiklund and Shepherd 2003). Risk-taking is
associated with a willingness to commit large amounts of resources to projects where the
cost of failure may be high or where the outcomes are unknown (Wiklund and Shepherd
2003). Using entrepreneurial opportunity as a substitute for alertness in the organizational
context and following Wiklund & Shepherd (2003), it was expected that organizations
that have a high level of entrepreneurial orientation are more prone to focus attention and
effort towards opportunities. Indeed, the empirical tests revealed that entrepreneurial
orientation is not only a strong moderator in the market knowledge – opportunity
recognition relationship, but it also has an independent, direct positive effect on
opportunities recognized.
Regardless of whether a firm’s level of market knowledge is low, medium, or high, a
high level of entrepreneurial orientation enhances a firm’s capability to recognize
opportunities. As a conclusion, firms that have a tendency to support new ideas and
creative processes (innovativeness), act on future wants and needs in the marketplace
before competitors do (proactiveness), and are willing to commit large amounts of
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resources to projects where the outcomes are unknown (risk taking) recognize more
opportunities than firms that lack these qualities.
Interestingly, the detected interaction of market knowledge and entrepreneurial
orientation suggests that the largest numbers of opportunities are recognized by firms that
have high levels of entrepreneurial orientation but only medium levels of market
knowledge. This is an unexpected finding, since entrepreneurial orientation was
hypothesized to further enhance the positive effects of high levels of market knowledge.
An ex post explanation for this finding might hold that entrepreneurial orientation can
actually, under some circumstances, compensate for a lack of elaborate market
knowledge. Firms that possess moderate levels of market knowledge can recognize
numerous opportunities provided that their postures and behaviors are entrepreneurially
oriented. When coupled with a high level of market knowledge, high entrepreneurial
orientation actually results in fewer opportunities recognized than when coupled with
only a moderate level of market knowledge (Figure 14). This unexpected finding can be
explained if we view discovering an opportunity as a combination of two distinct
activities: (1) Effective entrepreneurs identify problems which, if solved, would create
value, and (2) create efficient solutions to these problems (Hsieh, Nickerson and Zenger
2007). It may be that knowledge, including market knowledge, is particularly helpful
when in comes to finding solutions to the identified problems. However, in finding the
“right questions to ask” prior knowledge may be of lesser importance. As explained in
the literature review earlier, when dealing with radically new technology knowledge and
developing radically new products, conventional market knowledge is often of limited
utility. Customers have limited domains of expertise and they may be unable to articulate
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their underlying needs, resulting in user-developed problems that are not innovative or
creative. Instead of prompting entrepreneurs to ask revolutionary questions,
understanding the existing customers very well can lead entrepreneurs to recognize
problems that are of incremental or even trivial nature in the larger marketplace. Hence,
for a firm that has an innovative, proactive and risk-prone posture, medium levels of
market knowledge are enough to identify problems that are worth solving and to find
solutions to these problems. A high level of market knowledge in an entrepreneurially
oriented firm can actually take away from the firm’s willingness or capability to ask
revolutionary kinds of questions that could lead to recognizing multiple new
opportunities.
Taken together, the findings about the factors affecting entrepreneurial opportunity
recognition in the technology intensive environment of biotechnology ventures suggest
that market knowledge does, indeed, influence opportunity recognition through multiple
mechanisms. First, it has a somewhat significant positive role in contributing directly to
the numbers of opportunities recognized. Second, more importantly, its interaction with
technology knowledge (measured with the number of patents) has implications for
opportunity recognition. When a high level of market knowledge is combined with a high
level of technology knowledge in a firm, the firm’s subsequent opportunity recognition is
greatly enhanced. However, for those firms that have only low levels of technology
knowledge, high levels of market knowledge cannot compensate for the lack of
technology knowledge: High level of market knowledge combined with a low level of
technology knowledge results in low numbers of subsequent opportunities recognized
(See Figure 13). Third, market knowledge also interacts with a firm’s entrepreneurial
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orientation in influencing subsequent opportunity recognition. When a firm’s level of
entrepreneurial orientation is elevated, it recognizes more opportunities. Entrepreneurial
orientation can also compensate for a lack of elaborate market knowledge. Firms that
possess moderate levels of market knowledge recognize numerous opportunities provided
that their postures and behaviors are entrepreneurially oriented. These relationships
detected in empirical tests of hypotheses are illustrated in Figure 15 below. A solid arrow
indicates a relationship that is significant at p < .05, a dotted arrow stands for a
relationship significant at p < .10.

Technology knowledge
(patents) (t1)

+

Entrepreneurial
opportunities recognized
(t2)

+

+
+

Market
knowledge (t1)

Entrepreneurial
orientation (t1)

+

Figure 15: The direct and moderating effects of market knowledge on entrepreneurial
opportunity recognition. Ex post model.

Obviously, the simple “more market knowledge – more opportunities recognized”
kind of thinking that is currently prevalent in studies of entrepreneurial opportunities
seems naïve in the light of the above-presented findings. The mechanisms through which
entrepreneurial opportunities are recognized vary from a discovery of an arbitrage to the
creation of a radical opportunity, and the knowledge foundations of the different OpR
mechanisms are different. As far as the opportunities that are based on novel
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technological knowledge come into being through “creation” rather than discovery, it can
be concluded that in a “creation context” (Alvarez and Barney 2007) market knowledge
is only beneficial for opportunity recognition when it is coupled with a moderate or high
level of technology knowledge 26 . As far as market knowledge itself is a basis for
opportunity discovery (discovery context of Alvarez & Barney, 2007) more market
knowledge is not always better. When taking into account a firm’s entrepreneurial
orientation, the largest numbers of opportunities are recognized by those firms that have
high levels of entrepreneurial orientation but only moderate (not high) levels of market
knowledge.

The role of market knowledge in the exploitation of technology based entrepreneurial
opportunities

Once opportunities have been recognized, they also need to be exploited for rent
appropriation. Because of the long development time spans of biotechnology products
from laboratory to market launch and because of the concept of profit potential being
central in definitions of entrepreneurial opportunities (Singh 2000; Sarasvathy et al. 2003;
Shane 2003; Sanz-Velasco 2006; Companys and McMullen 2007; Goss 2007),
hypotheses were formulated to test the impact of opportunity recognition and market
knowledge on firm’s profit potential. Profit potential was measured through equity
investments in the firm, sales growth, sales turnover, and technology licensing & sales.

26

This finding is obviously specific to a context where technology knowledge is a relevant basis for
economic development.
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The only hypothesized relationship that was confirmed in empirical tests is
entrepreneurial opportunities’ influence on equity investments in the firm. Market
knowledge did not significantly moderate this relationship over and beyond the
independent main effects of opportunities recognized and market knowledge. Rather than
having the hypothesized moderating effect on the opportunity recognition – profit
potential relationship, market knowledge turned out to have a direct and positive effect on
sales turnover, technology licensing & sales, and equity investments. The significant
relationships are illustrated in Figure 16. All relationships are significant at p < .05.

Entrepreneurial
opportunities
recognized (t1)

Market knowledge
(t1)

+

Equity investments in
the firm (t2)

+

Technology licensing
and sales (t2)

+
+

Sales turnover (t2)
Sales growth (t2)

Figure 16: The relationships between market knowledge, entrepreneurial opportunities
recognized, and profit potential. Ex post model.

The positive findings with regard to the influence of market knowledge are in line
with the bulk of the literature on market orientation that has established a link between
market knowledge generation, dissemination and responsiveness on one hand and firm
performance on the other hand (See Rodriguez Cano et al. 2004 for a meta-analysis).
Better understanding of a firm’s current and future customers contributes to investor’s
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increased belief in the firm’s ability to break through in the markets. Previous literature
has suggested that investors evaluate both the technology/product aspects of the firm as
well as its market potential when making investment decisions (See for example Tyebjee
and Bruno 1984; Shepherd and Zacharakis 1999; Mason and Stark 2004).
Better understanding of a firm’s current and future customers also contributes to
potential partners’ increased willingness to buy into the firm’s technology base (positive
effect on technology licensing and sales). This finding adds to the increasing body of
literature on technology licensing which has, regardless of its recent growth, remained
focused on large corporations, universities, and macro-level drivers of efficiency in the
markets for technology (Arora et al. 2001). Previous empirical research on technology
transfer has focused on the factors that determine a firm’s choices among various
organizational forms (Teece 1986), especially its foreign market entry choices (e.g.
Kogut and Singh 1988). However, there is a lack of studies investigating the factors
underpinning the rate of technology licensing among firms, especially smaller and
younger firms that typically operate on the supplier-side of markets for technology
(Fosfuri 2006). Gans, Hsu, and Stern (2002) who do study the determinants of
commercialization strategy for start-up innovators only focus on the strength of
intellectual property protection, the cost of contracting, and the importance and
effectiveness of complementary-asset ownership as drivers of licensing activity by startup firms. The link established in this study between a young firm’s market knowledge
and its subsequent ability to license out technologies is unique in the current literature.
The mechanism behind this effect is open to speculation, but it is likely that a young firm
that knows about its markets and customers is better able to convince potential licensees
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of the value of its technologies. This finding opens up interesting questions for future
research with regard to the motivations of licensors and licensees as well as rent
appropriation in these collaborative arrangements. Market knowledge contributes to the
number of licensing deals that a start-up firm is able to complete, but what are the terms
of these agreements? One could assume that if the licensor is able to convince the
licensee about the value of the invention in the marketplace because of a good
understanding of markets and customers, the licensor should also be able to negotiate
favorable terms for the licensing deal. The current dataset does not contain information
on the value or terms of the individual licensing deals, but this could be an interesting
topic for future research. Also, technology licensing literature would benefit from a
deeper understanding of other firm-level attributes that contribute to licensing success in
young ventures. In addition to market knowledge the attributes of the technology itself,
connectedness of the firm, its legitimacy and reputation in the eyes of external
stakeholders, as well as the quality of its management team could be tested as antecedents
of licensing success. An improved understanding of the factors that contribute to
licensing success would benefit the managers in that growing number of firms that are
involved in these deals. In the United States alone, technology licensing revenues are
estimated to account for U.S. $45 billion annually; worldwide, the figure is around U.S.
$100 billion (Fosfuri 2006) 27 .
The positive relationship between market knowledge and subsequent sales turnover
established in this research is in line with those numerous studies in the marketing
domain that have established a link between market knowledge / market orientation and
27

Original source: The Economist. 2005. A market for ideas. 20 October: 48–51.
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sales (See Rodriguez Cano et al. 2004 for a meta-analysis). The lack of relationship
between market knowledge and sales growth is probably due to the nature of this growth
in the sample firms. For many firms, this percentage is very high since their initial sales
levels were minimal. In cases where sales growth during first years or months of firm
sales ever is captured, this measure is a biased estimator of the longer term sales potential
of the firm.
The lack of relationships between entrepreneurial opportunities recognized and the
subsequent profit potential measurements (with the exception of equity investments) is
most likely due to the time needed to convert opportunities recognized into actual dollars
or euros. Investors, who base their decisions on the future potential of a venture, are,
indeed, influenced by the amount of opportunities the firm has recognized. However,
more time than the 3.5 years allowed in this research design will need to elapse before
these opportunities are turned into concrete sales or even licensing deals.

Theoretical contribution of the research

This study makes numerous contributions to the literature that addresses
entrepreneurial opportunities and their origins. Contributions to establishing the domain
of entrepreneurial opportunities are reviewed first, after which contribution to
understanding the sources of these opportunities is discussed.
In the current literature on entrepreneurial opportunities there is no consensus
concerning the exact meaning of the entrepreneurial opportunity concept. However,
based on the definitions offered in existing literature this study concludes that some
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unifying themes exist; many researchers share the innovation-emphasis evident initially
in the writings of Kirzner (1979) and Schumpeter (1934b) (See also McMullen et al.
2007). To distinguish from “non-entrepreneurial” opportunities, some researchers have
also added the element of starting a firm. Ultimately, however, the firm is started with the
purpose of introducing a new good or service (McMullen et al. 2007). For the purposes of
this study, entrepreneurial opportunity has been defined as the possibility to introduce
innovative (rather than imitative) goods or services to a marketplace through starting a
firm or through the significant improvement of an existing venture (Inspired especially by
the definitions of Gaglio 2004, 534, Singh 2000, 23, and Mueller 2007, 356). This
definition is specific enough to distinguish entrepreneurial opportunities from the rest of
business opportunities, but it is also wide enough to include multiple contexts (new or
existing firms) where OpR can take place.
There are few attempts in the existing research to quantitatively measure
entrepreneurial opportunities. Those existing studies that have operationalized
entrepreneurial opportunities have made a wealth of implicit assumptions about the
nature of these opportunities but have seldom clearly communicated these assumptions.
For example, a new venture idea that leads to a business startup seems to be the
operationalization of a business opportunity for Baron & Ensley (2006), but the reader
has to infer this from their research design. Busenitz (1996) does not explicitly state what
entrepreneurial opportunities are, but since his empirical research compares managers in
publicly traded large corporations to founders of new ventures it can be assumed that
founders of new ventures have recognized entrepreneurial opportunities whereas
managers in large corporations have not. Young firms are also the incarnation of
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opportunities in the Saemundsson and Dahlstrand (2005) study. Shane’s (2000)
opportunities are startup activities geared at commercialization of a patented technology.
In some studies, the interpretation of what constitutes an opportunity seems to be left to
the respondents of an empirical study (Brown et al. 2001; Ozgen and Baron 2007).
Given the ambiguity in definitions and operationalizations of entrepreneurial
opportunities in previous research, one of the contributions of this study is definitional
clarity. Following the definition of entrepreneurial opportunity for the study,
entrepreneurial opportunity recognition has been separated from opportunity exploitation,
and both constructs have been operationalized after a thorough review of the empirical
context of the study. Even if the general definition of entrepreneurial opportunity
suggested in this study as well as the distinction between recognition and exploitation are
generalizable across time and industries, operationalizations are specific to the context of
biotechnology. To quantify the opportunities recognized by the sample firms we looked
into their product development pipelines to count the number of opportunities. One
aspect related to the complexity of the biotechnology innovation process is that there is
not normally a one-to-one relationship between a specific scientific discovery and a
certain industrial application. Any given biotechnology invention may be used in a
variety of applications and industries (McKelvey et al. 2004), and often firms have to
select which one of the many potential commercialization avenues they want to pursue
for any one invention. Industry-specific issues like this mean that researchers who
operationalize entrepreneurial opportunities in the future should be extremely cautious of
the influence of empirical research context on relevant operationalizations. The
operationalization of “entrepreneurial opportunities recognized” in this study was shown
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to have convergent validity (measurements at two points of time) as well as discriminant
validity (different from “entrepreneurial opportunities exploited”).
The hottest potato in today’s entrepreneurship research is the process of opportunity
recognition. The fresh first issue of Strategic Entrepreneurial Journal includes articles by
leading scholars in the field, and nearly all of them focus, in a way or another, on
opportunity recognition. Many of these contributions center on the question of whether –
or under what circumstances - opportunities are recognized, discovered, or created
(Alvarez and Barney 2007; Baron 2007; Miller 2007; Shepherd et al. 2007) and even
articles that focus on firm internationalization (Bingham, Eisenhardt and Furr 2007) or
users of juvenile products as entrepreneurs (Shah and Tripsas 2007) claim they are
making contributions to opportunity recognition literature. A clear juxtaposition of the
creation vs. discovery view of opportunity recognition (Alvarez and Barney 2007) may
be beneficial for illustrating the conceptual differences between the two approaches, but
in reality one can identify elements of creation, discovery, as well as effectuation
(Sarasvathy 2001b) in most new firm startups. This study concurs with the view that
entrepreneurial opportunities can be discovered based on a technological innovation
(Schumpeter 1934b; Drucker 1985), in which case the supply of technology is known and
demand is unknown (Sarasvathy et al. 2003) and / or they can be discovered because
different market participants have unequal access to information about the market
conditions (customers, markets, and ways to serve markets) (Kirzner 1997; Shane 2000,
2003), in which case the demand in the market is known to some, but the supply has to be
developed.
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Following this logic the findings of the empirical study have shown that both
technology knowledge and market knowledge do contribute to opportunity recognition in
young technology ventures. Firms that come up with most entrepreneurial opportunities
have high levels of both market knowledge and technology knowledge. This finding is in
line with, for example, the suggestions of Amabile (1999), who stressed the importance
of combining market knowledge and technology knowledge in the development of new
ideas. Numerous research insights from the new product development literature also
emphasize the role of divergent knowledge types in recognizing and developing
opportunities (Holt et al. 1984; Rothwell 1992; Cooper 1993; O’Connor and Veryzer
2001). However, there are also studies that have questioned the importance of marketand customer knowledge in the context of radically new innovations (Hamel and
Prahalad 1991; Leonard-Barton 1995; Leonard-Barton and Rayport 1997; Adams et al.
1998; O’Connor 1998; Takayama and Watanabe 2002; Im and Workman 2004; Marvel
and Lumpkin 2007). In the light of the findings of the current study, this body of
literature has underestimated the role of market knowledge in innovative and
entrepreneurial activities.
This study has employed entrepreneurial orientation (firm level construct) as a
substitute of entrepreneurial alertness (individual level construct) in opportunity
recognition. In the discovery-view of entrepreneurial opportunity recognition, where
idiosyncratic market knowledge plays a central role, alertness has been suggested as a
critical antecedent of opportunity recognition (Gaglio and Katz 2001). Supporting this
line of theory, the current study found that a firm’s entrepreneurial orientation enhances
the positive effects that market knowledge has on the number of opportunities
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recognized. Entrepreneurially oriented firms have the methods, practices, and managers
with a decision-making style that promote a willingness to use market knowledge by
engaging in entrepreneurial activities. This finding about the moderating role of
entrepreneurial orientation in the market knowledge – opportunity recognition
relationship has similarities with the findings of Wiklund & Shepherd (2003), who found
that entrepreneurial orientation moderates the relationship between knowledge based
resources and firm performance among Swedish SMEs. Firms with market knowledge
know where to look for opportunities and can more accurately assess the value of
potential opportunities, but unless the firm is willing to take a risk and proactively pursue
these opportunities, its market knowledge is likely to be underutilized. This finding of the
current study can also be interpreted as support for dynamic capabilities arguments; over
and above a firm’s stock of valuable and rare resources – like idiosyncratic market
knowledge - it is how management utilizes those resources that is important in explaining
opportunity recognition. Dynamic capabilities include difficult-to-replicate enterprise
capabilities required to adapt to changing customer and technological opportunities
(Teece 2007). Entrepreneurial orientation is a dynamic capability (Wiklund and Shepherd
2003) in a sense that it tells about a firm’s capacity to sense and shape opportunities and
threats, as well as its capacity to seize opportunities (Teece 2007).
Even if the contribution of market knowledge to opportunity recognition has been
widely discussed, researchers yet have to focus their attention on opportunity exploitation
in addition to opportunity recognition. Depending on the industry context, the paths from
opportunity recognition to opportunity exploitation vary, and in biotechnology that path
is particularly long and risky. The results of the empirical study have shown that market
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knowledge significantly and positively contributes to three out of four profit potential
measures, which illustrate a firm’s decision to exploit opportunities. This finding
concerning the importance of market knowledge in opportunity exploitation is in line
with Choi & Shepherd (2004). They find that entrepreneurs who believe that customers
will value their new product(s) are more likely to proceed with exploitation.
Entrepreneurs will need to resolve some of the uncertainty surrounding market demand
before they can determine whether their new product is sufficiently valuable to commit to
its full-scale exploitation (Choi and Shepherd 2004). A main mechanism for lowering
such demand uncertainty is increased market knowledge, achieved through market
research.

Managerial contribution

The managerial advice that can be derived from these research results applies to young
technology intensive firms operating – obviously – in the field of biotechnology, but also
in other technology intensive fields. Opportunity recognition is important for firm
renewal and continued success. Essentially, the study results show that there is no one
way to success in opportunity recognition. Firms that want to stay in the forefront of
innovation have to invest in technology knowledge as well as market knowledge. In
addition, they have to ensure that the firm stays alert to opportunities arising from the
environment. Hence, an organizational posture that emphasizes innovativeness,
proactiveness, and risk taking is beneficial when it comes to opportunity recognition.
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In a science driven field like biotechnology, investments in the development of market
knowledge base are often forgotten. Even though low hierarchies and centralization of
small organizations usually make firms’ internal communication easier, managers should
still pay special attention to the challenges of bridging boundaries between the scientific
and business personnel. At best, everyone in the firm is aware of the customer- and
competitor-related aspects, and can channel market information from the environment to
the firm whenever possible.
As far as acquisition is a preferred exit strategy for a young technology firm,
investments in market knowledge should be especially beneficial. Even if the current
study can only speculate about the mechanisms through which market knowledge of a
young venture has a positive effect on its subsequent likelihood to be involved in a
merger or acquisition, a significant relationship was detected between market knowledge
and subsequent M&A.
This study has also shown that market knowledge has positive effects on sales,
technology licensing, and capital invested in the firm. Because biotechnology start-ups
are often early entrants to their respective fields, they may be compelled by the scientific
advances and demonstrate low levels of market knowledge and orientation in the absence
of direct market competition. However, the positive linkages detected here between
market knowledge and the three important aspects of a young venture’s profit potential
should urge managers to invest in market intelligence generation and efficient
dissemination within their respective organizations.
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Limitations of the study

Empirical estimation of knowledge and its production and transfer is challenging.
Research results concerning knowledge, innovation and technological change have been
shaped by the nature of the data that has been available to scholars for analyses. Such
data have always been incomplete (Acs and Audretsch 2005), and this research is no
exception.
The main limitations of this study include single informant bias and limited statistical
conclusion validity as a result of the small sample size. The single informant problem is
typical for studies conducted in small firm settings. In this study, comparisons of patent
figures as well as sales turnover reported by the interviewees with data from secondary
sources were completed to ensure the reliability of the data. These comparisons indicate
that even though the self-reported numbers are not exactly similar to those available from
the secondary sources, there is no evidence that the measurements used would be biased
estimators. Also other tests that were reported under “Single respondent bias” provided
comforting evidence confirming the absence of this problem.
Most of the limitations of this study result from time and resource constraints in the
data collection. Had the initial sample size of firms interviewed in 2003-2004 been larger,
the final longitudinal sample could also have been more sizeable than the current 42
firms. Regardless of the small sample size, however, a longitudinal study provides a
better understanding of the nature of the relationships between market- and technologyrelated variables, opportunity recognition, and profit potential than what a cross sectional
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study would. Within a longitudinal sample of young ventures the amount of company
exits between data collection efforts is, unfortunately, bound to be substantial.
An additional limitation of this research – like many other studies - is the reliance on
self-reported judgments. While appropriate to the design, future research might combine
internal self-report measurements with other internal and external measurements, which
would enhance the generalizability of the findings.
The empirical data in this study was collected from a single industry, namely medical
biotechnology. Biotechnology markets are a prime example of markets for technology
(Arora et al. 2001). In addition to biotechnology there are numerous fields of business
that share similar market features typical of markets for technology. The results of this
study can and should be applicable within the context of a number of other knowledgeintensive, high-technology industries. As examples of markets for technology, Arora et
al. (2001) discuss, for example, the growing market for chip design modules in the
semiconductor business as well as the software, biotechnology and chemical processing
markets. All these industries rely heavily on science and technology, and are dynamic
fields where companies constantly need to reinvent themselves to stay in the forefront of
competition. What is more, in all these industries specialization relies heavily on patents
and intellectual property rights. Patents are increasingly being used as a means to define
the property rights on inventions to facilitate the trade of these property rights; the
creation and enforcement of intellectual property is extremely important. These
similarities described here lead to the conclusion that even though biotechnology is, in
many respects, a special kind of industry, the relationships detected in the empirical study
should be applicable in some other contexts as well.

183

The empirical study firms come from five locations on two continents. This has
benefits for external validity. Even though firms in the US differ from those in Finland
and Sweden along some criteria (most importantly, US-based firms have recognized
more opportunities than the Nordic firms), there were no major differences between US
vs. Nordic firms as far as the profit potential of the ventures, their market knowledge, or
their technology knowledge are concerned. This is strong evidence of the external
validity of the research results across geographical locations.
The final limitation of the study is the nature of the main dependent variable of the
study, namely “entrepreneurial opportunities recognized”. Even if the number of
therapeutic areas where an invention can be applied is a part of this measure, it is still
largely a measure of quantity rather than quality. Hence, even if the measure tells about
the amount of opportunities recognized in a firm, it is a poor measure of the market
potential of these opportunities. This may be another 28 reason why opportunities
recognized by a firm in phase 1 of the study were only related to one out of four profit
potential measures in phase 2. A firm can invent and patent endlessly, but unless those
inventions actually have market potential they will not lead to positive commercial
outcomes.

28

The reason for the lack of these relationships identified earlier is the short (relatively speaking, in the
context of biotechnology R&D) time lag of approximately 3.5 years between the two data collection
efforts.
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Future research directions

In addition to the “usual suspects” for future research directions (need for a longer time
lag between he measurement of opportunity recognition and exploitation, need to collect
more objective data about young, small firms, and the need to expand the geographic
scope of this study to further increase external validity), I would like to mention some
not-so-obvious ideas for future research in addition to the ideas that have already been
expressed earlier.
First and foremost, clear definitions of constructs employed in entrepreneurial
opportunity research would greatly advance the development of the field, regardless of
the specific research questions asked. Currently, too many researchers are not specific
enough about what they really mean by entrepreneurial opportunities.
Even if such relationship was not hypothesized, a significant positive association was
discovered in the current study between market knowledge and ending up acquired or
merged. This insight is not captured in the existing empirical literature on market
orientation or market knowledge. An interesting question for future research is why is
there such a relationship? In the current biotechnology environment, where opportunities
for investors’ successful exit through an initial public offering are few (Ernst&Young
2007), M&As offer an alternative exit strategy and improved liquidity. Are acquirers
more interested in more market oriented small firms because these firms already have
clear, market derived goals for their product development? Or are small firms that are
knowledgeable of their markets better in identifying potential partners for merger /
acquisitions? Research into the factors that contribute to a successful M&A as an exit
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strategy could provide valuable information not only for theory development in the area,
but also for managerial purposes.
Future research in the field of opportunity recognition should boldly tackle the
challenge of operationalizing concepts such as alertness, heuristics, knowledge based
resources, entrepreneurial opportunity recognition, and exploitation in multiple contexts.
A wealth of conceptual literature, including many conceptual models waiting to be tested
empirically, already exists. The field would benefit from further empirical research,
where operationalizations are context specific enough so that they actually measure the
proposed constructs. Even the kinds of knowledge- measurements used in this study are
not applicable to all kinds of contexts. Measurement of technology knowledge with
patents assumes that patents are a primary way for protecting that knowledge. This is not
the case in many industries (and countries). Even the market knowledge measure used in
this study, which has been widely used before within marketing literature, had to undergo
some transformations before it could be applied in the context of young biotechnology
ventures.
Future scholarship should also develop our understanding of opportunity exploitation
to complement recent works on opportunity discovery and recognition. All recognized
opportunities are not exploited by entrepreneurial firms, and a fine-grained analysis of the
attributes of the opportunities that end up exploited would be beneficial. Based on the
current research we know that market knowledge does contribute to licensing out
technologies, which can be considered one form of opportunity exploitation. However,
what are the other firm- and opportunity related characteristics that contribute to an
opportunity being exploited? We also know that market knowledge has a positive effect
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of investors’ willingness to invest in the firm as well as firm sales, but there are certainly
a wealth of other factors as well that contribute to opportunity exploitation and even
interact with the effect of market knowledge. For example, opportunities produce new
products that could be considered rare (Choi and Shepherd 2004). The level of this rarity
may moderate the relationship between market knowledge and opportunity exploitation.
In conclusion, this dissertation shows the value and importance of market knowledge
and technology knowledge as well as an entrepreneurial company posture for opportunity
recognition in young high technology ventures. Furthermore, it has shown that new
ventures with more market knowledge are able to gather more equity investments, license
out more technologies, and achieve higher sales than new ventures with lower levels of
market knowledge. Equity investments are also affected by the firm’s historical record in
opportunity recognition. Most likely, a future research with an extended time lag between
the measurement of opportunity recognition and sales /technology licensing will show
that also these outcomes are influenced by firm’s record in opportunity recognition.
Overall, the findings of this dissertation help further our understanding of the sources of
entrepreneurial opportunities, and should encourage further research in this area.
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Appendix 1: Questionnaire

SURVEY QUESTIONNAIRE
RESEARCH ON ENTREPRENEURIAL OPPORTUNITIES IN
BIOTECHNOLOGY FIRMS
Dear Biotechnology Professional,
Thank you for your assistance in this research project that will help to understand the mechanisms through
which market knowledge contributes to biotechnology firm success. I recognize that your time is extremely
valuable.
Please follow the instructions on the survey form to fill in the blanks and to circle or check the answers of
your choice. If you have any comments on the survey, please do not hesitate to write them down in the
space provided on the last page. Once you have filled in the survey, please return it in the stamped
envelope.
Because of the nature of the survey, it is important that you complete the questionnaire yourself. Please
return the completed questionnaire as soon as possible.
Sincerely,
Maija Renko, D.Sc.
Visiting Assistant Professor
Eugenio Pino and Family Global Entrepreneurship Center
Florida International University, Miami
Maija.renko@fiu.edu
786-218-2739
Company name

Year
founded

Your name
Your position
Your e-mail address
Your highest earned
educational degree
Field of this highest earned
educational degree
Today’s date
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Section A
1. Who are the customers of your firm?

2. Who are the competitors of your firm?

3. What are the most important sources of market related data for your firm?

4. What kinds of challenges are there when you try to integrate market data into your research
and development (R&D)?

5. How would you describe the relations between people working in marketing or sales in your
firm and other “departments”, like R&D?
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Section B
Please rank these performance indicators with the scale
given on the right.
Please circle one number for each statement.

1
very
weak

2
weak

3
neutral

4
good

5
very
good

1.Our firm’s overall performance relative to major
competitors last year.

1

2

3

4

5

2. Our firm’s success in completing business deals with
other firms last year.

1

2

3

4

5

3. Capital invested in our firm last year relative to major
competitors.

1

2

3

4

5

4. Our firm’s progress in the development of our lead
product last year.

1

2

3

4

5

5.Our firm’s progress in overall product development
last year.

1

2

3

4

5

6. Only firms with sales: Our firm’s market share
growth in our primary market last year.

1

2

3

4

5

7. Only firms with sales: Our firm’s sales growth last
year.

1

2

3

4

5

Section C
To what extent does each of the following
1
2
5
philosophies help guide your business operation? Does not
4
Does not
Describes
3
For each statement on the left, please circle one describe
Describes
describe Neutral
my firm
number.
my firm
my firm
my firm
very well
at all
1. The key to business success is producing quality
goods and services at a reasonable cost. Good
products and services sell themselves. If possible,
1
2
3
4
5
products and services should be standardized to
keep costs down.
2. The key to business success lies in persuading
potential customers to buy your goods and
services, through advertising, personal selling, or
other means. Potential customers must be informed
and convinced of the benefits of the products.

1

2

3

4

5

3. The key to business success is to integrate all
company activities and personnel toward satisfying
customers, while providing satisfactory profits to
the firm. The firm should find out what benefits
customers want and then provide these benefits
through goods and services.

1

2

3

4

5
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4. The key to business success lies in satisfying the
important ‘‘publics’’ of the company. These
publics include customers, employees,
stockholders, governmental agencies, suppliers,
and the public at large. All of their interests should
be considered when making decisions.
5. The key to business success is the ability and
will to acquire a substantial technological
background and use it in the development of new
products / services. This includes the activities of
R&D as well as technological scanning. Success is
achieved by being more innovative than
competitors.

1

2

3

4

5

1

2

3

4

5

Note: In the original questionnaire the line spacing and font were different from what is shown here, and
the sections followed directly after one another. Here, the dissertation margin requirements force extra cut
to the questionnaire.
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Section D
Please indicate how well the following descriptions
5
1
apply to your company.
2
3
4
strongly
strongly
Please circle one number for each statement.
disagree neutral agree
disagree
agree
1. Our company meets end-customers or potential endcustomers of our products at least once a year to find
out what their future needs are.

1

2

3

4

5

2. Our company meets opinion leaders (e.g. recognized
medical doctors) at least once a year to find out about
the future needs of our end-customers.

1

2

3

4

5

3. Individuals from our R&D and / or manufacturing
department interact directly with customers to learn
how to serve them better.

1

2

3

4

5

4. Our company conducts market research in-house.

1

2

3

4

5

5. Our company outsources market research.

1

2

3

4

5

6. Our company subscribes to industry (market)
databases

1

2

3

4

5

7. Our company is slow to detect changes in our
customers’ or potential customers’ product/service
preferences.

1

2

3

4

5

8. We often talk with or survey those who can influence
our end-users purchases (e.g. medical doctors)

1

2

3

4

5

9. We collect industry information by informal means
(e.g. lunch with industry friends)

1

2

3

4

5

10. In our company intelligence on our competitors is
generated independently by several individuals /
departments.

1

2

3

4

5

11. Our company is slow to detect fundamental shifts in
our industry (e.g. competition, technology, regulation).

1

2

3

4

5

12. Our company periodically reviews the likely effect
of changes in our business environment on customers
(e.g. regulation, competition, technology).

1

2

3

4

5

13. A lot of informal “hall talk” in our company
concerns our competitors’ tactics or strategies.

1

2

3

4

5

14. Our company holds regular interdepartmental
meetings to discuss market trends and developments.

1

2

3

4

5
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Please indicate how well the following descriptions
5
1
apply to your company.
2
3
4
strongly
strongly
Please circle one number for each statement.
disagree neutral agree
disagree
agree
15. Our company holds regular meetings with other
companies to discuss market trends and developments.

1

2

3

4

5

16. Our company’s marketing personnel / business
development personnel spends time discussing
customers’ future needs with the other functions.

1

2

3

4

5

17. Our company periodically circulates documents
(e.g. newspapers, e-mail alerts) that provide
information on customers.

1

2

3

4

5

18. When something important happens to customers in
our (potential) markets, the whole company knows
about it within a short period.

1

2

3

4

5

19. Our company disseminates data on customer
satisfaction at all levels in the company on a regular
basis.

1

2

3

4

5

20. There is minimal communication between people in
this firm concerning market developments.

1

2

3

4

5

21. There is a lot of market related communication
between individuals in our top management team.

1

2

3

4

5

22. When someone in our firm finds out something
important about the market (e.g. customers,
competitors), (s)he is slow to share this information
with others.

1

2

3

4

5

23. Our company interacts with regulators and
legislators that determine industry standards.

1

2

3

4

5

24. Understanding markets drives new product
development efforts in this company.

1

2

3

4

5

25. For one reason or another, our company tends to
ignore changes in our customer’s product/service needs
(e.g. make no response to the changes)

1

2

3

4

5

26. Our company periodically reviews our
product/service development efforts to ensure that they
are in line with what customers or potential customers
want.

1

2

3

4

5

27. Our business plans are driven more by
technological advances than by market research.

1

2

3

4

5
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Please indicate how well the following descriptions
5
1
apply to your company.
2
3
4
strongly
strongly
Please circle one number for each statement.
disagree neutral agree
disagree
agree
28. Several departments get together periodically to
plan a response to changes taking place in our business
environment.

1

2

3

4

5

29. Our firm gets together periodically with other
firms/organizations to plan a response to changes taking
place in our business environment.

1

2

3

4

5

30. The product lines we develop depends more on
internal politics than real market needs.

1

2

3

4

5

31. We are quick to respond to changes in the way our
competitors behave.

1

2

3

4

5

32. The activities of the different departments or
functions in our company are well coordinated.

1

2

3

4

5

33. Our company takes no action on customer’s
complaints.

1

2

3

4

5

34. Our company educates customers (or potential
customers) in the use of our products.

1

2

3

4

5

35. Even if our company came up with a good
marketing plan, our company probably would not be
able to implement it in a timely fashion.

1

2

3

4

5

36. Our company has little interaction with industry
regulators and legislators.

1

2

3

4

5

37. When we find out that customers are unhappy with
the quality of our product / service, we take corrective
action immediately.

1

2

3

4

5

38. When a product of our company is (will be) on the
market we modify (will modify) it if our customers
would like us to do so.

1

2

3

4

5
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Section E
Since June 2004, what is the number of …
1. New inventions for which the firm has filed
domestic or international patent application(s):
2. Therapeutic areas where these inventions are
useful (your own estimate):
3. End products that are / have been developed
based on this/these inventions in your firm or your
partners:
4. Domestic patent applications:
5. International patent applications (The same
application submitted to multiple countries counts
as one):
6. Domestic patent approvals:
7. International patent approvals (The same
approval in multiple countries counts as one):
8. New product introductions to the markets:
9. New product development projects started:
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Please insert number in
this column

Section F
Please circle the number on the scale (in the middle column) that best describes your
company:
2= description in the left hand column
describes your firm more than
description in the right hand column

4= description in the right hand
column describes your firm more
than description in the left hand
column

3=neutral

5=description in the right hand
column describes your firm very
well

1=description in the left hand column
describes your firm very well

A. How many new lines of products or services has your firm marketed since the year 2000?
Very many new lines of products or
No new lines of products or services
1 2 3 4 5
services
Changes in product or service lines
have been mostly of a minor nature

1

2

3

4

5

Changes in product or service lines
have usually been quite dramatic

B. How many new lines o f products or services does your firm have under research and
development right now?
Very many new lines of products or
No new lines of products or services
1 2 3 4 5
services
C. In general, top managers in my firm favor….
A strong emphasis on R&D, technoA strong emphasis on the marketing
1 2 3 4 5
logical leadership, and innovations
of tried and true products or services
D. In dealing with competitors, my firm . . .
Is very seldom the first business to
introduce or involve in the
development of new
1 2 3
products/services, administrative
techniques, operating technologies,
etc.
E. In dealing with competitors, my firm . . .
Typically seeks to avoid cornpetitive
clashes, preferring a "live-and-let1 2 3
live" posture
F. In general, the top managers at my firm . . .
Have a strong proclivity for low-risk
1 2 3
projects (with normal and certain
rates of return)
G. In general, the top managers at my firm . . .
Believe that, owing to the nature of
the environment, it's best to explore
1 2 3
it gradually via careful, incremental
behavior

Is very often the first business to
introduce or involve in the
development of new products/services,
administrative techniques, operating
technologies, etc.

4

5

4

5

4

5

Have a strong proclivity for highrisk projects (with chances of very
high returns)

5

Believe that, owing to the nature of
the environment, bold, wide-ranging
acts are necessary to achieve the
firm's objectives

4

Typically adopts a very competitive,
"undo-the-competitors" posture

H. When confronted with decision-making situations involving uncertainty, my firm. . .
Typically adopts a cautious, "waitTypically adopts a bold, aggressive
and-see" posture in order to
posture in order to maximize the
1 2 3 4 5
minimize the probability of making
probability of exploiting potential
costly decisions
opportunities
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Section G
Drug discovery/ development company
1. The nature of your
business and the
biotechnology industry
(Please check all that
apply)

Fully integrated pharmaceutical company
Diagnostics firm
Medical device firm
Tool /platform company
Something else, please specify:

Marketed by our partner company
2. Phase of most advanced
product
(Please check one)

Marketed by our company
Late stage clinical development (III-IV)
Early stage clinical development (I-II)
Preclinical development
Something else, please specify:

We do not currently sell products
3. Do you currently sell
products?
(Please check all that
apply)

We have our own distribution and sales
We sell through a partner company
Our original product(s) is on the market through a licensing
agreement
Something else, please specify:

4. In the future we plan to…
(Please check all that
apply)

Have our own distribution and sales
Sell through a partner company
Have our product(s) on the market through a licensing
agreement
Something else, please specify:
Privately held

5. Firm structure

Publicly held

(Please check one)

Government-owned
University-owned
Something else, please specify:
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6. Our most advanced product will reach the markets OR was launched to the markets in year:
___________

A. Full-time
7. Please fill in the number of employees as at May 2006
B. Part-time

A. Full-time
8. Please fill in the number of employees as at May 2007
B. Part-time

9. Please fill in the approx. annual sales turnover in 2006:
_______________________

Please circle your
currency:
USD
EUR
SEK

11. Share of service sales in 2006:

10. Share of product sales in 2006: __________%

__________%

12. Please fill in the approx. annual sales turnover in 2005:
______________________

Please circle your
currency:
USD
EUR
SEK

14. Share of service sales in 2005:
__________%

13. Share of product sales in 2005: __________%

15. Percentage of sales generated by new products in 2006: ________________%
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16. Technology licensing prior to year 2003 (Please fill in the blanks):
A. Our firm licensed ________ (number of

B. Our firm sold ________ (number of

technologies) proprietary technologies out to ________

technologies) proprietary technologies to

(number of companies) firms.

________ (number of companies) firms.

17. Technology licensing in 2004-2005 (Please fill in the blanks):
A. Our firm licensed ________ (number of

B. Our firm sold ________ (number of

technologies) proprietary technologies out to ________

technologies) proprietary technologies to

(number of companies) firms.

________ (number of companies) firms.

18. Technology licensing since the beginning of 2006 (Please fill in the blanks):
B. Our firm has sold ________ (number

A. Our firm has licensed ________ (number of
technologies) proprietary technologies out to ________
(number of companies) firms.

of technologies) proprietary technologies
out to ________ (number of companies)
firms.

19. Do you have a separate sales / marketing department in your firm?

YES

20. Please fill in the total amount of capital raised by the company by May
2007:
________________________________________________________________

21. R&D intensity
(Please fill in):

NO
Please circle your
currency:
USD
EUR
SEK

R&D expenses comprise _________% of all the expenses of our
company.
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Section H
1. Which one of the following five alternatives best describes your company? (Please check one)
a) Our firm’s most important partnerships with other organizations are actually the
informal contacts (e.g. friendships) the individuals in our management team have.
b) Our firm’s most important partnerships are with a number of (non-profit)
technology partners and universities.
c) Our firm’s most important partnerships are with a number of commercial
companies.
d) Our firm’s most important partnership is actually our relationship with one major,
dedicated partner company.
e) Our firm does not have any important partnerships with outside parties.

2. Which one of the following five alternatives best describes the commercial potential of your firm’s
most advanced product development project? (Please check one)
a) We do not know yet if this product we develop has any commercial potential.
b) We know that this product we develop has commercial potential in a number of
markets (e.g. various indications) but we DO NOT know yet for which market(s)
we actually develop this product.
c) We know that this product we develop has commercial potential in a number of
markets (e.g. various indications) and we DO already know for which market(s)
we actually develop this product. However, we are not selling the product yet.
d) We know that this product we develop has commercial potential in one market and
we aim to launch this product in that market.
e) This product is already marketed and generates sales.
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Comments regarding the survey or specific questions:

THANK YOU!

Return mailing address:
Dr. Maija Renko
Eugenio Pino and Family Global Entrepreneurship Center
Florida International University
11110 Southwest 11th Street
University Park - VH 130
Miami, Florida 33199-0001, USA
Fax: 305-348-0011

223

Appendix 2: Pilot testing of the final questionnaire, relevant issues and actions taken.
Item in the questionnaire

Comment(s) by the interviewees

Action taken

Difficult to assess.

N reporting
(n=10)
2

Firm level data: ROS and % of
sales generated by new products
last year.
Company characteristics and
performance: Number of
therapeutic areas where firm’s
inventions are useful.

How do you define a therapeutic area?

4

Formulating a definition for a therapeutic area.

Company characteristics and
performance: Countries of
international patent approvals.

Impossible to count, patents filed by areas,
e.g. US, EU, not by national states only.

7

Question changed to “Do you file your patents
internationally?”

Company characteristics and
performance: New process
introductions.

What is a process introduction? Not
relevant for small R&D firms.

10

Question dropped.

Questions about collaboration
with other firms to identify market
trends, etc.

Where are the limits of anticompetitive
behavior? Collaboration with competitors
may be illegal.

2

Questions kept as such, but comments taken into
account when analyzing the data.

Subjective performance
assessment on the 1-5 scale

“What do you mean by competitors?”

2

Statement #1 in Business
Philosophy (Section C)

The sentences within the statement are
controversial. You can agree with one part
of the statement but not another.

2

Respondents given the clarification that for each
statement they should think of the relevant
competition in the case of that question.
None. The statement has been used by Harris
2002, Harris 2001, Deng and Dart (1994) and
Peterson (1989)

Section D, MARKOR scale

No departments or even different
“functions” in small firms Æ statements
about dissemination of information not
relevant.

2
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Not an issue for respondents from firms with no
sales. Question kept as such for firms with sales.

None. In each of the 85 interviews the
respondent was encouraged to comment on the
statements that felt irrelevant for his / her firm
for one reason or another.

Appendix 3: Descriptive figures
These tables summarize some descriptives from the sample firms.

Table 29: Position of respondents
Phase 1
N
%
48
57
2
2
19
22
16
19
85
100

Position of the respondent
CEO
Founder
CEO and Founder
Vice President, Bus. Dev.
Total

Phase 2
N
%
25
60
1
2
10
24
6
14
42
100

Field of business

34 %

39 %

1%
19 %

7%

Drug discovery/development company (n=29)
Fully integrated pharmaceutical company (n=1)
Diagnostics firm (n=6)
Medical device firm (n=16)
Tool / platform company (n=33)

Figure 17: Sample companies (phase 1, n = 85) by field of business 29 .

29

Distribution remained similar in phase 2
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Table 30: Phase of most advanced product

Phase of most advanced product
Marketed by our partner company
Marketed by our company
Late stage clinical development (Phase
III-IV)
Early stage clinical development
(Phase I-II)
Preclinical development
Other / Not applicable
Total
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Phase 1
N
%
16
19
24
28
16
19

Phase 2
N
%
8
19
13
31
8
19

6

7

4

10

19
4
85

22
5
100

7
2
42

17
5
101
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